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1 Zusammenfassung 
 
Die Töchter hämatopoetischer Stammzellen können verschiedene Schicksale 
annehmen. Ob die Entscheidung des Zellschicksals während der Zellteilung oder 
danach durch extrinsische Ereignisse die nicht im Zusammenhang zur Teilung 
stehen bestimmt wird konnte bisher nicht geklärt werden. Obwohl asymmetrische 
Zellteilung als möglicher Mechanismus dieser Entscheidung vorgeschlagen wurde, 
konnte weder die asymmetrische Vererbung von Faktoren die das Zellschicksal 
bestimmen noch deren Funktionen in hoch aufgereinigten, lebenden 
hämatopoetischen Stammzellen quantitativ demonstriert werden. Um dieses Problem 
zu addressieren haben wir 17 Kandidaten auswählt und deren Vererbung während 
der Teilung hämatopoetischer Stammzellen in vitro mit Hilfe eines neuen, 
kontinuierlichen und quantitativen biologischen Bildverarbeitungsverfahrens mittels 
mikroskopischer Zeitrafferaufnahmen analysiert. Drei verschiedene in vitro Verfahren 
um symmetrische und asymmetrische Zellschicksale im Hinblick auf Differenzierung 
und Linienentscheidung unterscheiden zu können wurden entwickelt und mit der 
Vererbung der Kandidaten während der ersten in vitro Zellteilung korreliert. 
Durch die quantitative Analyse von über 6000 Zellteilungen konnte gezeigt werden 
das vier Proteine, CD63, VANGL2, SCA1 und LAMP1 während der Zellteilung von 
hämatopoetischen Stamm- und Vorläuferzellen asymmetrisch vererbt werden. Des 
Weiteren konnte gezeigt werden das diese Proteine mit Lysosomen kolokalisieren 
welche ebenfalls asymmetrisch während der Zellteilung von hämatopoetischen 
Stamm- und Vorläuferzellen vererbt werden. Die asymmetrische Vererbung ist dabei 
unabhängig von Zell-Zell oder Zell-Matrix Interaktionen, kann aber durch die Zugabe 
verschiedener Wachstumsfaktoren beeinflusst werden. Die asymmetrische 
Vererbung von Lysosomen scheint dabei weder mit Differenzierung noch mit der 
hämatopoetischen Linienentscheidungen zu korrelieren. 
Die hier dargestellten Ergebnisse unterstützen die Theorie der asymmetrischen 
Zellteilung. Experimentelle Ansätze und Methoden zur kontinuierlichen und 
quantitativen Analyse von Zellteilungen und asymmetrischen Zellschicksalen werden 
diskutiert und dargestellt. 
 
 
Dirk Löffler – Research Unit Stem Cell Dynamics 
 
14 Abstract 
14 
2 Abstract 
 
Hematopoietic stem cells (HSC) give rise to daughters that adopt different cell fates. 
Whether these cell fate decisions are made during division or are determined by 
extrinsic post-mitotic events remains unclear. Although asymmetric cell division has 
been suggested as a mechanism to regulate these decisions, neither the asymmetric 
segregation of cell fate determinants, nor their function has been demonstrated 
quantitatively, in highly purified, living HSCs. To address this issue, we chose 17 
putative cell fate determinants or markers and analyzed their protein segregation 
during in vitro HSC divisions by a novel, continuous, quantitative bioimaging 
approach. Three different in vitro read-outs to distinguish symmetric from asymmetric 
daughter cell fates were established for differentiation and lineage choice and 
correlated to the segregation of candidates during the first in vitro divisions of HSCs. 
Over 6.000 cell divisions were analyzed, providing quantitative evidence that four 
proteins, CD63, VANGL2, SCA1 and LAMP1 are asymmetrically segregating in living 
hematopoietic stem and progenitor cells (HSPCs). We further demonstrate that these 
proteins colocalize to lysosomes which are asymmetrically inherited during HSPC 
divisions. We also show that the degree of asymmetry is independent of cell-cell or 
cell-matrix interactions, but can be actively modulated by the presence of secreted 
growth factors. However, the asymmetric segregation of lysosomes does not seem to 
correlate with differentiation or lineage choice.  
These results contribute further evidence to the asymmetric cell division theory, and 
provide the tools to analyze cells divisions and asymmetric daughter cells fates 
quantitatively over time.  
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3 Introduction 
3.1 Blood 
 
Blood is an important tissue in higher organisms. Its functions are versatile and 
include the transport of various components (oxygen, carbon dioxide, water, 
nutrients, ions, hormones, etc.), thermoregulation, the regulation of the body pH, 
coagulation, osmoregulation, the immune response and hydraulics. Its constituents 
are divided into a liquid part, referred to as plasma, containing proteins, sugars and 
lipids, and a cellular part, named hematocrit, containing erythrocytes, thrombocytes 
and leukocytes. While erythrocytes are responsible for the efficient oxygen transport 
throughout the organism, leukocytes are specialized cells of the immune system. 
Thrombocytes are important for the coagulation process and prevent excess bleeding 
by clotting to close wounds. A healthy human has to generate 1011-1012 new blood 
cells every day in order to maintain homeostasis, numbers that are even exceeded 
during challenge by injury or disease. The highly complex and plastic process of 
blood cell generation is called hematopoiesis. 
A number of diseases are caused or associated with changes in hematopoiesis. 
Leukemia, myelomas and lymphomas are estimated to be the cause of death of over 
54.000 people in the United States in 2013 (Howlader, 2012). A deeper 
understanding about mechanisms regulating hematopoiesis is therefore important to 
develop novel therapies and improve current treatments to reduce the mortality rate 
and to improve the quality of life of patients. 
One of these treatments is based on the transplantation of bone marrow cells from 
either autologous or allogenic sources. The procedure involves the supralethal 
irradiation or chemotherapy of patients to eradicate their functionally compromised 
(i.e. leukemic, anemic) bone marrow. If successful, the eradication is complete and 
the transplant engrafts and repopulates the entire hematopoietic system of the 
recipient. Since its first application in 1959 the number of hematopoietic stem cells 
transplantations is increasing every year with an estimated global number of 50.417 
in 2006 (Gratwohl et al., 2010; Jenq and van den Brink, 2010; Thomas and Blume, 
1999; Thomas et al., 1959). Although techniques to harvest and transplant 
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hematopoietic stem cells are constantly refined, the available material is limited. This 
is especially true for allogenic sources such as umbilical cord blood which is 
increasingly used since incidences of graft-versus-host disease are less frequent and 
severe (Tse and Laughlin, 2005). 
One way to overcome these limitations is the expansion of hematopoietic stem cells. 
However, until today no one was able to expand genetically unmodified HSCs for 
extended periods of time ex vivo. In fact even the prolonged maintenance of HSCs in 
defined stroma and serum free conditions has not been accomplished yet, illustrating 
that the underlying mechanisms are not understood. The reason for this is that the 
research of HSCs is hampered by their extremely low frequency (0.0008% of total 
nucleated BM cells) and their technically challenging analysis. Assays capable of 
reading out stem cell function are time consuming, expensive and allow only 
retrospective conclusions.  
The prerequisite to expand hematopoietic stem cells is the generation of two identical 
daughters. It is generally assumed that this is accomplished by symmetric self-
renewal divisions of the HSC mother cells. Additional division modes such as 
asymmetric cell division and symmetric differentiation division have been suggested 
to participate in the regulation of HSC numbers. However, neither of these modes 
has been observed directly and their role in the regulation of HSC numbers is 
unknown. In order to understand how self-renewal of HSC is regulated and can be 
controlled, a better understanding of HSC division modes is required. The elucidation 
of the underlying mechanisms might pave the way to unravel the mystery of HSC 
self-renewal in homeostasis and disease.  
 
 
 
 
 
 
 
Dirk Löffler – Research Unit Stem Cell Dynamics 
 
17 Introduction 
17 
3.2 Hematopoiesis 
3.2.1 Hematopoietic stem cells 
3.2.1.1 Definition and functional readouts 
 
Hematopoietic stem cells (HSCs) are able to maintain their numbers (self-renewal) 
while giving rise to all differentiated cells of the hematopoietic system for the entire 
life on an organism. This functional definition is based on studies demonstrating that 
the transplantation of a single HSC is sufficient to regenerate the hematopoietic 
system of lethally irradiated mice and that this potential is maintained over multiple 
rounds of consecutive transplantations into secondary or tertiary recipients (Dykstra 
et al., 2007a; Osawa et al., 1996; Sieburg et al., 2011). Although the functional 
definition is constantly redefined, the currently used criteria to demonstrate stem cell 
potential include ≥1% contribution to both myeloid and lymphoid progeny over at 
least 16 weeks in primary and secondary recipients (Dykstra et al., 2007a). Aside 
from their functional definition, HSCs have been demonstrated to be quiescent and 
enter the cell cycle infrequently about every 36-145 days in vivo (Wilson et al., 2008). 
They have been calculated to represent around 0.008% of total nucleated bone 
marrow cells (Osawa et al., 1996) and been shown to efflux dyes like Hoechst33342 
and other chemicals due to the expression of multidrug resistance proteins (MDR) 
(Goodell et al., 1996). Multiple surface antigens have been identified allowing the 
prospective isolation of HSCs with purities around 50% as discussed in section 
2.2.1.2. Although these populations are isolated based on a common 
immunophenotype, HSCs enriched by current purification schemes are highly 
heterogeneous in regard to their repopulation kinetics, lineage bias and durability of 
regenerative potential (Benveniste et al., 2010; Dykstra et al., 2007a; Müller-Sieburg 
et al., 2002; Sieburg et al., 2011). 
In addition to transplantation assays, in vitro surrogate assays have been described 
to detect HSC potential in a shorter period of time, and without ethical constraints. 
Although these assays cannot replace transplantations, they represent a valuable 
tool for screening approaches. One of these assays is called Long-Term Culture-
Initiating Cell (LTC-IC) assay. Hematopoietic cells are seeded in limiting dilutions or 
as single cells onto a stromal cell line (i.e. S17, AFT024) able to support the 
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maintenance of HSC in vitro. After several weeks in culture the number of colonies is 
either determined directly or after re-plating in semi-solid medium. Every colony 
formed is derived from a LTC-IC, of which 50% are able to repopulate the 
hematopoietic system of W41/W41 recipients after 3 weeks of culture on S17 (Cho 
and Müller-Sieburg, 2000).  
Another assay is called Single-Cell Liquid Culture Colony Assay (SC-LCCA). Cells 
that are able to give rise to colonies containing megakaryocytes, erythrocytes, 
granulocytes and macrophages are considered to be multi-potent and have therefore 
been HSCs or early progenitors when initially isolated. The number of cells able to 
give rise to all four lineages correlates well with the number of freshly isolated cells 
capable of repopulating bone marrow upon transplantation. Since the culture 
conditions used only support the generation of myeloid cells, the lymphoid 
differentiation cannot be used as a criterion for multi-potency in this assay. Until 
today, no in vitro culture conditions are described that robustly support the generation 
of all hematopoietic lineages in vitro at the same time. However, keeping the 
limitations of the assay in mind, it provides the means to analyze myeloid lineage 
differentiation of individual cells over a short period of time and is therefore suitable 
for high throughput approaches.   
 
3.2.1.2 Prospective isolation of hematopoietic stem cells 
 
Technical advances in the 1960/70s, in particular the development and 
commercialization of the first fluorescence based flow cytometer (Dittrich W., 1971) 
and the generation of monoclonal antibodies with defined specificity (Köhler and 
Milstein, 1975) made it feasible to analyze and purify heterogeneous cell populations 
based on the presence of cell surface antigens. In 1986, Müller-Sieburg et al. was 
able to accomplish for the first time an enrichment of hematopoietic cells with radio-
protective properties by sorting a Thy-1low population negative for several lineage 
marker (Muller-Sieburg et al., 1986). Since then, various purification strategies 
utilizing fluorescent labeled antibodies or fluorescent dyes have been developed. 
Today, the combination of modern flow cytometers and sophisticated purification 
strategies enables us to reach HSC purities around 50% (Kent et al., 2009; Kiel et al., 
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2005a).In the present study hematopoietic cells with the following immunophenotype 
were utilized: CD150+CD34-CD48-cKIT+SCA1+Lin- 
Table 3.1: Overview about the most common HSC purification strategies. 
Immunophenotype purity References 
CD34-KSL 21% (Osawa et al., 1996) 
KSL Thy1.1low 18% (Wagers et al., 2002) 
SP+ Rholow Lin- 40% (Uchida et al., 2003) 
KSL SP+ CD34- 96% (Matsuzaki et al., 2004) 
CD150+ CD48- CD41- 47% (Kiel et al., 2005b) 
KSL SP+ CD34- 35% (Camargo et al., 2006) 
CD48-CD150+ CD201+ CD45+ 56% (Kent et al., 2009) 
KSL: cKIT+SCA1+Lin-. Population of hematopoietic stem and progenitor cells 
expressing the surface antigens cKIT+ and SCA1+ while being negative or low for 
several lineage marker of mature blood cells, SP: side population. Population 
enriched for HSCs that is not or weakly stained by the fluorescence dye Hoechst. 
Rho: Population that is weakly stained by the fluorescence dye rhodamine. 
 
3.2.1.3 Niche 
 
The major site of hematopoiesis in the adult is the bone marrow. HSCs have been 
found near the endosteum, the interface of bone and bone marrow, as well as 
adjacent to sinusoidal blood vessels (Kiel and Morrison, 2008; Kiel et al., 2005b). 
Cells of both sites have been described to influence the maintenance, quiescence, 
differentiation and migration of HSC by either secreted or membrane bound factors 
and are therefore thought to provide a specialized microenvironment (niche), a 
concept first proposed over 30 years ago (Schofield, 1978). If cells of the endosteum 
and sinusoids represent different parts of a single niche or if they are functionally 
different is currently controversial (Kiel and Morrison, 2008). Recently, these sites 
have been further subdivided by discriminating the sinusoids into vascular and 
perivascular niche, further complicating the issue (Nakamura-Ishizu and Suda, 2013). 
For simplicity we focus on endosteum and sinusoids and describe the cellular 
components of those two anatomical sites separately. 
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3.2.1.3.1 Endosteal niche 
 
The endosteal surface is highly vascularized and is lined with cells of the osteoblastic 
lineage and osteoclasts. Since the number of HSCs increases with the number of 
osteoblasts in vivo, osteoblasts have been suggested to participate in their regulation 
(Calvi et al., 2003; Zhang et al., 2003). In line with this observation, it has been 
shown that the selective depletion of osteoblasts reduces HSC numbers (Visnjic et 
al., 2004). Angiopoietin (ANG1), Thrombopoietin (TPO) and CXC-chemokine ligand 
12 (CXCL12) have been suggested to be secreted by osteoblasts. While TPO and 
ANG1 are thought to maintain HSC quiescence, CXCL12 affects their migration (Arai 
et al., 2004; Petit et al., 2002; Qian et al., 2007; Yoshihara et al., 2007). Notch 
signaling via JAGGED1 has been shown to promote HSC maintenance in vitro (Calvi 
et al., 2003). However, conditional deletion of Jagged1 and Notch1 does not affect 
maintenance of HSC in vivo (Mancini et al., 2005). 
In addition to osteoblasts, osteoclasts have been shown to regulate HSC 
maintenance by secreting CXCL12 or proteases. Matrix metalloproteinase 9 (MPP9) 
and Cathepsin K play important roles in bone remodeling and the release of 
membrane-bound growth factors like stem cell factor (SCF) (Kollet et al., 2006). In a 
recent study, osteoclasts have been shown to be necessary for the initial formation of 
the niche. In this model, the absence of osteoclast activity leads to a reduction of 
osteoblast differentiation and an impaired homing of HSC to the bone marrow 
(Mansour et al., 2012). 
 
3.2.1.3.2 Vascular niche 
 
The vascular niche is thought to consist of specialized blood vessels carrying venous 
blood, referred to as sinusoids, and a variety of perivascular cells, including 
perivascular reticular cells, mesenchymal progenitors, and megakaryocytes (Ding et 
al., 2012; Méndez-Ferrer et al., 2010; Sacchetti et al., 2007; Sugiyama et al., 2006). 
The walls of the blood vessel are comprised of endothelial cells which allow HSC to 
enter or exit circulation. Endothelial cells were initially thought to regulate HSCs due 
to their close proximity in bone sections (Kiel et al., 2005b). This view is supported by 
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studies showing that endothelial cells can promote the maintenance of HSC in vitro 
(Li et al., 2004; Ohneda et al., 1998). Further evidence of this idea comes from a 
recent study showing that deletion of Scf in endothelial cells leads to a reduction of 
HSCs in vivo, highlighting their importance for HSC maintenance (Ding et al., 2012). 
In addition to endothelial cells, several different cell types surrounding the sinusoids 
have been described to influence HSCs. Perivascular reticular cells have been 
shown to express high levels of CXCL12, a factor required for HSC maintenance. 
Interestingly, HSCs seem to localize to CXCL12 secreting cells in the endosteum as 
well as the sinusoids (Sugiyama et al., 2006). Functional evidence comes from a 
study showing that the deletion of Scf in Lepr-expressing perivascular stromal cells 
leads to a reduction of HSCs in vivo (Ding et al., 2012).  
Other cell types such as NESTIN+ perivascular mesenchymal progenitors have been 
associated with a reduction of HSCs in vivo as well (Méndez-Ferrer et al., 2010). 
Non-myelenating Schwann cells have been shown to regulate HSC dormancy via 
localized activation of transforming growth factor β1 (TGFβ1) (Yamazaki et al., 2011). 
In addition, megakaryocytes, monocytes and t-cells have been suggested to be parts 
of the vascular niche (Avecilla et al., 2004; Chow et al., 2011; Li et al., 2012; Winkler 
et al., 2010). 
 
3.2.1.4 Signaling 
 
Many either secreted or membrane bond growth factors have been suggested to 
regulate the maintenance of HSCs (Kent et al., 2008b; Yamazaki et al., 2007). Three 
of these growth factors, namely stem cell factor (SCF), thrombopoietin (TPO) and 
transforming growth factor β1 (TGFβ1) have commonly been used to study HSCs 
divisions in vitro and have been demonstrated in different combinations to be able to 
maintain HSCs for  limited amounts of time (Ema et al., 2000a; Takano et al., 2004; 
Yamazaki et al., 2009).  
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3.2.1.4.1 Stem cell factor (SCF) 
 
Stem cell factor (SCF) was among the first cytokines reported to affect HSC function. 
It binds the receptor tyrosine kinase c-KIT and is essential for HSC maintenance 
since stem cells isolated from mice deficient for Scf are not capable of maintaining 
repopulation activity (McCarthy et al., 1977). Mutations in c-KIT are frequently 
associated with impaired HSC function as well (Kent et al., 2008a). Almost all in vitro 
culture conditions used today intended to either maintain or expand HSCs contain 
SCF.  
 
3.2.1.4.2 Thrombopoietin (TPO) 
 
Thrombopoietin (TPO) is thought to regulate HSC self-renewal given that knock-out 
mice of either Tpo itself or its receptor c-Mpl have reduced numbers of HSCs 
(Alexander et al., 1996; Carver-Moore et al., 1996). The accelerated cell cycle 
kinetics of HSCs derived from c-Mpl deficient mice have led to the conclusion that 
TPO/c-MPL signaling is important for HSC maintenance by regulating their dormancy 
(Yamazaki and Nakauchi, 2009). Although TPO seems to be required for HSC 
maintenance in vivo its effects on in vitro cultured HSCs are controversial.  
A study conducted by Ema et al. using single cell transplantation assays, suggested 
that HSCs cultured in SCF and TPO maintain their self-renewal capacity more 
efficiently than in other culture conditions using combinations of SCF, Interleukin-3 
(IL3) and Interleukin-6 (IL6) (Ema et al., 2000a). These results were confirmed by 
Takano et al. who showed that HSCs cultured in SCF and TPO maintain their in vitro 
multi lineage differentiation potential more efficiently than in other culture conditions 
(Takano et al., 2004).  
However, there are also reports suggesting that TPO exerts negative effects on the in 
vitro self-renewal of HSCs. NUP98-HOXA10hd is an engineered fusion protein 
capable of stimulating a >1000 fold in vitro expansion of murine HSCs. Sekulovic et 
al. demonstrated that the in vitro culture conditions influence NUP98-HOXA10hd 
mediated HSC expansion. Several cytokine combinations were compared and could 
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be grouped into positive and negative regulators. Interestingly, although the NUP98-
HOXA10hd mediated expansion could be observed in all culture conditions, the 
expansion was significantly reduced as soon as TPO was present (Sekulovic et al., 
2011). In another study CD34-KSL transplanted after an extended in vitro culture for 
7 days in SCF and TPO had strongly reduced repopulation activity suggesting that 
the presence of TPO alone is not sufficient to maintain HSCs for longer periods of 
time (Noda et al., 2008). 
 
3.2.1.4.3 Transforming growth factor-β1 (TGFβ1) 
 
Transforming growth factor β1 (TGFβ1) is a suppressive cytokine known to 
negatively regulate the proliferation of various cell types, including hematopoietic 
progenitor cells and populations enriched for hematopoietic stem cells (Keller et al., 
1988; Sitnicka et al., 1996). In addition to its effect on proliferation, TGFβ1 has been 
shown to suppress HSC differentiation in vitro (Sitnicka et al., 1996; Yamazaki et al., 
2009). It has also been reported to induce their hibernation by inhibiting the formation 
of lipid raft clusters, a process thought to be required for successful signal 
transduction (Yamazaki et al., 2009). The relevance of TGFβ1 signaling for the 
maintenance of HSC quiescence in vivo was recently demonstrated. HSCs isolated 
from TGFβRII /-Rag2-/- mice have reduced long-term repopulation activity and 
enter the cell cycle more frequently (Yamazaki et al., 2011). 
 
3.2.1.5 Heterogeneity 
 
The HSC compartment was long thought to be homogenous, consisting of stem cells 
with equal self-renewal capacity and differentiation potential (Blackett et al., 1986; 
Muller-Sieburg et al., 2012). Early experimental results pointing towards 
heterogeneous behavior of HSCs were explained by stochastic or random events 
controlling self-renewal and differentiation (Ogawa et al., 1983; Suda et al., 1984b; 
TILL et al., 1964). It was only until about 10 years ago that carefully carried out single 
cell transplantation studies revealed a tremendous amount of heterogeneity in regard 
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to self-renewal capacity, differentiation propensity, kinetics of maturation and 
durability of contribution (Challen et al., 2010; Dykstra et al., 2007b; Morita et al., 
2010; Müller-Sieburg et al., 2002). Although the degree of heterogeneity depends on 
the purification strategy used, patterns within the observed heterogeneities emerged, 
pointing towards the existence of HSC subsets biased in their differentiation potential. 
These subsets are defined by the ratio of lymphoid to myeloid cells in the peripheral 
blood of recipients. While balanced-HSCs have comparable numbers of lymphoid 
and myeloid cells, myeloid-biased HSCs have a lower lymphoid to myeloid cell ratio. 
Lymphoid-biased HSCs on the contrary are characterized by a high lymphoid to 
myeloid cell ratio (Müller-Sieburg et al., 2002). The interrelationship between different 
HSC subpopulations is currently not well understood and it has yet to be determined 
if the different HSC subsets are organized in a hierarchy or if they were initiated 
“independently” during the development of the hematopoietic system (Muller-Sieburg 
et al., 2012). Since the lineage bias is stably inherited over several rounds of self-
renewal and even daughters transplanted into different recipients show the same 
lineage propensity, the lineage bias seems to be an intrinsic property of HSCs, 
arguing for the diversification of HSCs during development (Muller-Sieburg et al., 
2012). Others have shown that CD150highmyeloid-biased HSCs are able to give rise 
to CD150negativelymphoid-biased HSCs but not vice versa, implying a hierarchical 
relationship (Morita et al., 2010). The hierarchical model is further supported by the 
observation that myeloid-biased HSC have a higher self-renewal potential (Muller-
Sieburg et al., 2004). 
Recent studies were able to prospectively isolate myeloid and lymphoid biased HSCs 
by flow cytometry using the surface antigens CD150, CD41, CD86 and CD229 
(Gekas and Graf, 2013; Morita et al., 2010; Oguro et al., 2013; Shimazu et al., 2012). 
Although these studies applied different purification strategies and further research is 
required, myeloid-biased HSCs seem to be CD150highCD41+CD86-CD229-/low while 
lymphoid-biased HSCs are contained in the CD150low/neg, CD41-CD86+CD229+ 
population. 
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3.2.2 Classical model of hematopoiesis 
 
In the classical model of hematopoiesis (Figure 2.1) (Akashi et al., 2000; Bryder et 
al., 2006) HSCs are divided into “long-term” (LT-HSC: Lin-c-KIT+SCA1+Flk2-CD34-
CD150+) and “short-term” HSCs (ST-HSC: Lin-c-KIT+SCA1+Fkl2-CD34+CD150+/-) 
highlighting the fact that ST-HSCs are only capable to regenerate the hematopoietic 
system for periods shorter than 16 weeks (Dykstra et al., 2007a). In this model, ST-
HSCs give rise to a cell population termed multipotent progenitors (MPP: Lin-c-
KIT+SCA1+Flk2+CD34+CD150-), cells temporally even more restricted in their 
capacity to repopulate the hematopoietic system. Downstream of the MPPs, 
oligopotent progenitors called common myeloid progenitor (CMP: Lin-cKIT+SCA1-
CD34+FcγRlow) and common lymphoid progenitor (CLP: Lin-c-
KITlowSCA1lowIL7Rα+Flk2hi) with limited differentiation potential appear. While the 
CMP is limited to give rise to the Megakaryocytic-erythroid lineage and Granulocyte-
Macrophage lineage, the CLP is restricted to give rise to lymphoid cells (B-Cells, T-
Cells, Natural Killer Cells). Further differentiation of the CMP leads to the formation of 
Megakaryocyte-Erythrocyte Progenitors (MEP: Lin-cKIT+SCA1- CD34-FcγR-), 
restricted to give rise to Megakaryocytes and Erythrocytes, and the formation of 
Granulocyte-Macrophage Progenitors (GMP: Lin-cKIT+SCA1-CD34+FcγR+), restricted 
to give rise to granulocytes and macrophages. Further subsequent differentiation 
steps finally lead to the formation of all mature blood cells: erythrocytes, 
megakaryocytes, thrombocytes, granulocytes, macrophages, dendritic cells, B-Cells, 
T-Cells, Natural Killer cells and their various subtypes. 
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Figure 3.1: Classical model of the hematopoietic hierarchy (Akashi et al., 2000). 
 
3.2.3 Revision of the hematopoietic hierarchy 
 
Although widely used, the classical model of the hematopoietic hierarchy is highly 
controversial and constantly adjusted. Novel hematopoietic subpopulations are 
discovered by subdividing previously described ones and new branches are added 
while others are removed. One of these population is named the lymphoid primed 
multipotent progenitor (LMPP) and thought to have strongly reduced or no 
megakaryocytic-erythroid potential, while being capable of generating the 
granulocytic-monocytic as well as the lymphoid lineage, a feature clearly distinct from 
classical CMP and CLPs (Adolfsson et al., 2001; Luc et al., 2007). Another 
population is called pre-GMP to illustrate their appearance before the classical GMP 
(Pronk et al., 2007).  
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Figure 3.2: One of several revised models of the hematopoietic hierarchy (Seita 
et al., 2012). 
A recent study, using a more comprehensive approach, combined the gene 
expression data of 39 hematopoietic populations in a common database. The gene 
expression levels were compared to >10.000 publicly available microarrays in order 
to assess absolute instead of relative gene expression levels (Seita et al., 2012). 
Based on the similarity of the populations, the authors deduced a novel 
hematopoietic roadmap (Figure 2.2) and combined elements of the classical 
hematopoietic hierarchy with more recently identified subpopulations. 
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3.3 Asymmetric cell division 
3.3.1 The generation of cellular diversity – different modes of cell 
division 
 
Heterogeneity within the hematopoietic system has long been appreciated. HSCs 
have self-renew potential while giving rise to cells committed to differentiation. These 
committed cells lose their self-renewal capacity and give rise to cells with more and 
more restricted lineage potential to finally generate all different cell types of the 
hematopoietic system. Recent work suggests that even the HSC compartment, 
previously thought to be rather homogenous, consists of a variety of stem cell 
subsets (Muller-Sieburg et al., 2012; Sieburg et al., 2006).  
How this heterogeneity is established and maintained, and in particular how HSCs 
are able to self-renew to stably maintain HSC numbers, while simultaneously 
generating their differentiated progeny has been controversial for decades.  
 
In principle, cellular heterogeneity can be achieved by two distinct mechanisms 
(Horvitz and Herskowitz, 1992): 
 
1) A mother cell gives rise to identical daughters and cellular diversification is 
accomplished by some event later in their life time (symmetric cell division). 
 
2) A polarized mother cell gives rise to daughters that are different from the moment 
of their generation (asymmetric cell division). 
 
Early observations that distinct cytoplasmic domains of the leech egg differentially 
segregate to its progeny lead to the formulation of the hypothesis that two intrinsically 
different daughters can be generated during cell divisions (Horvitz and Herskowitz, 
1992; Whitman, 1878). This idea was supported by later studies of the ascidian egg, 
where tracing of cytoplasmic pigmented areas over several cell divisions correlated 
with the generation of certain tissues (Conklin, 1905; Neumüller and Knoblich, 2009). 
In 1994, the asymmetric segregation of the protein NUMB in the sensory organ 
precursor (SOP) of Drosophila melanogaster could be functionally linked to future 
daughter cell fates for the first time (Rhyu et al., 1994). Since then, more  
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Figure 3.3: Cellular heterogeneity can be explained by two mechanisms 
 
asymmetrically segregating proteins were identified and linked to their future 
daughter cell fates (Neumüller and Knoblich, 2009). Taken together, over a hundred 
years after the hypothesis has been formulated, experimental evidence clearly 
indicates that asymmetric cell division is a common mechanism for cellular 
diversification during development. It is important to point out that the majority of this 
data has been acquired through the observation of the development of organisms 
like Drosophila melanogaster and Caenorhabditis elegans and it is yet unclear if and 
how these concepts apply to somatic tissues, in particular somatic tissue stem cells, 
such as HSCs (Neumüller and Knoblich, 2009). 
 
3.3.2 Different modes of asymmetric cell division 
 
The prerequisite to give rise to daughters with different cellular compositions is the 
establishment of some kind of polarity in the mother cell before or during division. 
This polarity can in principle be established in two ways (Neumüller and Knoblich, 
2009): 
 
1) The polarization of the mother cell is preprogrammed and therefore cell-
autonomous (intrinsic regulation). 
2) The polarization of the mother cell is dictated by the microenvironment (extrinsic 
regulation). 
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Examples for both extrinsic and intrinsic regulation of asymmetric cell division have 
been described in invertebrates and are exemplified below. 
 
3.3.2.1 Intrinsic regulation of asymmetric cell division 
 
The Par protein complex is an example for intrinsically regulated asymmetric cell 
division. It is highly conserved and has been shown to control cellular asymmetry in 
Caenorhabditis elegans, Drosophila melanogaster and vertebrates.  
In the C. elegans zygote the core components of the complex, PAR3, PAR6 and 
PKC3 (aPKC) are distributed along the entire cell cortex. After fertilization, PAR3 and 
PAR6 disappear from the cortex within close proximity to the sperm centrosome. This 
enables PAR2, another component of the complex, to locate to the cortex. The PAR2 
area subsequently expands until an equally sized anterior PAR3/6 and posterior 
PAR2 domain is formed. After the domains have been formed, cortical polarity is 
maintained by inhibitory interactions between anterior and posterior Par proteins. 
While anterior PKC3 phosphorylates PAR2 to prevent its recruitment to the anterior 
part of the cortex, PAR2 inhibits PAR3´s localization to the posterior part. Once the 
cortical polarity is established it is used by a complex machinery to exert unequal 
pulling force upon mother and daughter centrosomes which result in the 
displacement of the mitotic spindle towards the posterior pole of the cells during 
mitosis. The displacement results in the generation of an larger anterior AB and a 
smaller posterior P1 daughter cells (Cowan and Hyman, 2004; Neumüller and 
Knoblich, 2009). 
 
3.3.2.2 Extrinsic regulation of asymmetric cell division 
 
The hub is a cluster of somatic cells located at the apical tip of Drosophila testis. It 
functions as the niche for germ line stem cells (GSC) by secretion of the signaling 
ligand Unpaired. Unpaired maintains GSC by activating the Janus kinase-signal 
transducer and activator of transcription (JAK-STAT) signaling pathway. During 
division the mitotic spindle orients perpendicular to the Hub-GSC interface resulting 
in the displacement of the daughter cell away from the niche (Kiger et al., 2001; 
Yamashita et al., 2003). Since the loss of contact to the niche induces differentiation, 
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GSCs are thought to be preprogrammed to differentiate. GSC differentiation is 
therefore repressed by signals emanating from the niche and differentiation is 
induced by derepression upon loss of contact (Morrison and Spradling, 2008).  
 
While the maintenance of Drosophila GSC has been shown to depend on the contact 
to the hub, intestinal stem cells (ISC), scattered along the basement membrane of 
the mid gut have been suggested to require signals to differentiate (Morrison and 
Spradling, 2008). Upon ISC division, vesicles containing the NOTCH1 ligand DELTA 
are asymmetrically inherited, so that only one daughter receives notch signaling, 
specifying thereby its future fate (Morrison and Spradling, 2008; Ohlstein and 
Spradling, 2007).  
 
Although there are several examples on how the microenvironment can modulate 
stem cell maintenance in invertebrates, it remains unclear if hematopoietic stem cells 
maintain themselves by displacing one daughter out of the niche (Morrison and 
Spradling, 2008).  
 
 
3.3.3 Asymmetric inheritance 
 
The asymmetric inheritance of cell fate determinants is a prerequisite for asymmetric 
cell division. Both intrinsically regulated asymmetric cell divisions as well as divisions 
regulated by the environment have been shown to segregate cellular components 
asymmetrically. The list of cellular organelles and proteins involved is this process 
has grown over the last decade and involves centrosomes (Yamashita and Fuller, 
2008), midbodies (Gromley et al., 2005), midbody remnants (Schink and Stenmark, 
2011), chromatin (Rando, 2007), various cell fate determinants (Rhyu et al., 1994; 
Spana et al., 1995), proteasomes (Chang et al., 2011), aggresomes (Lerit et al., 
2013), various endosomes (Emery et al., 2005) and mitochondria (Lerit et al., 2013). 
Some asymmetric segregations have thereby been observed in various model 
organisms such as S. cerevisae, C. elegans and D. melanogaster suggesting that the 
underlying mechanisms are highly conserved throughout evolution (Neumüller and 
Knoblich, 2009). However, other mitotic asymmetries have so far only been observed 
 
Dirk Löffler – Research Unit Stem Cell Dynamics 
 
32 Introduction 
32 
in cultured cells and their functional relevance remains to be demonstrated 
(Neumüller and Knoblich, 2009). As stated by Horvitz and Herskowitz, “any molecule 
that is asymmetrically segregated could in principle be used to distinguish sister cells 
and hence serve as a developmental determinant” (Horvitz and Herskowitz, 1992). 
 
3.3.4 Asymmetric cell fates 
 
Sister cells that show differences in size, shape or other morphological or 
biochemical features have acquired asymmetric fates. This also holds true for their 
subsequent patterns of cell division and the number or nature of descendants 
(Horvitz and Herskowitz, 1992). Asymmetric fates occur frequently in vivo as well as 
in vitro but it has only been possible for the last 20 years to demonstrate that events 
happening during cell divisions can be responsible for these future differences in 
sister cell fates (Neumüller and Knoblich, 2009; Rhyu et al., 1994; Spana et al., 
1995). Not every asymmetric fate has to be caused by the asymmetric segregation of 
cell fate determinants. Alternative models trying to explain how HSCs decide 
between self-renewal and commitment have been formulated over 30 years ago 
(Ogawa et al., 1983). While some of these models suggested an underlying 
stochastic process, others proposed a more deterministic approach in which for 
instance the microenvironment or growth factors dictate the cellular fates (Korn et al., 
1973; Ogawa et al., 1983; TILL et al., 1964; Trentin, 1971). The asymmetric cell 
division theory is another model proposed to explain how these decisions are made 
and is discussed below.  
 
 
3.3.5 The hypothesis of asymmetric cell division of hematopoietic 
stem cells 
 
The functional demonstration of asymmetric cell division during the development of 
several model organisms (S. cerevisae, C. elegans and D. melanogaster) led many 
scientists to conclude that the same principles apply to other organisms and somatic 
tissue stem cell, such as HSCs. Although it is still unclear if those mechanisms can 
be generalized, the concept of asymmetric cell division has evolved into a paradigm 
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and alternative explanations are often disregarded (Neumüller and Knoblich, 2009). 
The main reason for this is the inconsistent or even incorrect use of the terms 
asymmetric segregation/inheritance, asymmetric cell fate and asymmetric cell 
division.  
As pointed out by others, the asymmetric segregation of cellular components during 
stem cell divisions is not sufficient to demonstrate its function (Horvitz and 
Herskowitz, 1992; Morrison and Spradling, 2008). In other words, asymmetric 
segregation has to be linked to future asymmetric cell fates to be regarded as an 
asymmetric cell division. This concept has been nicely applied to demonstrate 
functional asymmetric cell divisions in C. elegans and D. melanogaster and it is 
therefore surprising that these terms are confused in the hematopoietic field. Many 
examples for apparent asymmetric cell division in the blood field rely on the 
polarization of the mother cell or the asymmetric segregation of specific markers in 
cells fixed during mitosis by single snap shot analysis. Since these techniques are 
intrinsically static, dynamic processes such as cell divisions cannot be analyzed 
reliably. Proteins that are polarized during one phase of the cell cycle might change 
their localization and pattern of distribution in another cell cycle phase. Furthermore 
fixed cells are dead and the influence of putative asymmetrically inherited proteins on 
future daughter cell fates cannot be determined. These reports can therefore only be 
considered as circumstantial evidence (Horvitz and Herskowitz, 1992). Although 
circumstantial evidence might imply the occurrence of asymmetric cell division in 
hematopoietic stem cells, it has yet to be functionally demonstrated.  
 
3.3.6 Circumstantial evidence for asymmetric cell division of 
hematopoietic stem cells 
 
The two prerequisites, neither of which alone is sufficient, to show functional 
asymmetric cell division are the demonstration of 
 
1) asymmetric segregation of cellular components during cell division (or 
asymmetric signaling inputs by asymmetric orientation towards the niche) 
2) asymmetric daughter cell fates that correlate with the asymmetric inheritance of 
cellular components or signals 
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Asymmetric daughter cell fates have been demonstrated over 30 years ago, when 
Suda et al. showed that daughters of in vitro separated murine hematopoietic 
progenitors can differ in their differentiation potential as well as proliferative 
capacities (Suda et al., 1984a, 1984b). These observations were later confirmed with 
human hematopoietic progenitors (Leary et al., 1985) and more recently with 
populations highly enriched for murine HSCs (Ema et al., 2000a; Takano et al., 2004; 
Yamamoto et al., 2013). 
 
Although asymmetric cell division is commonly assumed in many textbooks to be a 
property of HSCs the first reports of asymmetric segregation of cellular components 
in the hematopoietic system were published less than 10 years ago. In 2007, 
Beckmann et al. suggested CD53, CD62L, CD63 and CD71 as proteins that 
asymmetrically segregate in human hematopoietic progenitors in vitro (Beckmann et 
al., 2007). However, since their screen was based on immunofluorescence analysis 
of fixed samples, the future cell fates of the daughters could not be determined and 
the potential asymmetric inheritance in living daughters could not be proven. In 
addition, given the extremely low purity of the used human HSCs (with <1% being 
HSCs) no conclusions about HSCs were possible from this study. In another study 
Wu et al. claimed that numb, the notch signaling inhibitor involved in asymmetric cell 
division in Drosophila melanogaster SOP and neuroblasts, is also asymmetrically 
segregated during the in vitro culture of murine hematopoietic progenitors cultured on 
7F2 or OP9 stromal cells. Although cells from a transgenic fluorescence Notch 
reporter mouse were used to indicate the differentiation status of CD34-KSL by time-
lapse imaging, the technique was solely applied to detect asymmetric cell fates 
(notch signaling hi/low). The asymmetric segregation of NUMB on the contrary was 
determined by classical immunofluorescence analysis of fixed cells. Although indirect 
evidence for its functional relevance was provided by the observation that GFP+ cells 
are in general lower in their NUMB expression level than GFP- cells, the asymmetric 
segregation of numb could not be directly linked to future daughter cell fates. 
In a more recent study Ting et al. used time-lapse microscopy to demonstrate that 
the protein AP2A2, previously shown to bind NUMB and part of the adaptor-protein 2 
(AP-2) heterotetrameric complex in clathrin coated pits can asymmetrically segregate 
during hematopoietic stem and progenitor cell divisions when overexpressed in vitro 
(Ting et al., 2012). Although transplantation assays indicated that AP2A2 
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overexpression slightly increases HSC capacity, which is indicative of AP2A2s 
putative role during HSC cell divisions, differences in daughter cell fates were not 
determined. Importantly, it must also be mentioned that only 7% of all cell divisions 
classified as asymmetric segregations completed mitosis successfully. If this unusual 
high mitotic failure rate is caused by the overexpression of AP2A2 or is indicative of 
an imaging artifact is unclear. Conclusions of this study therefore must be taken with 
caution. Interestingly, in contrast to the previous study of Wu (Wu et al., 2007a), 
HSPCs overexpressing a NUMB-mCHERRY fusion protein cultured on OP9 stromal 
cells did not show any signs of asymmetric segregation of NUMB (Ting et al., 2012). 
 
Asymmetrically segregating proteins have also been identified in dividing T-cells 
upon stimulation by antigen presenting cells (Chang et al., 2007). T-cells labeled with 
CarboxyFluorescein Succinimidyl Ester (CFSE) were transferred into recipients 
infected with recombinant Listeria monocytogenes bacteria. After 32h the undivided 
T-cells were isolated and cultured with Cytochalasin B, an inhibitor of actin 
polymerization, before fixation for subsequent immunofluorescence analysis. Among 
other potential candidates, CD8, PKCζ, IFNγR and NUMB were found to localize 
asymmetrically to one pole of cell doublets arrested in telophase. Although the 
asymmetric segregation of these proteins was not monitored live via time-lapse 
imaging, subsequent flow cytometric analysis of living cells revealed populations 
distinguishable in several features. These populations were shown to differ in their 
protective ability upon transplantation and were therefore correlated with T-cell 
memory and effector fates. A more recent study using the same model was able to 
shed light on the underlying mechanism and could show that the transcription factor 
T-BET is asymmetrically segregated during T-cell division and that its unequal 
appearance is caused by the asymmetric segregation of the proteasome (Chang et 
al., 2011). Additional evidence for asymmetric cell division of T-cells comes from a 
study utilizing an in vitro T-cell / dendritic cell co-culture system. Since PAR3, 
SCRIBBLE, DLG, NUMB and PINS were shown to segregate asymmetrically this 
study suggests that the mechanisms controlling asymmetric cell division in 
Drosophila melanogaster are conserved and used by T-cells (Oliaro et al., 2010). 
 
Recently, B-cells have been shown to asymmetrically segregate proteins via a 
different mechanism that does not seem to depend on prolonged interaction with an 
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antigen presenting cells (Thaunat et al., 2012). Upon activation, B-cells store 
antigens for extended periods of time in an intracellular compartment. This 
intracellular compartment can segregate during B-cell division in symmetric as well 
as asymmetric manner. B-cell daughters receiving more antigens are more potent in 
inducing T-cell proliferation than daughter receiving less.  
 
 
3.3.7 Candidates for asymmetric segregation screen 
 
All proteins previously suggested to be asymmetrically inherited during cell divisions 
in other model organisms, tissues or in hematopoietic cells were considered as 
putative candidates and a selection was cloned as fluorescence reporter fusions into 
lentiviral vectors (i.e. NUMB1, CD63, CD53, etc.). In addition, proteins described in 
other cell types to be either highly polarized themselves or to be part of a polarized 
complex were included (i.e. SCA1, VANGL2, Inversin, Inturned). While some of these 
proteins have been demonstrated to be expressed in HSCs, the expression of others 
was less clear. However, since even proteins that are not expressed in HSCs would 
be useful tools to trace divisions if asymmetric segregations were detected, we did 
not exclude these candidates. Most of the candidates have been reported to be 
associated with endosomes, lysosomes or the cell membrane but also proteins 
associated with the polarity complex (PRKC, PRKCζ), mitochondria (mito) or 
centrosomes (Centrin1) have been included. All these cellular compartments have 
been demonstrated or suggested in different cellular contexts to be asymmetrically 
segregated, polarized or associated with the occurrence of asymmetric daughter cell 
fates. A detailed description of all these candidates would exceed the scope of this 
study but a few are exemplified below. A complete list of all analyzed candidates can 
be found below.  
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Table 3.2: Candidates for asymmetric inheritance screen 
candidate ID Expressed  Localization Reference 
NUMB1 1162 protein endosomal (Wu et al., 2007b) 
CD63 1160 RNA lysosomal (Beckmann et al., 2007) 
CD53 1283 protein endosomal (Beckmann et al., 2007) 
Centrin1 1848 protein centrosome (Yamashita and Fuller, 
2008) 
Prominin1 596 protein membrane (Lathia et al., 2011) 
LAMP1 1980 not reported lysosomal (Bergeland et al., 2001) 
FYVE 1630 protein endosomal (Coumailleau et al., 2009) 
SCA1 1687 protein membrane (Vannini et al., 2012) 
TGFβRI 1979 protein membrane (Yamazaki et al., 2009) 
Inscuteable 1983 Not reported polarity 
complex 
(Kraut et al., 1996) 
PRKC 1282 protein Polarity 
complex 
(Lee et al., 2006) 
PRKCζ 1385 protein Polarity 
complex 
(Chang et al., 2007) 
Musashi-2 1373 protein RNA (Hope et al., 2010) 
Mitochondria 1379 protein mitochondria (Lerit et al., 2013) 
Inversin 1206 Not reported PCP complex (Sugimura et al., 2012) 
VANGL2 1219 Not reported PCP complex (Sugimura et al., 2012) 
Inturned 1218 Not reported PCP complex (Sugimura et al., 2012) 
 
3.3.7.1 NUMB1 
 
NUMB was the first protein shown to determine the fate of daughter cells upon its 
asymmetric segregation during mitosis (Rhyu et al., 1994; Spana et al., 1995). In 
Drosophila, the sensory organ precursor (SOP) gives rise to an external sensory 
organ consisting of a total number of 4 cells, a neuron, its sheath cell as well as two 
supporting cells forming the hair and socket. Upon its initial division the SOP gives 
rise to daughters referred to as pIIa and pIIb. The pIIb cell gives rise to a pIIIb cell 
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and a glial cell. While the glial cell undergoes apoptosis, the pIIIb divides to produce 
the neuron and its sheath cell. The pIIa on the contrary divides only once to generate 
the outer support cells (Neumüller and Knoblich, 2009; Rhyu et al., 1994). NUMB is 
asymmetrically segregated into pIIb, where is has been shown to interact with the 
notch receptor to inhibit signal transduction (Giebel and Wodarz, 2012; Guo et al., 
1996). Although both daughters express NOTCH, only pIIa retains its responsiveness 
to NOTCH ligands due to the absence of NUMB (Guo et al., 1996; Santolini et al., 
2000). The differences in signaling activity lead subsequently to the acquisition of 
asymmetric daughter cell fates. 
NUMB’s role as a cell fate determinant is based on its ability to control the endosomal 
trafficking of other proteins (Couturier et al., 2012; Giebel and Wodarz, 2012). NUMB 
binds the α-adaptin subunit of the adaptor protein complex 2 (AP-2), an interaction 
required for asymmetric cell division in the SOP (Berdnik et al., 2002). Since the AP-2 
complex is a major component of clathrin-coated pits a regulatory role for 
endocytosis was suggested (Santolini et al., 2000). This role was confirmed when 
NUMB was found to regulate the internalization of NOTCH and its positive regulator 
SANPODO, thereby modulating the notch signaling responsiveness during 
asymmetric cell division (Couturier et al., 2012; Giebel and Wodarz, 2012). 
Since its initial discovery as a cell fate determinant, numb has been shown to act in a 
similar fashion in other tissues of Drosophila (i.e. central nervous system, 
malphighian tubules, gut and muscles) and other organisms, for example mus 
musculus (Carmena et al., 1998; Neumüller and Knoblich, 2009). Since it possesses 
a high degree of conservation among different tissues and species, NUMB has been 
suggested to exert similar functions by being asymmetrically segregated during HSC 
divisions. 
NUMB as well as NOTCH1 are expressed in HSCs and have been suggested to 
regulate their maintenance (Duncan et al., 2005; Stier et al., 2002; Wu et al., 2007a). 
This idea was supported by the observation that notch activation by its ligand 
JAGGED1 promotes HSC maintenance in vitro (Calvi et al., 2003). However, later 
reports showing that abrogation of notch signaling by either deletion of Notch1 and/or 
Jagged1, or expression of dominant-negative Mastermind-like1, does not affect HSC 
self-renewal or differentiation. This demonstrates that notch signaling is not required 
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for HSC maintenance in vivo (Maillard et al., 2008; Mancini et al., 2005). In addition, 
simultaneous deletion of Numb and its mammalian homolog Numblike in HSCs did 
not affect HSC self-renewal or differentiation (Wilson et al., 2007). Although these 
reports highlight the controversy about the role of numb/notch signaling in HSCs, the 
later do not exclude a potential function under certain circumstances. However, it 
seems that numb and notch signaling is not required under homeostasis or that their 
loss might be compensated by other mechanisms. 
Whether or not NUMB is segregated asymmetrically during HSC division is 
controversial. Wu et al. reported asymmetric segregation of NUMB in hematopoietic 
stem and progenitor cells, cultured on OP9 and 7F2 stromal cell lines in vitro, while a 
more recent study by Ting et al., using the same stromal cell line, could not confirm 
this observation (Ting et al., 2012; Wu et al., 2007a). This discrepancy might be 
explained by the different experimental approaches. Wu´s observation was based on 
the immunofluorescence analysis of fixed HSPCs (Wu et al., 2007a). Ting and 
colleagues on the other hand were using time-lapse microscopy of living HSPCs 
overexpressing a NUMB-mCHERRY fusion (Ting et al., 2012). Further research is 
required to clarify this issue. Even if Wu´s observations prove to be correct, the 
functional relevance of numbs asymmetric segregation remains to be demonstrated. 
The observation that NUMB low expressing cells tend to have in general lower Notch 
reporter levels is indicative of its function but not sufficient to meet the previously 
stated criteria required to prove asymmetric cell division (Giebel and Beckmann, 
2007; Horvitz and Herskowitz, 1992). 
However, evidence that NUMB is asymmetrically segregating in hematopoietic cells, 
although not necessarily in HSCs, is coming from studies demonstrating asymmetric 
cell division of T-cells (Chang et al., 2007; Oliaro et al., 2010). Interestingly, the 
asymmetric segregation of NUMB in these studies was shown in fixed cells via 
immunofluorescence analysis. 
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3.3.7.2 CD63/MLA1 
 
CD63/MLA1 is an integral membrane protein belonging to the tetraspanin family. It is 
present in tetraspanin-enriched microdomains (TEMs) at the cell surface, but is also 
abundantly localized to late endosomes/multivesicular bodies, lysosome-related 
organelles, lysosomes and exosomes (Hemler, 2005; Pols and Klumperman, 2009; 
Tarrant et al., 2003). CD63/MLA1 is considered to be ubiquitously expressed and is 
used, due to its high abundance in LAMP1 and LAMP2 positive compartments, as a 
lysosomal marker (Metzelaar et al., 1991). It has also been demonstrated to interact 
with MHCII and a role in antigen uptake and/or presentation has been suggested 
(Engering and Pieters, 2001; Glickman et al., 1996; Mantegazza et al., 2004; Peters 
et al., 1991). In another study CD63 was shown to regulate the migration of human 
CD4+ T-Cells by locating CXCR4 from the cell surface to lysosomes, thereby 
reducing the SDF1 responsiveness (Yoshida et al., 2008). Further interaction 
partners include a variety of integrins (α4β1, α3β1, α6β1, LFA-1), tetraspanins 
(CD81, CD82, CD9, CD151), cell surface receptors (CD3. FcεRI), kinases and 
adaptor proteins, highlighting CD63s functional diversity (Pols and Klumperman, 
2009).  
CD63 has been shown to be expressed in murine HSCs at the RNA level (Akashi et 
al., 2003; Forsberg et al., 2005). Its asymmetric segregation has been suggested in 
fixed human cord blood derived CD34+CD133+ hematopoietic progenitor cells via 
immunofluorescence analysis (Beckmann et al., 2007). Beckmann demonstrated that 
in vitro cultured CD63low expressing CD34+CD133+ are more immature due to a 
higher LTC-IC frequency. The direct functional correlation between its asymmetric 
segregation and function however, was not demonstrated.  
 
3.3.7.3 Stem cell antigen-1 (SCA1/Ly-6A/E) 
 
SCA1 is a GPI-anchored surface protein expressed on murine hematopoietic stem 
and progenitor cells (Spangrude et al., 1988). Its function is largely unknown and its 
role in HSC regulation is controversial. It was initially reported that HSPCs derived 
from Sca1-/- mice have impaired competitive short-term repopulation activity as well 
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as a reduced self-renewal, determined by serial transplantation assays (Ito et al., 
2003). However, a later study conducted by Bradfute et al., although confirming 
impaired short-term repopulation activity, did not observe defects in HSC self-
renewal. Instead, a reduction of c-KIT expression, lineage skewing in B-cells, NK-
cells as well as granulocytes and macrophages and a homing defect were reported 
(Bradfute et al., 2005). Although Ito et al. also observed differences in the lineage 
output after transplantations as well, the reported decrease in megakaryocytes and 
platelets does not agree with Bradfute´s observations (Bradfute et al., 2005; Ito et al., 
2003). The differences between these studies might be explained by their use of 
different transplantation techniques. While Ito et al. utilized serial transplantations, 
commonly used as a readout for self-renewal, Bradfute used serial treatment of 5-
Fluorouracil after one round of transplantation, arguing that serial transplantations 
might preferentially read out homing defects (Bradfute et al., 2005). Further studies 
are required to clarify if SCA1 is required for HSC self-renewal. Although it is not 
clear yet if SCA1 is required for self-renewal, it is highly expressed on stem cells and 
early progenitors, not only in the hematopoietic system, but also in other tissues, like 
the mammary glands, dermis, skeletal muscle and others (Holmes and Stanford, 
2007). The down regulation of SCA1 is accompanied with a loss of self-renewal and 
sca-1low expressing hematopoietic stem and progenitor cells have been shown to be 
committed to differentiation (Akashi, 2009). 
Besides its potential role in self-renewal and/or homing, HSC derived from Sca1-/- 
mice have been shown to be insensitive to Interferon α (IFNα) stimulation. INFα 
activates quiescent HSC by activating STAT1 and PKB/AKT signaling which 
subsequently leads to an upregulation of SCA1 (Essers et al., 2009). SCA1 has also 
been suggested to act as a suppressor of TGFβ1 signaling by disrupting the 
heterodimerization of TGFβRI and TGFβRII in the  NMuMG cell line (Upadhyay et al., 
2011). A more recent study reported SCA1 having a negative effect on erythropoiesis 
(Azalea-Romero et al., 2012). This observation is in line with an earlier study 
investigating the differentiation propensities of SCA1low, SCA1mid and SCA1high 
subpopulation, isolated from the EML cell line (Chang et al., 2008). 
As other GPI-anchored proteins, SCA1 is believed to reside in lipid rafts (cholesterol 
rich membrane domains) thought to be involved in the modulation of signaling 
cascades (Horejsí et al., 1999). Lipid rafts, identified by the GM1 marker Cholera 
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toxin B, have been shown to be evenly distributed in the membrane of freshly 
isolated hematopoietic CD34-KSL cells. After stimulation with growth factors in vitro, 
lipid rafts form clusters and intracellular signaling pathways are activated. Treatment 
of HSCs with the cholesterol depleting agent methyl-β-cyclodextrin (MβCD) prevents 
lipid raft clustering and abrogates intracellular signaling (Yamazaki et al., 2006).  
SCA1 has not been shown to segregate asymmetrically so far. However, based on its 
location in lipid rafts we speculated that upon cytokine stimulation SCA1 might cluster 
along with other lipid raft associated proteins and that the clusters might segregate 
asymmetrically during HSC division in vitro. The idea is supported by a recent study, 
investigating the effect of different growth factors on lipid raft clusters in 
hematopoietic CD150+KSL in vitro. As expected, cytokine stimulation induced SCA1 
clustering, a process that was inhibited by MβCD treatment (Vannini et al., 2012). 
 
3.3.7.4 Vang-like 2 (VANGL2/Loop tail) 
 
VANGL2/Loop tail is a four-pass trans membrane protein and a core component of 
the Frizzled/planar cell polarity (PCP-) complex (Seifert and Mlodzik, 2007). The 
PCP-complex is evolutionary conserved from D. melanogaster to vertebrates and 
controls proper cell orientation within tissues. This orientation is achieved by the 
polarized localization of PCP-complex proteins within cells. In a recent study, 
Sugimura et al. demonstrated, using a Scl-tTA inducible H2B-GFP reporter mice to 
identify label retaining cells, that quiescent but not actively cycling hematopoietic 
CD34-CD135-KSL express the PCP-Components CELSR2/Fmi and Frizzled-8 (FZ8) 
(Sugimura et al., 2012). CELSR2 and FZ8 have been shown to be highly polarized 
and to predominantly localize at the interface to N-Cadherin (N-CAD) positive 
osteoblast progenitors in vivo. This observation could also be confirmed in vitro when 
quiescent HSCs were cocultured with the osteoblast progenitor cell line OP9 in vitro 
(Sugimura et al., 2012). Although the study did not address what happens with the 
highly polarized PCP-complex during HSC division we speculate that VANGL2 and 
other components of this complex are asymmetrically segregated during HSC 
divisions. 
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3.3.7.5 CD107a/LAMP1 
 
CD107a/LAMP1 is an integral membrane glycoprotein highly abundant in lysosomes. 
Although it can be detected in the MHCII compartment, to a lesser extent in late 
endosomes and at the cell surface as well, it is generally considered to be a 
lysosomal marker (Escola, 1998; Williams and Fukuda, 1990). So far, LAMP1 has not 
directly been shown to segregate asymmetrically. However, Bergeland et al. 
demonstrated via life cell imaging of BSA-alexa594 pulsed MDCK cells that the 
observed segregation of the late endosomal/lysosomal compartment does not fit the 
expected stochastic distribution and concluded that there is no evidence “for a strict 
mechanism assuring an equal division of endosomes/lysosomes into the two 
daughter cells” (Bergeland et al., 2001). He suggested that the segregation of 
lysosomes might be ordered, although the accuracy would equal a stochastic 
process. Although not stated by the authors, the observation indicates that at least 
some part of the lysosomal compartment might segregate asymmetrically during 
MDCK cell divisions. Since CD63, another marker for late endosomes and lysosomes 
has been suggested to segregate asymmetrically during human hematopoietic 
progenitor divisions we speculated that LAMP1, labeling the same cellular 
compartment might show similar behaviors during hematopoietic stem cell division 
(Beckmann et al., 2007).  
 
3.4 Experimental approach 
3.4.1 The necessity for single cell analysis and its limitations 
 
Classical biological assays are based on the analysis of thousands or even millions 
of cells and represent population averages. Although these assays can be used to 
address certain questions they are less useful for others. In fact, population averages 
can be interpreted in multiple ways, which led to controversies in the past. For 
example, the cytoplasmic to nuclear oscillations of NF-b was missed until single 
cells were observed (Bakstad et al., 2012). The advent of clonal assays, 
immunofluorescence and high throughput single cell analysis by flow cytometry 
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demonstrated that even populations assumed to be rather homogenous, like 
embryonic stem cells, are highly diverse (Chambers et al., 2007).  
Assays with single cell resolution are a prerequisite to study cell divisions. However 
since these assays are usually based on single snap-shot analysis the dynamics of 
the process are lost. This makes it difficult to judge if the observed polarization in 
mitotic cells would have led to asymmetric inheritance or is simply transient. In 
addition, most of these assays require fixation of the cells rendering any subsequent 
analysis and thereby proof of functional relevance for the observed asymmetry 
impossible. Furthermore, assays based on fixed cells are intrinsically artificial and are 
highly inefficient when rare cell populations such as HSCs have to be analyzed. In 
order to increase the frequency of mitotic cells upon fixation, cytokinesis inhibiting 
chemicals have been used in the past (Wu et al., 2007b). One of them, nocodazol, 
was recently shown to be inappropriate to study cell divisions due to its impact on cell 
viability and interference with proper centrosome localization (Nteliopoulos and 
Gordon, 2012). This demonstrates that results accomplished utilizing these reagents 
should be interpreted with care and that previously drawn conclusions based on 
these experiments require reevaluation. 
 
3.4.2 Continuous single cell analysis – a prerequisite to study cell 
division 
 
Single cell snap shot analysis has been useful in mapping cellular heterogeneity but 
is insufficient to elucidate dynamic processes like migration, differentiation, signaling 
or cell division. Although it is possible to study these processes indirectly by merging 
the analysis of independent samples at consecutive time points (time course 
analysis), single cell identity and cell viability are lost and subsequent functional 
assays are not possible. Simple single snap shot analysis of dynamic processes can 
therefore be interpreted in several ways. As with the interpretation of data derived 
from population averages this has led to decade long controversies about basic 
biological questions. It is thus not sufficient to analyze cell divisions by snap shot 
analysis, but a prerequisite to observe single living cells continuously over time. 
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3.4.3 Quantification of cell divisions 
 
In order to assess if proteins are inherited in a symmetric or asymmetric fashion 
during cell division their abundance needs to be determined and compared between 
sister cells. Proteins of interest can either be genetically engineered and fused to 
fluorescent reporters or labeled directly with antibodies conjugated to fluorescent 
dyes. In both approaches, the amount of light emitted upon excitation of the 
fluorochrome is detected and used as a reporter for the presence, localization and 
abundance of the protein.  
The most physiological way to express fluorescently tagged proteins is the 
generation of knock-in mice. Since the regulatory elements of the endogenous gene 
are maintained, the fusion protein is assumed to be expressed at physiological levels. 
Unfortunately, the generation of knock-in mice is time consuming and expensive and 
therefore not suited to screen a bigger number of candidate genes.  
Viral delivery of fusion genes is a commonly used alternative. It is considerably faster 
and cheaper to generate viruses encoding fusion genes making it suitable for 
screening approaches. The technique comes with several drawbacks that need to be 
considered when experimental results are interpreted. The fusion protein is 
overexpressed, which might alter cellular behavior or protein localization itself. Clone 
to clone variability is likely since neither the number of viral integrations nor the viral 
integration site itself can be controlled. The detection of asymmetric fates is unlikely if 
the overexpressed protein acts as a cell fate determinant.  
Manipulating cells by introducing genetically engineered fusion proteins might alter 
protein function and thereby cellular behavior. Although this is true for knock-in 
strategies as well, it is a major concern if fusion proteins are delivered virally. If the 
protein of interest is located at the cell surface, live antibody staining offers an 
alternative way to label proteins. In contrast to viral delivery, endogenous proteins 
levels are detected. Since live antibody staining circumvents the need for 
overexpression, the detection of asymmetric fates is more likely. Potential 
asymmetries established during mitosis are expected to be more stable since the 
expression of candidate genes and their downstream effects is not enforced in both 
daughters. Although live antibody staining avoids many issues associated with viral 
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delivery approaches it is not readily available for every surface antigen. For yet 
unknown reasons only some antibodies stain living cells during continuous 
observation. In addition, some antibodies may possess either blocking or activating 
properties and are therefore limited in their usability. 
Based on careful evaluation of the advantages as well as drawbacks of the described 
approaches for our initial screen we decided to use virally delivered fluorescence 
reporter fusions and supplemented this approach with live antibody staining where 
ever possible.  
 
3.4.4 In vitro maintenance of hematopoietic stem cells 
 
Observing single, living hematopoietic stem cells continuously and quantitatively over 
time is a prerequisite to analyze dynamic processes such as cell divisions and should 
ideally be done in vivo, where the cells are undisturbed in their natural cellular 
environment. Imaging of living HSCs in vivo has been reported before (Lo Celso et 
al., 2009). However, the associated technical and ethical constraints limit the 
temporal as well as spatial resolution necessary to reliably detect and quantify the 
asymmetric segregation of proteins. In addition, the functional relevance of any 
putative asymmetry cannot be tested since cellular identities are soon lost using 
current technologies. We therefore decided to image HSC divisions in vitro where 
ethical and technical requirements can be fulfilled.  
Despite repeated efforts around the globe, conditions that maintain or expand 
genetically unmodified HSCs indefinitely in vitro have not been described. However, 
several culture conditions have been shown to maintain HSCs for a limited period of 
time. These culture conditions are of particular interest for this study given that the 
limited maintenance of HSCs might be associated with asymmetric cell fates within 
single colonies and could therefore provide the functional relevance of putative 
asymmetric segregation. What is known about the behavior of HSCs in these culture 
conditions and why we intend to use them is discussed below. 
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3.4.4.1 In vitro model of the niche 
 
Hematopoietic stem cells reside in a special microenvironment termed the “niche”. 
When the niche is ablated for instance by irradiation, HSC activity is lost. Stromal cell 
lines such as OP9 are frequently used as an in vitro model for the niche since they 
possess the capacity to maintain HSCs for limited amounts of time (Ueno et al., 
2003; Wu et al., 2007a). The OP9 stromal cell line consists of osteoblast progenitors, 
a lineage that has been shown to be capable to support the maintenance of in vitro 
cultured HSCs (Taichman and Emerson, 1994). Increasing the number of osteoblasts 
by genetic manipulation has been shown to also increase the number of HSCs in vivo 
(Calvi et al., 2003; Zhang et al., 2003). In addition to their supporting abilities OP9s 
have been used in several other studies investigating in vitro cell divisions of 
hematopoietic stem and progenitor cells and has been shown to interact and polarize 
HSCs in a FZ8/CELSR2 dependent manner (Sugimura et al., 2012). This cell line has 
also been used in studies that suggested that NUMB and AP2A2 are asymmetrically 
segregating (Ting et al., 2012; Wu et al., 2007b).   
 
3.4.4.2 Maintaining HSC in stromal cell free culture conditions 
3.4.4.2.1 Culturing HSCs in SCF and TPO 
 
Until today it is not possible to maintain HSCs for extended periods of time in stromal 
cell free culture conditions. However, several studies have reported culture conditions 
exerting positive effects on HSC activity. One of these culture condition contains SCF 
and TPO (Ema et al., 2000a; Takano et al., 2004). This combination has been 
demonstrated to be able to maintain in vitro cultured HSCs for at least 6 days (Ema 
et al., 2000b; Takano et al., 2004). In addition, daughters of HSCs cultured in these 
conditions have been demonstrated to differ in their differentiation potential (Takano 
et al., 2004). We therefore speculated that putative asymmetric segregation in these 
culture conditions might be correlated to the previous described asymmetric fates. 
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3.4.4.2.2 Culturing HSCs in SCF, TPO and TGFβ1 
 
Another study used a cytokine cocktail containing SCF, TPO and TGFβ1 (Yamazaki 
et al., 2009). Interestingly, over an in vitro culture period of 5 days all differentiated 
CD34+KSL died while 50% of the HSCs survived. Functional tests revealed that the 
surviving cells that had not been divided retained HSC activity in a similar fashion as 
freshly isolated CD34-KSL. Based on this, the study concluded that TGFβ1 induces 
HSC hibernation. However, since HSCs were not observed continuously it cannot be 
excluded that HSCs underwent divisions followed by cell death of one daughter. 
Based on this we speculated that TGFβ1 selectively induces cell death of 
differentiated cells while maintaining HSCs and that apoptosis of one daughter after 
cell division could serve as an in vitro read out for asymmetric cell fates and loss of 
HSC activity.  
 
3.5 Rational – Objective of the study 
 
Hematopoietic stem cells have the ability to self-renewal and differentiate into all 
hematopoietic lineages. After cell division these properties can either be retained by 
both daughters (expansion), one daughter (maintenance) or can be completely lost 
(differentiation). It is currently not understood whether these outcomes are regulated 
by mechanisms that act during cell division or are determined by post mitotic events. 
Based on studies of invertebrates, symmetric or asymmetric segregation of cell fate 
determinants has been proposed to regulate the outcome of HSC divisions. However, 
this hypothesis has not been tested and neither the symmetric or asymmetric 
segregation of cell fate determinants, nor their functional relevance has been 
demonstrated in highly purified, living HSCs.  
The objective of the study is to test this hypothesis. Therefore novel, continuous, 
quantitative bioimaging approaches were used. Fusion proteins of selected candidate 
genes previously suggested to be associated with asymmetric cell divisions were 
cloned and analyzed quantitatively for their segregation mode in HSCs as well as 
early hematopoietic populations under different culture conditions. In vitro read-outs 
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to distinguish symmetric from asymmetric daughter cell fates were established for 
differentiation and self-renewal potential and correlated to the segregation of 
candidates during initial in culture divisions. 
 
4 Material 
4.1 Devices 
4.1.1 Centrifuges 
 
Name Company 
Rotanta 460R Hettich Holding GmbH & Co. oHG, Kirchlengern, 
Germany 
Rotina 380R Hettich Holding GmbH & Co. oHG, Kirchlengern, 
Germany 
Mikro 200 Hettich Holding GmbH & Co. oHG, Kirchlengern, 
Germany 
Mikro 200R Hettich Holding GmbH & Co. oHG, Kirchlengern, 
Germany 
Avanti-J-E Beckman Coulter GmbH, Krefeld, Germany 
Avanti-J30I Beckman Coulter GmbH, Krefeld, Germany 
Galaxy Mini Microcentrifuge VWF International Inc. 
Centrifuge/Vortexer neoLab Migge Laborbedarf-Vertriebs GmbH, 
Heidelberg, Germany 
4.1.2 Tissue culture hood 
 
Name Company 
HERA safe KS Thermo Electron Corporation 
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4.1.3 Incubators 
 
Name Company 
Microbiol. Incubator CD210 Binder, Tuttlingen, Germany 
Shaking incubator Sheldon Manufacturing, Inc. Cronelius, USA 
 
4.1.4 Transilluminator 
 
Name Company 
UV Transilluminator 2000 Bio-Rad Laboratories, München, Germany 
Geneflash Syngene, Cambridge, UK 
TM-300 Miniature CCD 
Camera 
JAI A/S, Grosswallstadt , Germany 
 
4.1.5 Freezer 
 
Name Company 
-20°C Premium No Frost, small Liebherr-International GmbH, Germany 
-20°C Premium No Frost, big Liebherr-International GmbH, Germany 
-80°C Sanyo Ultra low Panasonic Healthcare Company, USA 
-80°C New Brunswick Scientific, Germany 
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4.1.6 Pipettes 
 
Name Catalog no. Company 
Accujet Pro 26300 BRAND GMBH + CO KG, Germany 
Pipetman Classic P2 F144801 Gilson, Inc. USA 
Pipetman Classic P20 F123600 Gilson, Inc. USA 
Pipetman Classic P200 F123601 Gilson, Inc. USA 
Pipetman Classic P1000 F123602 Gilson, Inc. USA 
Transferpette 20-200µL 703730 BRAND GMBH + CO KG, Germany 
Pipet-LiteMultichannel 
Pipette 2 - 20µL 
17013808 Rainin, USA 
 
4.1.7 PCR Cycler 
 
Name Company 
PCR sprint system Thermo Fisher Scientific Inc. Schwerte, Germany 
Px2 thermal cycler Thermo Fisher Scientific Inc. Schwerte, Germany 
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4.1.8 Miscellaneous 
 
Name Company 
Nanodrop Thermo Fisher Scientific Inc. Schwerte, 
Germany 
Vortex Genie 2 Scientific Industries, Inc., New York, USA 
Heating block HBT-2-131 Heinrich Haep HLC, Bovenden, Germany 
Cryo Freezing Containing Nalgene, Rochester, USA 
Gaswash bottleincl.filter  Carl Roth GmbH + Co. KG, Karlsruhe, 
Germany 
Drossel-Rückschlagventil GR-QS-
4 
FESTO 
Powerpac Basic Power Suppyly Bio-Rad Laboratories GmbH, Germany 
Reax top vortexer Heidolph Instruments GmbH & Co.KG, 
Germany 
inoLab pH-meter WTW GmbH, Germany 
ABS weight Kern & Sohn GmbH, Germany 
Microwave Severin Elektrogeräte GmbH, Germany 
4.1.9 Microscopes 
 
4.1.9.1 Epifluorescence microscopes 
4.1.9.1.1 Microscope body 
 
Name Catalog number Company 
Eclipse TS100 - Nikon 
Axiovert 40C - Carl Zeiss AG, Oberkochen, Germany 
Axiovert 200M 000000 1312 732 Carl Zeiss AG, Oberkochen, Germany 
AxioObserver 
Z1 
431007 9902 000 Carl Zeiss AG, Oberkochen, Germany 
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4.1.9.1.2 Hardware autofocus 
 
Name Catalog number Company 
Definite Focusincl. Objective 
revolver mot. ACR 
424533 9000 000 Carl Zeiss AG, 
Oberkochen, 
Germany 
 
4.1.9.1.3 Optical filter 
 
name Ex. 
filter 
Beam-
splitter 
Em. 
filter 
Catalog 
number 
Company 
DAPI HC 
 
387/11 
 
BS 409 
 
447/60 
 
F36-513 AHF analysentechnik 
AG, Tübingen, Germany 
38 HE 470/40 
 
FT 495 
 
525/50 
 
489038-
9901-000 
Carl Zeiss AG, 
Oberkochen 
GFP 470/40 
 
495 LP 
 
525/50 
 
F46-002 
 
AHF analysentechnik 
AG, Tübingen, Germany 
46 HE 500/25 
 
FT 515 
 
535/30 
 
489046-
9901-000 
Carl Zeiss AG, 
Oberkochen 
YFP ET 
 
500/20 
 
515 LP 
 
535/30 
 
F46-003 
 
AHF analysentechnik 
AG, Tübingen, Germany 
43 HE 550/25 
 
FT 570 
 
605/70 
 
489043-
9901-000 
Carl Zeiss AG, 
Oberkochen 
mCherry 
HC 
562/40 
 
BS 593 
 
641/75 
 
F36-508 
 
AHF analysentechnik 
AG, Tübingen, Germany 
ET-SET 
Cy5 
620/60 
 
LPXR 
660  
 
700/75 
 
F46-006 
 
AHF analysentechnik 
AG, Tübingen, Germany 
Dualband 
GFP/mCHE
RRY ET 
474/25+ 
570/40 
 
ET 
525/25 + 
635/70 
525/25 
+ 
635/70 
F56-019 AHF analysentechnik 
AG, Tübingen, Germany 
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4.1.9.1.4 Objectives 
 
Name Catalog number Company 
Fluar 10x/0,5 M27 420140-9900 Carl Zeiss AG, 
Oberkochen 
Fluar 10x/0,50 440135-0000 Carl Zeiss AG, 
Oberkochen 
EC Plan-Neofluar 10x/0,3 Ph1 
M27 
420341-9911 Carl Zeiss AG, 
Oberkochen 
EC Plan-Neofluar 10x/0,3 Ph1 440331-9902 Carl Zeiss AG, 
Oberkochen 
OEC Plan-Neofluar 10x/0,3 Ph1 440331-9902 Carl Zeiss AG, 
Oberkochen 
ObjektivFluar 20x/0,75 440145-9901 Carl Zeiss AG, 
Oberkochen 
 
4.1.9.1.5 Camera 
 
Name Company 
AxiocamHRm Rev.2 Carl Zeiss AG, Oberkochen, Germany 
AxiocamHRm Rev.3 Carl Zeiss AG, Oberkochen, Germany 
Axiocam MRc5 Carl Zeiss AG, Oberkochen, Germany 
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4.1.9.1.6 TV-Adapter 
 
Name Catalog number Company 
Camera-Adapter 60C 1" 1,0x 456105 9901 000 Carl Zeiss AG, Oberkochen, 
Germany 
Video-Adapter 60 C 2/3" 0,63x 000000 1069 414 Carl Zeiss AG, Oberkochen, 
Germany 
Camera-Adapter 60N-C 2/3" 
0,5x 
426112 0000 000 Carl Zeiss AG, Oberkochen, 
Germany 
Video-Adapter 60 C 1/3" 0,4x 456108 0000 000 Carl Zeiss AG, Oberkochen, 
Germany 
 
4.1.9.1.7 Motorized Stages 
 
Name Catalog no. Company 
Ludl MAC5000 XY stage 
130x100 
000000 0431 478 Märzhäuser Wetzlar GmbH 
& Co. KG 
Ludl MAC6000 XY stage 
130x100 
000000 1695 168 Märzhäuser Wetzlar GmbH 
& Co. KG 
Motorized stage  130x85 mot P; 
CAN 
432031 9902 000 Carl Zeiss AG, Oberkochen, 
Germany 
 
 
4.1.9.1.8 Computer 
 
Name Catalog number Company 
Raidsonic Icy Box IB IB-169SK-B RaidSonic Technology GmbH, 
Ahrensburg, Germany 
Siemens Workstation 
FSC Celsius R630-2 
S26361-K680-
V215 
Fujitsu Technology Solutions 
GmbH, München, Germany 
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4.1.9.1.9 Hard drives 
 
Name Company 
0.5TB HD501LJ Samsung Electronics GmbH, Germany 
1TB HD103SJ Samsung Electronics GmbH, Germany 
2TB Barracuda Seagate Technology LLC, Germany 
 
4.1.9.1.10 Temperature control 
 
Name Catalog number Company 
Heating Unit 000000 1116 061 Carl Zeiss AG, Oberkochen, 
Germany 
Temperature Control Unit 000000 1052 320 Carl Zeiss AG, Oberkochen, 
Germany 
Temperature Module S1 411860 9010 000 Carl Zeiss AG, Oberkochen, 
Germany 
Heating Unit XL S1 411857 9030 000 Carl Zeiss AG, Oberkochen, 
Germany 
 
4.1.9.1.11 Light sources 
4.1.9.1.11.1 Transmitted light 
 
Name Catalog number Company 
Halogen bulb with 
collector 
423000 000 000 Carl Zeiss AG, Oberkochen, 
Germany 
Transmitted light VIS-
LED 
423053 9030 000 Carl Zeiss AG, Oberkochen, 
Germany 
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4.1.9.1.11.2 Reflected light 
 
Name Catalog number Company 
HXP 120C 423013 9000 777 Leistungselektronik JENA, 
Germany 
Liquid light guide 000000 0482 760 Carl Zeiss AG, Oberkochen, 
Germany 
SPECTRA X light 
engine™ 
 
- Lumencor, Inc., Beaverton, USA 
 
4.1.9.2 Confocal microscopes 
 
Name Company 
Leica TCS SP5 Leica Microsystems GmbH, 
Germany 
 
4.1.10 Flow cytometer 
 
4.1.10.1 Model 
 
Name Company 
BD FACS Aria III Becton, Dickinson and Company, 
Germany 
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4.1.10.2 Filters and settings 
 
561nm Laser (561) beamsplitter PMT voltage 
582/15 -  
610/20 600LP  
670/14 630LP  
780/60 I 735LP  
Red Laser (633nm)   
660/20 -  
730/45 690LP  
780/60 II 755LP  
Blue Laser (488nm)   
530/30 I 502LP  
695/40 655LP  
Violet Laser (405nm)   
450/40 -  
530/30 502LP  
585/40 556LP  
 
4.2 Chemicals and reagents 
 
4.2.1 General 
 
Name Catalog no. Company 
Agarose 870055 Biozym Scienfitic GmbH, Germany 
Ampicillin sodium salt K029.1 Carl Roth GmbH, Germany 
BD Cellclean 349524 BD Biosciences, San Jose, USA 
BD FACS Clean Solution 340345 BD Biosciences, San Jose, USA 
BD FACSFlow Sheath 
Fluid 
342003 BD Biosciences, San Jose, USA 
DMSO D2438 Sigma-Aldrich, USA 
dNTP Set R0181 Thermo Fisher Scientific, Germany 
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DPBS, -Ca, -Mg 14190-094 Life Technologies, Grand Island, USA 
EDTA CN063 Carl Roth GmbH, Germany 
Ethanol 100% 100983  Merck KGaA, Darmstadt, Germany 
Ethidiumbromid solution 
1% 
2218.2 Carl Roth GmbH, Germany 
Gelatin from porcine skin G1890 Sigma-Aldrich, USA 
GeneRuler DNA Ladder 
Mix 
SM0331 Thermo Fisher Scientific, Germany 
Giemsa stain, mod. 
solution 
48900 Sigma-Aldrich, USA 
Hamster Fibronectin IHMFBN Dunn Labortechnik GMBH 
Heparin H3149 Sigma-Aldrich, USA 
LB Broth Base 12780-029 Life Technologies, Grand Island, USA 
Lichrosolv HPLC H2O 1.15333.1000 Merck KGaA, Darmstadt, Germany 
May-Grünwald solution T863.1 Carl Roth GmbH, Germany 
Nail polish, essence gel-
look 
- Cosnova GmbH, Germany 
NaN3 S2002 Sigma-Aldrich, USA 
Paraformaldehyde 0335.3 Carl Roth GmbH, Germany 
Pertex, Hist. mounting sol. 41-4010-00 Medite GmbH, Germany 
Polyethylenimine, Lin 
(25k) 
23966 PolySciences Inc., Germany 
Poly-L-Lysine P8920-
100mL 
Sigma-Aldrich, USA 
Probumin 81-068-3 EMD Millipore Corporation, 
Billerica,USA 
Roti-MagBeads 
Streptavidin 
HP57.1 Carl Roth GmbH, Germany 
Sodium chloride 1064060500  Merck KGaA, Germany 
Taq DNA Polymerase EP0072 Thermo Fisher Scientific, Germany 
Triton-X 3051.3 Carl Roth GmbH, Germany 
Trypan Blue Sol. 0.4% 15250 Life Technologies, Grand Island, USA 
Tween-20 9127.1 Carl Roth GmbH, Germany 
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4.2.2 Tissue culture media and reagents 
 
Reagent Catalog number Company 
2-mercaptoethanol 
 
M3148-25ML 
 
Sigma-Aldrich, USA 
EDTA Dinatriumsalz P.A 
 
8043.2 
 
Carl Roth GmbH + Co. KG, 
Karlsruhe, Germany 
L-Glutamine 25030-081 Life Technologies, Grand 
Island, USA 
Penicillin-Streptomycin 
(100X) 
 
15140-122 Life Technologies, Grand 
Island, USA 
Silicone oil AR 200  
 
85419-100ML  
 
Sigma-Aldrich, USA 
Sodium Pyruvate Solution 
 
S8636 
 
Sigma-Aldrich, USA 
StemPro®-34 SFM (1X), 
Liquid 
10639-011 Life Technologies, Grand 
Island, USA 
StemSpan™ SFEM 
 
09650 STEMCELL Technologies 
SARL, Grenoble, France 
StemSpan™ SFEM 
(phenol red free) 
- STEMCELL Technologies 
SARL, Grenoble, France 
Trypsin-EDTA (1X), Phenol 
Red (0.05%) 
25300-054 Life Technologies, Grand 
Island, USA 
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4.2.3 Serum 
 
Reagent Lot No. Catalog no. Company 
FETAL BOVINE SERUM 
QUALIFIED (FCS 13) 
S05130S1
900 
S1900-500 Biowest (Distributor 
Th.Geyer) 
Fetal Bovine Serum (FCS 
14) 
A10108-
2429 
A15-101 PAA Laboraties, Velizy-
Villacoublay, France 
Fetal Bovine Serum (FCS 
17) 
- 30-2020 
 
ATCC, Manassas, USA 
Donkey serum - 17-000-121 
 
Dianova GmbH, 
Germany 
 
4.2.4 Cytokines 
 
Cytokine Catalog number Company 
Recombinant human SCF 167300-07-B Tebu Bio (Peprotech) 
Recombinant human TPO 167300-18-B Tebu Bio (Peprotech) 
Recombinant mouse IL-3 167213-13-B Tebu Bio (Peprotech) 
Recombinant human EPOα C-60022 Promokine 
Recombinant human TGF-
beta 1 
240-B-010 R&D Systems, Miineapolis, 
USA 
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4.2.5 Antibodies 
4.2.5.1 Flow cytometry 
 
Antigen conjugate Clone Catalog 
no. 
company 
B220  Biotin RA3-6B2 13-0452-
86 
eBioscience 
CD11b Biotin M1/70 13-0112-
85 
eBioscience 
CD11b eFluor® 450 M1/70 48-0112-
82 
eBioscience 
CD150 PE TC15-
12F12.2 
115904 Biolegend 
CD16/CD3
2 
Per-CP Cy5.5 93 45-0161-
82 
Biolegend 
CD19 Biotin eBio1D3 
(1D3) 
13-0193-
85 
eBioscience 
CD34  eFluor® 450 RAM34 48-0341 eBioscience 
CD3ε Biotin 145-2C11 13-0031-
85 
eBioscience 
CD41 Biotin eBioMWReg3
0 
13-0411-
85 
eBioscience 
CD41 APC eBioMWReg3
0 
17-0411-
82 
eBioscience 
CD48 FITC HM48-1 103404 Biolegend 
CD48 APC HM48-1  17-0481-
82 
eBioscience 
CD48 purified HM48-1 16-0481-
85 
eBioscience 
c-KIT PE-Cy7 2B8 25-1171-
82 
eBioscience 
c-KIT APC 
eFluor®780 
2B8 47-1171-
82 
eBioscience 
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Gr-1 Biotin RB6-8C5 13-5931-
85 
eBioscience 
Gr-1 FITC RB6-8C5  11-5931-
82 
eBioscience 
Gr-1 Alexa700 RB6-8C5 56-5931 eBioscience 
Sca-1 Per-CP Cy5.5 D7 45-5981-
82 
eBioscience 
Sca-1 purified D7 14-5981-
82 
eBioscience 
Streptavidi
n  
APC 
eFluor®780 
- 47-4317-
82 
eBioscience 
Ter119 Biotin TER-119  13-5921-
85 
eBioscience 
Ter119 PE TER-119  12-5921-
81 
eBioscience 
 
4.2.5.2 Live cell labeling 
 
Name Catalog no. Company 
Hoechst33342 H1399 Life Technologies GmbH, 
Darmstadt, Germany 
LysoTracker® Red DND-
99 
L-7528 Life Technologies GmbH, 
Darmstadt, Germany 
Cyto-ID® Autophagy 
detection kit 
ENZ-51031-K200 Enzo Life Sciences, Inc., Lörrach, 
Germany 
Cholera Toxin Subunit B 
(Recombinant), Alexa 
Fluor® 488 Conjugate 
C-34775 Life Technologies GmbH, 
Darmstadt, Germany 
Cholera Toxin Subunit B 
(Recombinant), Alexa 
Fluor® 647 Conjugate 
C-34778 Life Technologies GmbH, 
Darmstadt, Germany 
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4.2.6 Enzymes 
 
Name Catalog no. Company 
DNA Pol. Lg. Fragm. 
(Klenow) 
M0210 S New England Biolabs, Ipswich, 
USA 
Taq DNA Polymerase EP0072 Thermo Fisher Scientific , Germany 
Advantage Polymerase Mix 639201 Takara Bio Europe 
Antarctic Phosphatase M0289 S New England Biolabs, Ipswich, 
USA 
T4 DNA Ligase M0202 S New England Biolabs, Ipswich, 
USA 
All restriction enzymes used for molecular cloning were purchased either from New 
England Biolabs (NEB) or Fermentas.  
 
4.2.6.1 Buffer solutions 
 
Name Catalog no. Company 
NEB1 B7001S New England Biolabs, Ipswich, USA 
NEB2 B7002S New England Biolabs, Ipswich, USA 
NEB3 B7003S New England Biolabs, Ipswich, USA 
NEB4 B7004S New England Biolabs, Ipswich, USA 
Blue B30 Thermo Fisher Scientific Inc. Germany 
Green B30 Thermo Fisher Scientific Inc. Germany 
Orange B30 Thermo Fisher Scientific Inc. Germany 
Red B30 Thermo Fisher Scientific Inc. Germany 
Yellow B30 Thermo Fisher Scientific Inc. Germany 
10X Advantage® 2 SA 
PCR Buffer 
639147 
 
Takara Bio Europe/Clonetech, France 
T4 DNA Ligase 
Reaction buffer 
B0202S New England Biolabs, Ipswich, USA 
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4.3 Disposables 
4.3.1 Multi well plates 
4.3.1.1 Tissue culture 
 
Name Catalog no. Company 
Nunc Flat Bottom 96-well 
polystyrene plates 
167008 Thermo Fisher Scientific Inc. 
Schwerte, Germany 
Nunc™ MiniTrays, Nunclon™ 
Delta surface 
163118 Thermo Fisher Scientific Inc. 
Schwerte, Germany 
6-well Falcon microtiter plate, 
flat bottom 
353046 Beckman Coulter GmbH, 
Krefeld, Germany 
12-well Falcon microtiter plate, 
flat bottom 
353043 Beckman Coulter GmbH, 
Krefeld, Germany 
24-well Falcon microtiter plate, 
flat bottom 
353047 Beckman Coulter GmbH, 
Krefeld, Germany 
48-well Falcon microtiter plate, 
flat bottom 
353078 Beckman Coulter GmbH, 
Krefeld, Germany 
96-well Falcon microtiter plate, 
round bottom 
353077 Beckman Coulter GmbH, 
Krefeld, Germany 
 
4.3.1.2 Imaging 
 
Name Catalog no. Company 
12 well glass bottom plates 
 
P12-1.5H-N In Vitro Scientific, Sunnyvale, 
USA 
SENSOPLATE, 24 WELL, 
glass bottom,flat 
662892 Greiner Bio-One GmbH. 
Frickenhausen, Germany 
µ-Plate 384 well 
 
88401 Ibidi GmbH, München, Germany 
SENSOPLATE, 1536 WELL, 
glass bottom, low base, flat  
783892 
 
Greiner Bio-One GmbH. 
Frickenhausen, Germany 
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4.3.2 Cell strainer 
 
Name Catalog no. Company 
Cell Strainer, 40 µm, blue 
 
352340 Beckman Coulter GmbH, 
Krefeld, Germany 
Cell Strainer, 100 µm, yellow 352360 Beckman Coulter GmbH, 
Krefeld, Germany 
Cell strainer tubes 35 µm FALC352235 
 
Corning B.V. Life Sciences, 
Netherlands 
 
4.3.3 Tissue culture silicon inserts 
 
Name Catalog no. Company 
Silicon inserts (4 chamber) 80246 Ibidi GmbH, München, Germany 
Silicon inserts (2 Chamber) 80209 Ibidi GmbH, München, Germany 
 
4.3.4 Sterile filter 
 
Name Catalog no. Company 
Minisart® high flow Syringe 
Filters (0.2µm pore size) 
16532 
 
Sartorius AG, Göttingen, 
Germany 
“rapid” Filtermax 99250 TPP, Techo Plastic Products AG 
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4.3.5 Tubes 
 
Name Catalog no. Company 
15 ml high-clarity 
polypropylene conical 
centrifuge tube 
352096 Beckman Coulter GmbH, 
Krefeld, Germany 
50 ml high-clarity 
polypropylene conical 
centrifuge tube 
352070 Beckman Coulter GmbH, 
Krefeld, Germany 
17x100 mm, 14 ml high-clarity 
polypropylene round bottom 
tube 
352059 Beckman Coulter GmbH, 
Krefeld, Germany 
12 x 75 mm tube with cell 
strainer cap 
352235 Beckman Coulter GmbH, 
Krefeld, Germany 
12x75 mm, 5 ml high-clarity 
polypropylene round bottom 
tube 
352063 Beckman Coulter GmbH, 
Krefeld, Germany 
   
4.3.6 Syringes 
 
Name Catalog no. Company 
50ml Syringe Concentric Luer 
Lock x 60 
300865 
 
Beckman Coulter GmbH, 
Krefeld, Germany 
1mL Omnifix Syringe  H999.1 
 
Carl Roth GmbH + Co. KG, 
Karlsruhe, Germany  
5 mL Syringe with Luor lock  0057.1 
 
Carl Roth GmbH + Co. KG, 
Karlsruhe, Germany 
20mL Syringe with Luor lock  0059.1 
 
Carl Roth GmbH + Co. KG, 
Karlsruhe, Germany  
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4.3.7 Object slides 
 
Name Catalog no. Company 
µ-Slide VI 0.4 80606 Ibidi GmbH, München, Germany 
Microscope slides “Elka” 2401 Glaswarenfabrik Karl Hecht 
GmbH & Co KG 
Superfrost Plus microscope 
slides 
10149870 Thermo Fisher Scientific Inc. 
Schwerte, Germany 
Superfrost Gold Plus 
microscope slides 
10609895 
 
Thermo Fisher Scientific Inc. 
Schwerte, Germany 
 
4.3.8 Tissue culture flasks 
 
Name Catalog no. Company 
12.5 cm² Cell Culture Flask, 
25 ml, tissue-culture treated 
polystyrene 
353018 Beckman Coulter GmbH, 
Krefeld, Germany 
25 cm² Cell Culture Flask, 25 
ml, tissue-culture treated 
polystyrene 
353109 Beckman Coulter GmbH, 
Krefeld, Germany 
 
4.3.9 Tissue culture dishes 
 
Name Catalog no. Company 
Cell culture Dish 60x15mm 150288 Thermo Fisher Scientific Inc. 
Schwerte, Germany 
Cell culture Dish 100x15mm 150350 Thermo Fisher Scientific Inc. 
Schwerte, Germany 
Cell culture Dish 150x20mm 168381 Thermo Fisher Scientific Inc. 
Schwerte, Germany 
35mm TC-treated culture dish 430165 Corning, USA 
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4.3.10 Miscellaneous 
 
Name Catalog no. Company 
Breathe-Easy 
 
BEM-1 Diversified Biotech, Deham, 
USA 
The Big Easy EasySep™ 
Magnet 
 
18001 STEMCELL Technologies 
SARL, Grenoble, France 
Pressured air spray 67 NF  TC26.1    
 
Carl Roth GmbH + Co. KG, 
Karlsruhe, Germany 
BD™ Accudrop Fluorescent 
Beads 
345249 Beckman Coulter GmbH, 
Krefeld, Germany 
HXP-R 120W/45C VIS  8-
12500302919345 
Leuchtmittelmarkt 
 
14mm round Coverslip 631-0899 
 
VWR, Germany 
Coverslips for hemocytometer 03-0000 Peske 
Vectashield Hardset mounting 
medium with DAPI 
H-1500 Vector Laboratories Inc., 
Burlingame, USA 
Fisherbrand Pasteur pipets FB50251 Thermo Fisher Scientific Inc. 
Schwerte, Germany 
170µm precision coverslips 
22x22mm 
LH24.1 Carl Roth GmbH + Co. KG, 
Karlsruhe, Germany 
170µm precision coverslips 
24x60mm 
LH26.1 Carl Roth GmbH + Co. KG, 
Karlsruhe, Germany 
Cell culture cryogenic tubes 375418 Thermo Fisher Scientific Inc. 
Schwerte, Germany 
reagent reservoirs 4870 Corning, USA 
hemocytometer 0640010 Paul Marienfeld GmbH & Co. 
KG 
   
 
Dirk Löffler – Research Unit Stem Cell Dynamics 
 
70 Material 
70 
4.4 Bacteria 
 
Strain: DH5α 
 
4.5 Cell lines 
 
Name Medium Serum Supplements 
HEK293T DMEM 10% FCS 13 1% P/S 
NIH-3T3 DMEM 10% FCS 13 1% P/S 
OP9 α-MEM 20% FCS 14 1% P/S 
7F2 α-MEM(-nucleosides) 20% FCS 17 1% P/S 
 
4.5.1 Commercial Kits 
 
Name Catalog no. Company 
QIAGEN Plasmid Maxi Kit 
(100) 
12165 QIAGEN GmbH, Hilden, Germany 
QIAGEN Plasmid Mini Kit 
(100) 
12125 QIAGEN GmbH, Hilden, Germany 
QIAquick PCR Purification 
Kit (250) 
28106 QIAGEN GmbH, Hilden, Germany 
QIAquick Gel Extraction 
Kit (250) 
28706 QIAGEN GmbH, Hilden, Germany 
Alexa Fluor® 488 
Antibody Labeling Kit 
A20181 Life Technologies, Grand Island, 
USA 
Alexa Fluor® 555 
Antibody Labeling Kit 
A20187 Life Technologies, Grand Island, 
USA 
Alexa Fluor® 647 
Antibody Labeling Kit 
A20186 Life Technologies, Grand Island, 
USA 
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4.6 Plasmids 
4.6.1 Commercial 
 
No. Interna
l no. 
Name Catalog no. Company / Reference 
1 1515 pKOF2.Flag.msi2.P
GK.GFP 
- (Deneault et al., 2009) 
2 1241 pCMV-Prkci  IRAVp968F0244D Source BioScience UK 
Limited, Nottingham 
3 1280 pSPORT-CD53  IRAVp968A01108
D 
Source BioScience UK 
Limited, Nottingham 
4 1380 pCR-BluntII-TOPO-
Prkcz 
IRCLp5011E1035
D 
Source BioScience UK 
Limited, Nottingham 
5 1686 pCMV-SPORT6.sca-
1 
IRAVp968E033D Source BioScience UK 
Limited, Nottingham 
6 1852 pDNT-LIB.Centrin1 IRAWp5000B127D Source BioScience UK 
Limited, Nottingham 
7 1427 pYX-Asc.Lamp-1 IRAVp968G11125
D 
Source BioScience UK 
Limited, Nottingham 
8 1428 pYX-Asc.EEA-1 IRAVp968A10135
D 
Source BioScience UK 
Limited, Nottingham 
9 1430 pCMV-
SPORT6.Inscuteable 
IRAVp968B04167
D 
Source BioScience UK 
Limited, Nottingham 
10 1628 pCMV-hSara 
 
IRATp970D0956D Source BioScience UK 
Limited, Nottingham 
11 1855 pCMV-
SPORT6.Rab11a 
IRAVp968A0211D Source BioScience UK 
Limited, Nottingham 
12 1429 pYX-Asc.TGFβRI IRAVp968C09115
D 
Source BioScience UK 
Limited, Nottingham 
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4.6.2 Generated in this thesis 
 
No. Internal 
no. 
Name 
1 445 pRRL.PPT.SF.VENUS.pre 
2 596 pRRL.PPT.SF.Prom1VENUS SpeI pre 
3 1162 pRRL.PPT.SF.Numb1VENUS.WPRE.SIN 
4 1206 pRRL.PPT.SFFV.InversinVENUS.WPRE.SIN 
5 1218 pRRL.PPT.SFFV.VENUSInturned.WPRE.SIN 
6 1219 pRRL.PPT.SFFV.Vangl2VENUS.WPRE.SIN 
7 1282 pRRL.PPT.SF.PrkciVENUS pre 
8 1283 pRRL.PPT.SF.CD53VENUS pre 
9 1373 pRRL.PPT.SF.msi2VENUS.PRE 
10 1379 pRRL.PPT.SF.mitoVENUS.pre 
11 1385 pRRL.PPT.SF.PrkczVENUS.PRE 
12 1630 pRRL.PPT.SF.FYVE(Sara)VENUS.pre 
13 1687 pRRL.PPT.SF.sca1VENUS.PRE 
14 1848 pRRL.PPT.PGK.Centrin1VENUS.PRE 
15 1851 pRRL.PPT.PGK.VENUSRab11a.PRE 
16 1979 pRRL.PPT.SF.TGFbRIVENUS.PRE 
17 1980 pRRL.PPT.SF.Lamp1VENUS.PRE 
18 1981 pRRL.PPT.SF.EEA1VENUS.PRE 
19 1983 pRRL.PPT.SF.InscVENUS.PRE 
20 1530 pRRL.PPT.SF.MCS.linker.VENUS.PRE 
21 1368 pRRL.PPT.SF.MCS.PRE 
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4.7 Primer 
 
Internal 
no. 
Sequence 
1455  5´-ATATATCCGGATCCATGGAGGCAAATGGGAGCCCAGG-3´ 
 
1487 5´-ATCTCTACGGATCCGGCGTGGTATCCATTTGTAAAGGCCGTTGC-3´ 
 
1309  5´-ATTGGATCCCGGGGGAGTGAGGAGATG-3´ 
 
1303 5´-ACCGGATCCCGGCAAGCAGAACCAGACAC-3´ 
 
1305 5´-TACTACCGGTGTTGCAAGCCACAGCCCTAAAGC-3´ 
 
1308 5´-TTCACCGGTCACTGCCTTCAAAAGGG-3´ 
 
1425 5´-ATCGTCACTAGTATGAAAGTGACCGTGTGCTTCG-3´ 
 
1426 5´-ATATCCACTAGTCCGGAGTAGAAGGGCCGCCCTTTC-3´ 
 
1522 5´-
ATATATATGGATCCATGGACACTTCTCACACTACAAAGTCCTGTTTGC-
3´ 
 
1523 5´-
ATATATATGGATCCACCGCCTCCACCGAGCAAGGTCTGCAGGAGGA-
3´ 
 
1935 5´-TTAATTAAGGATCCATGGCGTCCACCTTCAGGAAG-3´ 
 
1936 5´-
TTAACCGGTCTAGAGGATAAAGGTTGGTCTTTTTCATGATCTTAAGAA
ACTC-3´ 
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2315 5´-TACCTATAGGATCCGCCGCCACCATGGCGGCCCCCGGCGCCC-3´ 
 
2316 5´-
TACCTATATCTAGACCGATGGTCTGATAGCCGGCGTGACTCCTCTTCC
TGCCAATG-3´ 
2317 5´-TACCTATAGGATCCGCCGCCACCATGTTTCGAAGGATCTTG-3´ 
 
2318 5´-TACGGCTATCTAGACCTCCTTGCAAATCATTGAAGCATG-3´ 
 
2319 5´-TAGGTATAGGATCCGCCGCCACCATGATGGCACTGCCTGGAG-3´ 
 
2320 5´-
TACCTATATCTAGACCCACAAAACTCTCCTCCATATTGCTACACAGTAA
GAAG-3´ 
1514 5´-ATATCCATGGATCCATGGTGGCTCCAGTATGGGTACC-3´ 
 
1515 5´-
ATATCGATGGATCCGCCACCTCCACCCATTAGCACTGAATGGCAGAT
T-3´ 
 
1941 5´-TTAACTAAACCGGTGTATGGGCACCCGCGACGACGAG-3´ 
 
1942 5´-
GCTCGCGCTTAATTAATTAGATGTTCTGACAGCACTGCACCTTTGGCT
TG-3´ 
2323 5´-TACCTATAACCGGTGCCACCATGGAGGCGGCGGCCGCTG-3´ 
 
2324 5´-
TACCTACCACTAGTCATTTTGATGCCTTCCTGTTGGCTGAGTTGTGAC
AATGTTT-3´ 
521 5´-GAACCGCATCGAGCTGAAGG-3´ 
 
522 5´-TCCATGCCGAGAGTGATCCC-3´ 
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670 5´-TGCGCAACTACGGCAAGAC-3´ 
 
671 5´-GGGCGACGGGTTAATGCTATG-3´ 
 
672 5´-TCAGCTCGATGCGGTTCAC-3´ 
 
434 5´-GCATGGACGAGCTGTACAAG-3´ 
 
1451 5´-AGGTACTGCCCACCTCTATC-3´ 
 
1452 5´-GCAGGAGAATGGGAAATGTG-3´ 
 
 
4.8 Mice 
 
Strain Gender Age 
[weeks] 
Reference 
C57Bl6/J male 12-14 - 
PU.1YFP/GATA1-
mCherry  
male 12-14 (Hoppe et al., 2013, submitted) 
VWF2-eGFP male 12-14 (Sanjuan-Pla et al., 2013) 
 
4.9 Software 
4.9.1 Commercial 
 
Name Version company 
Clone Manager 
Prof. 
9 Scientific & Educational Software, Cary, USA 
Microsoft Office 2007, 2010 Microsoft Corporation, Redmond, USA 
Fiji/ImageJ 1.47b Wayne Rasband, NIH, USA 
Axiovision 4.5 – 4.8.2 Carl Zeiss AG, Oberkochen, Germany 
 
Dirk Löffler – Research Unit Stem Cell Dynamics 
 
76 Material 
76 
Flowjo 10.0.0-
10.0.6 
Tree Star, Inc. 
BD FACSDiva 4.1.1 BD Biosciences, San Jose, USA 
GraphPad Prism 5.03 GraphPad Software, Inc., La Jolla, USA 
FileZilla 3.5.3 Tim Kosse, http://filezilla-protect.org 
LAS AF 2.60.7266 Leica Microsystems GmbH, Mannheim, 
Germany 
Mendeley Desktop 1.8.4 Mendeley Ltd. 
Bulk Rename Utility 2.7.1.2 TGRMN Software 
VirtualBox Manager 4.1.2 Oracle Corporation 
BOXIT  BOXIT LabSoftware 
 
4.9.2 Custom made 
 
name Programmed by  
TAT – Timm´s Acquisition Tool Prof. Dr. Timm Schroeder Prof. Dr. Timm 
Schroeder 
TTT – Timm´s Tracking Tool Bernd Straubinger, Oliver 
Hilsenbeck 
Prof. Dr. Timm 
Schroeder 
staTTTs Laura Skylaki, Bernd 
Streppel, Konstantin 
Azadov 
Prof. Dr. Timm 
Schroeder 
Qtfy – Quantify Michael Schwarzfischer Prof. Dr. Timm 
Schroeder Prof. Dr. Dr. 
Fabian Theis 
Qtfy single – Quantify single Michael Schwarzfischer Prof. Dr. Timm 
Schroeder Prof. Dr. Dr. 
Fabian Theis 
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5 Methods 
5.1 Molecular biology 
5.1.1 DNA Preparation 
 
The isolation of Plasmid DNA from a DH5α bacteria culture was done using the 
QIAgen Plasmid purification kit according to the manufacturer´s instructions. The 
principle of the kit is based on the alkaline lysis of bacteria and the purification of the 
released DNA by anion exchange chromatography, followed by its elution and 
precipitation. The negative charge of DNA enables a high affinity binding to the solid 
phase of the chromatography column in low pH and low salt solutions. Application of 
solutions having a high concentration of salts will lead to the release of the DNA.  
Briefly, 300mL of LB-medium were inoculated with DH5α and incubated over night at 
37°C. After centrifugation for 15min at 4600rpm, room temperature, the supernatant 
was discarded and the pellet was resuspended in 10mL P1 buffer (resuspension 
buffer). The RNase A in this buffer will lead to the selective degradation of RNA and 
therefore increase the DNA purity at the end of the procedure. The bacteria were 
lysed for 5min at room temperature by the addition of 10mL of P2 buffer (lysis buffer). 
After the reaction was neutralized by the addition of 10mL P3 (neutralizing buffer) the 
suspension was incubated for 20min on ice. Cell debris was pelleted in a 30min 
centrifugation step at 20.000xg, 4°C. The supernatant was afterwards transferred to 
a column that has been equilibrated with 10mL P4 (equilibration buffer) before and 
washed twice by the addition of 30mL QC-buffer (washing buffer), respectively. The 
addition of 15mL QF-buffer (elution buffer) induced the elution of DNA. In order to 
purify the DNA from salts present in the elution buffer, 10,5mL isopropanol were 
added. After an additional centrifugation of 10min at 4.600rpm, 4°C the precipitated 
DNA was pelleted. In an additional washing step with 5mL 70% EtOH and 10min at 
4.600rpm, 4°C residual salts were removed. In order to remove EtOH the DNA was 
dried at room temperature before being resuspended in H2O.  
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5.1.2 DNA Quantification 
 
The concentration of all DNA containing solutions was determined with the Nano 
Drop ND-1000 spectrometer by loading the 1µL onto the device and comparing it´s 
absorbance to H2O. In order to determine the DNA concentration the device 
determines the absorbance of the loaded sample across wavelengths and calculates 
based on the absorbance at λ=260nm and λ=280nm the concentration and purity of 
nucleic acids in the solution based on the Beer-Lambert law as follows: 
 
       
  
  
        
 
Eλ Extinction  
I1 Intensity of transmitted light 
I0 Intensity of  
c Concentration in µg/mL 
d Travel length of light 
eλ Molar extinction coefficient depending on λ (DNA: λ260=50µg/mL; RNA:λ280 = 
40µg/mL) 
 
The purity of DNA in the sample is thereby assessed by the λ260/λ280 ratio of 
absorbance. A ratio of 1.8 is considered to be “pure” for DNA, while a ratio of 2.0 is 
supposed to be “pure” RNA. Lower ratios indicate the presence of proteins, phenol or 
other contaminants that absorb at 280nm in the sample. 
 
5.1.3 Digestion of DNA 
 
The digestion of DNA is a controlled reaction catalyzed by enzymes referred to 
restriction endonuclease. It is commonly used to cut circular as well as linear DNA 
molecules into smaller fragments for analytical or preparative purposes. The catalytic 
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activity of restriction endonucleases requires specific buffer systems and cofactors. A 
typical digestion reaction is described below: 
 
Table 5.1: Catalytic digestion of DNA with restriction endonucleases 
Volume [µL] Reagents 
2 DNA (0,5µg/µL) 
2 10x buffer 
1 Restriction enzyme (5U/µL] 
14,5 ddH2O 
20 Total volume 
 
After the reaction mix is prepared it is incubated for 1-2h at 37°C. Depending on the 
restriction enzymes used this temperature might be different. In case a heat sensitive 
restriction enzyme was used the solution was incubated for 20min at 65°C to stop the 
reaction. 
 
5.1.4 Agarose gelelectrophoresis 
 
All DNA derived from either analytical or preparative digestions was separated on 
agarose gels based on its charge and size.Depending on the size of the expected 
DNA fragments agarose gels are casted at different concentrations. Higher agarose 
concentrations (>2%) are used to separate smallerDNA fragments (<100bp) while 
lower agarose concentrations (<1%) are used to separate bigger DNA fragments 
(>3kb).The desired agarose solution (0,5-3% (w/v)) is preparedin TAE-buffer (40mM 
Tris-Acetat, 1mM EDTA) and heated until the agarose is completely dissolved. 
Afterwards the agarose solution issupplemented with 0.1µg/mL ethidiumbromide and 
casted into a designated casting chamber. After the gel has been polymerized it was 
placed into the electrophoresis chamber which was afterwards filled with 1xTAE 
buffer until the gel was completely covered. Before the samples were loaded onto the 
gel, 0,17x volumes of a 6x loading buffer (15% (w/v) Ficoll, 0,25% (v/v) 
Bromophenolblue, 0,25% (v/v) Xylenocyanol) were added. In addition to the samples 
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a DNA ladder was loaded onto the gel.In order to separate the samples a voltage of 
100-160V was applied for 10-30min. Analytical restrictions were afterwards analyzed 
by illuminating the gel with UV-light (λ=302) and documented with a TM-300 
Miniature CCD Camera (JAI A/S, Grosswallstadt, Germany). 
 
5.1.5 Gelextraction 
 
The gel extraction reaction allows the recovery and purification of a DNA fragment 
from anagarose gel after it has been separated from other contaminating DNA 
fragments. The reaction is based on the QIAquick Gel Extraction KIT was performed 
according to manufacturer’s instructions.  
Briefly, the desired DNA fragment was isolated from the agarose gel by cutting the 
gel with a scalpel into pieces. In order to prevent the introduction of point mutations 
or double strand breaksthe DNA used for the subsequent extraction reaction was not 
illuminated with UV-light. Three gel volumes of QG-buffer were added to the isolated 
slice and incubated for 10min at 50°C until the gel has been completely dissolved. 
After 1 gel volume of isopropanol has been added the solution was transferred to a 
QIAquick spin column and centrifuged for 1min at 10.000rpm. Afterwards the column 
was washed by added 0,5mL of QG buffer and spinning for 1min at 10.000rpm.  Two 
additional washing steps by adding 0,75mL of PE-buffer and centrifugation for 1min 
at 10.000 rpm respectively followed before the DNA was eluted by adding 20µL 
bidest. H2O and spinning for 1min at 10.000rpm.  
 
5.1.6 DNA purification 
 
The purification of DNA was done using the QIAquick PCR purification kit according 
to the manufacturer´s instructions. The kit is based on the principle of ion exchange 
chromatography and uses the differential adsorption of DNA to chromatography 
matrix with changing pH-values to separate DNA from contaminants. The silica 
membrane used as a matrix in thiskits spincolumns is optimized to adsorb DNA in 
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aqueous solution with pH-value´sbelow 7.5, while solutions with higher pH-value lead 
to the elution of DNA. After loading the DNA to the columns a series of wash steps in 
low pH-buffers remove contaminants and are followed by the elution of purified DNA 
with H2O. 
 
5.1.7 Klenow fill-in reaction 
 
The ends of two DNA fragments that have been cut with different restriction enzymes 
are usually not compatible during a ligation reaction (see section 5.1.10). However, it 
is possible to ligate these fragments by modifying their ends with the Klenow-
Fragment of the DNA-Polymerase I. The enzyme catalyzes the addition of free 
nucleotides to the complementary strand of the 5´ extension by its 5´->3´ polymerase 
activity. 3´extensions on the contrary are modified by the 3´->5´exonuclease activity 
of the enzyme.  
The reaction is prepared by mixing 50ng/µL DNA with 10x NEB buffer 2 (100mM, 
Tris-HCl, 10mM Dithiothreitol (DTT), 100mM MgCl, 500mM NaCl, pH7,9) and dNTPs 
to a final concentration of 33µM. The addition of 1U Klenow Polymerase per µg DNA 
starts the reaction which is stopped by heat inactivation for 10min at 75°C after 
20min incubation at 25°C. Before processing with the ligation reaction the DNA was 
purified as described in section 5.1.6. 
 
5.1.8 Dephosphorylation DNA 
 
The dephosphorylation of DNA is an enzymatic reaction applied to linearized 
plasmids to prevent theirreligation before the integration of the insert. The reaction 
thereby significantly impacts the efficiency of the ligation reaction (see section 5.1.10) 
by reducing the frequency of false positive clones during selection to a minimum.   
The reaction was carried out by mixing 1-5µg of DNA with 10x Antartic Phosphatase 
buffer (50mM Bis-Tris-Propane-HCl, 1mM MgCl2, 0,1mM ZnCl2, pH 6 at 25°C) and 
5U of Antartic Phosphatase (NEB) and subsequent incubation for 15min at 37°C for 
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5´extension or blunt-ends or 60min for 3´extensions. Alternatively the enzyme and 
buffer were added directly to a heat inactivated digestion reaction. In order to stop 
the reaction the mixture was heat inactivated for 5 min at 65°C. 
 
5.1.9 Polymerase Chain Reaction (PCR) 
 
The purpose of the polymerase chain reaction(PCR) is the sequence specific 
amplification of DNA molecules for either analytical or preparative reasons. It has 
been described for the first time by Mullis in 1985/86 (Mullis et al., 1986). 
The principle of the reaction is based on the sequence specific annealing of two 
oligonucleotides, usually referred to as primers, to a DNA template. The sequence of 
the primers has to be chosen in a way that they bind to the complementary strands of 
the template. The region lying between the primers defines the amplicon, the DNA 
sequence that is amplified during the PCR reaction.In addition to template and 
primers, desoxyribonucleotides (dNTPs), an enzyme catalyzing the reaction (DNA 
polymerase) and an appropriate buffer containing cofactors etc. are required for the 
reaction. The reaction is started by increasing the temperature to 95°C, a step called 
denaturation, which is supposed to induce separation of the complementary DNA 
strands of the template. In the second step the temperature of the reaction is reduced 
to enable the sequence specific annealing of the primers to the DNA template. The 
temperature of this step depends on the size and sequence of the primer pair and 
has to be determined for every reaction. After the primers have annealed the 
temperature is changed to meet the temperature optimum of the DNA polymerase 
which varies depending on the enzyme used in the reaction. During this step, the 
polymerase is catalyzing the sequence specific extension of both primers in 5´-
>3´direction. The dNTPs present in the solution are thereby used as a substrate. 
After the reaction is completed each DNA strand has been replicated once and is 
present as a double stranded DNA molecule. The reaction continues by changing the 
temperatures in the described order to induce an additional cycle of denaturation, 
annealing and extension until the desired degree of amplification is accomplished. 
The reaction used in this work is based on the Advantage Polymerase Kit 
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(Clonetech) and was done according to the manufacturer´s instructions. Briefly, 
500ng of template DNA were mixed with 320µM dNTPs, 5µM forward primer, 5µM 
reverse primer, 10x Advantage Polymerase buffer and H2O. Optionally, DMSO was 
added to a final concentration of 2% (v/v) to prevent the formation of secondary 
structures in the DNA template. The reaction was started by the addition of 2U 
Advantage Polymerase and placed into a Thermo Cycler (PCR sprint system, 
Thermo Fisher Scientific) programmed as described below: 
Table 5.2: Polymerase Chain Reaction – exemplified programm 
 
Step description Temperature [°C] Time [min] 
1 Initial Denaturation 85 5 
2 Denaturation 90 1 
3 Annealing * 1 
4 Extension 68 ** 
 
The annealing temperature * strongly depends on the primer sequence and should 
be 5°C below the estimated melting temperature as determined by the simplified 
formula below. However, the optimal annealing temperature has to be empirically be 
determined and can deviate from the calculated value: 
 
        (   )       (   ) 
 
Tm Melting temperature 
A Number of adenine 
T Number of thymidine 
G Number of guanine 
C Number of cytosine 
 
The elongation time ** varies with the size of the amplified sequence and depends on 
the processing efficiency of the Polymerase. In order to calculate the extension time 
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for the Advantage Polymerase a processing speed of 1kb/min was used. 
The primers were used for the PCR reaction were designed using Clone manager 9 
and are listed in section4.7. 
 
5.1.10 Ligation 
 
During the ligation reaction two linearized, doublestranded DNA molecules, usually 
referred to as insert and backbone/vector are connected to yield a circularized DNA 
molecule called plasmid.The backbone has been dephosphorylated as described in 
section 5.1.8 while the insert is usually derived from a digestion (see section 5.1.3) or 
PCR reaction (see section 5.1.9). The reaction is catalyzed by the ATP dependent 
enzyme T4- ligase and carried out as follows. 20-100ng of vector and insert DNA are 
added in molar ratio of 1:3 to 1x T4 ligase buffer (50mM Tris-HCl, 10mM MgCl2, 1mM 
ATP, 10mM DTT, pH 7,5) and H2O. The amount of DNA required to accomplish the 
molar ratio was thereby calculated as follows: 
 
           
           
 
 
 
 
          
          
 
 
The reaction is started by the addition of 1U T4-Ligase (NEB) and incubated either 
for 1-2h at room temperature or at 16°Covernight. In order to stop the reaction and 
inactivate the ligase the solution was incubated for 20min at 65°C. 
 
5.1.11 Generation of chemocompetent bacteria 
 
In order to generate chemocompetent bacteria an overnight culture DH5α was 
started in 20mL LB-medium and incubated at 37°C. The next day the bacteria culture 
was transferred to 250mL LB-medium and incubated at 37°C until an Optical Density 
(λ=600nm) of 0,65-0,8 (ODλ600)was reached. Next, the bacteria culture was 
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centrifuged for 10min at 5.000xg and washed once with 1 volume of precooled H2O. 
After an additional washing step with 0.5 volumes of H2O the bacteria were 
centrifuged for 10min at 5000xg and resuspended in 30mL of precooled 10% 
glycerin.After an additional centrifugation step the bacteria were resuspended in 1mL 
glycerin and distributed in 50µL aliquots. The aliquots were frozen in liquid nitrogen 
and afterwards stored at -80°C. 
 
5.1.12 Transformation 
 
An aliquot in chemo competent DH5α (see section5.1.11) was thawed for 30min on 
ice and mixed with 50ng of DNA derived from a ligation reaction. After 30min on ice 
the bacteria were heat shocked for 90s at 42°C and incubated on ice for another 
2min. Next, 200µL of LB-medium without antibiotics were added and incubated for 1h 
at 37°C. Afterwards the solution was plated on a pre-warmed agar plate containing 
the antibiotic required for selection and incubated over night at 37°C. 
 
5.1.13 Preparation of glycerol stocks 
 
Glycerol stocks are prepared to store successfully transformed bacteria and are used 
to circumvent the transformation reaction when more DNA of a previously cloned 
plasmid has to be generated.Glycerol stocks can be used directly to inoculate a 
culture of bacteria by adding a small amount to LB-medium containing the desired 
antibiotics required for successful selection. In order to prepare a glycerol stock, 
700µL of bacteria culture were mixed with 300µL of a 50% glycerol solution and 
frozen/stored at -80°C.  
 
5.1.14 Sequencing 
 
All sequencing reactions were performed using the BigDye Terminator 3.1 Cycle 
Sequencing Kit (Applied Biosystems) and analyzed in the sequencing facility of the 
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Helmholtz-Zentrum München using an ABI 3730 48-capillary sequencer. The 
sequencing results were manually analyzed using Clone Manager Software 9 (Sci-
Ed). 
The sequencing reaction consists of the following 4 consecutive steps which are 
described below: (1) Polymerase Chain Reaction (2) Ethanol precipitation of the PCR 
products (3) Analysis by electrophoresis in (4) manual analysis of sequencing results. 
 
5.1.14.1 PCR - Sequencing reaction 
 
The PCR reaction was carried out in a total volume of 5µL as described below using 
the BigDye Terminator 3.1 Cycle Sequencing Kit (Applied Biosystems).  
 
Table 5.3: PCR reaction for DNA sequencing 
 
Reagent Volume [µL] 
Big Dye (incl. dTNPs, polymerase) 0.5 
5x BigDye buffer 1 
DMSO 0.1 
Primer 1 
DNA template  x (= 150-300ng) 
H2O x 
total 5 
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Table 5.4: PCR program for sequencing reactions 
 
Step description Cycle Temp. [°C] Time [s] 
1 Initial Denaturation 1 96 60 
2 Denaturation 35 96 10 
 Annealing  50 5 
 Extension  60 240 
3 - - 12 - 
 
5.1.14.2 Ethanol precipitation of sequencing product 
 
After the PCR reaction 0.5µL of 125mM EDTA, 2µL 3M Na-Acetate and 50µL 100% 
EtOH were added to each reaction in order to precipitate the DNA. After 15min 
incubation at RT in the dark the samples were centrifuged for 30min at 2.000xg at 
4°C and the supernatant removed by spinning the inverted plate briefly at 180xg. 
After an additional wash step with 70µL 70% EtOH and a subsequent incubation step 
for 2min in the dark to ensure its complete evaporation the DNA was resuspended in 
20µL HLPC water (LiChrosoly, #1.15333.1000, Merck).   
 
5.2 Cell culture 
5.2.1 General cell culture conditions 
 
All cell lines or freshly isolated hematopoietic cells were cultured in sterile conditions 
in a standard humidified tissue culture incubator at 37°C, 5% (v/v) CO2 
(Microbiological Incubator CD210; Binder, Tuttlingen, Germany). Media exchanges 
and passages were done under were carried out under a standard tissue culture flow 
hood (HERA safe KS) using sterile plastic, glassware and media. 
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5.2.2 Freezing of cell lines 
 
OP9 and 7F2 cell lines were trypsinized and resuspended in their standard tissue 
culture medium and pelleted by centrifugation for 5min 1.200rpm. After the 
supernatant had been discarded the cells were resuspended in FCS containing 10% 
DMSO and transferred into cryotubes. The cryo tubes were put into with 100% 
isopropanol containing Cryo Freezing container (cat no 5100-0001, Nalgene, 
Rochester, USA) and stored at -80°C to allow a gradual decrease in temperature at a 
rate of -1°C/min. After 24h the cryotubes were transferred into a liquid nitrogen tank 
for long term storage.  
 
5.2.3 Thawing of cell lines 
 
In order to thaw OP9 and 7F2 cell lines the cryotubes were removed from the liquid 
nitrogen tank and opened slightly to allow depressurization. Afterwards the cryotubes 
were transferred to a 37°C water bath until almost the entire vial was thawed. Next,   
9mL of standard tissue culture medium were added and the cells were centrifuged for 
5min 1200rpm at 4°C. After the supernatant was discarded the cells were plated at 
an approximate density of 1.6x104 / cm2.   
 
5.3 Transfection 
 
The term transfection is used for a series of procedures by which DNA is introduced 
into eukaryotic cells. It can be accomplished by a variety of techniques, but is mainly 
achieved by the application of certain chemicals, mechanical forces or particles. The 
transfection methods used in this work are all chemically based and are described 
below. The transfections were done using HEK293T cells to determine the 
localization of the fluorescence fusion reporters cloned in this study. 
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5.3.1 Polyethylimine (PEI) 
 
Transfections using polyethylimine (PEI) are based on its properties to condense 
DNA into positively charged aggregates (Boussif et al., 1995). Due to their charge the 
particles are able to attach efficiently to anionic residues at the cell surface and are 
subsequently taken up via endocytosis. For transfections HEK293T were seeded in 
500µL of standard tissue culture medium in a 24 multi well plate and incubated 
overnight. At the next day, the transfection reagent was prepared by adding 300-
500ng of DNA to 66µL of a previously prepared PEI solution (4µM PEI (PolySciences 
Inc., cat. no.: 23966), 15mM NaCl, pH 7.8). After the solution had been vortexed and 
incubated 10min at RT it was added directly onto the cells and incubated for at least 
6h prior to medium exchanged. The cells were incubated for another 24h at 37°C, 
5%CO2 before analysis.  
 
5.3.2 Lipofectamine 
 
The transfection of cells with Lipofectamine is based on the formation of a DNA-
liposome complex which can be taken up by various cell types. The transfection was 
carried out using the Lipofactamine 2000 Transfection Reagent (Life technologies) 
following the manufacturer´s instructions. Briefly, 10µL Lipofectamin2000 were added 
to 90µL Opti-MEM. After 15min incubation at RT, 100µL Opti-MEM containing 2µg 
DNA were added and vortexed. After an additional incubation for 15min at RT the 
standard tissue culture medium from a previously prepare 10cm2 dish containing 
HEK293T cells was discarded and replaced with the prepared solution. The cells 
were incubated for 24h at 37°C, 5%CO2 before analysis. 
 
5.3.3 CaPO4Transfection 
 
The CaPO4 transfection has been described for the first time in 1973 and is based on 
the formation of a DNA-CaPO4 co-precipitate which is bound and internalized by 
cells(Graham and van der Eb, 1973). The procedure was carried out using the 
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Calcium Phosphate Transfection Kit (Sigma-Aldrich, CAPHOS-1KT) following the 
manufacturer´s instructions. Briefly, HEK293T cells were plated at a density of 5x106 
cells/60cm2 in DMEM (10%FCS13, 1%P/S). After 24h 5µg of DNA were mixed with 
50µL of 2,5M CaCl2and H2O to a final volume of 500µL. Next, 500µL of 2x HBS 
(50mM HEPES, 280mM NaCl, 1,5mM Na2HPO4) were added drop wise while 
vortexing the solution. After 20min incubation at room temperature, the HEK293T 
standard tissue culture medium was discarded and replaced with transfection 
medium (DMEM, L-Gln, 100mg/mL sodium pyruvate, 10%FCS13, 1%P/S, 2mM 
HEPES).After 6-12h incubation at 37°C, 5%CO2 the medium was replaced and the 
cells were incubated for additional 24h at 37°C, 5%CO2.  
 
5.4 Virus production 
5.4.1 Generation of lentiviral supernatants 
 
The production of viral particles is based on the parallel transfection of 4 plasmids 
and was done as previously described (Schambach et al., 2006). Briefly, the four 
plasmids are transiently cotransfected, (1) a lentiviral vector plasmid (2) a plasmid 
encoding for the HIV-Rev gene, (3) for the HIV-gag/pol genes and (4) the viral 
envelope (i.e. VSG-g). As basic lentiviral vector plasmid we used the previously 
published pRRL.PPT.PGKGFP.pre packaging plasmid and modified it according to 
our needs (i.e. exchange of promoter, fluorescence protein, etc.). The transfection 
was carried out using the CaPO4 methods as described before (section 5.3.3). Once 
transfected, the viral genes and the gene of interest are expressed and the latter 
mRNA is packaged into viral particles.  
The viral supernatants were collected 36 hours after transfection and were 
centrifuged for 5min at 240xg, 4°C and filtered to remove cellular debris (0.2µm pore 
size). After filtration the concentration of viral particles by ultracentrifugation at 
50.000xg for 1h at 4°C and resuspended in 200µL SFEM, aliquoted and frozen and 
stored at -80°C. 
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Table 5.5: Transfected plasmid for the generation of lentiviral supernatants 
[µg] no. Name Function 
2 495 pMD2.VSVG VSVG pseudotyped envelope protein 
5 392 PRSC_Rev Regulator of expression of virion proteins (Rev) 
10 393 pMDLg_pPRE Gag, pol 
5* - - Transfer vector containing genes of interest 
*the amount of vector DNA was adjusted according to its size. The indicated amount 
of DNA was used for a 7kb vector. 
 
5.4.2 Virus Titration 
 
In order to determine the number of infectious viral particles per volume 
(titer),2x104NIH3T3 cells per well were seeded into a 24 well plate and incubated for 
16h at 37°C, 5%CO2. Afterwards, NIH3T3 cells were counted and previously 
concentrated and aliquoted viral supernatants were thawed and added in several 
dilutions (ranging from 1x10-1 to 1x10-4). After 48h of incubation at 37°C, 5%CO2, 
NIH3T3 cells were trypsinized, harvested, washed and analyzed by flow cytometry. 
The titer was subsequently determined using the following formula: 
        
          
   
            
           
 
Abbrev. Description 
Titer Number of virus particle / µL 
Cell number Number of NIH3T3 when virus supernatant was applied 
% positive Percentage of positive cells as analyzed by flow cytometry, gated 
according to the negative control 
Volume Volume of viral supernatant used for infection 
The virus titer were determined in 3 technical replicates and only dilutions yielding 
infection rates between 3% and 30% were regarded for the titer determination to 
minimize inaccuracies caused by multiple infections.  
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5.5 Flow cytometry 
5.5.1 Analysis 
 
Flow cytometric analysis was done using the BD FACS Aria III. All samples were 
washed, resuspended in 50µL FACS buffer (PBS, 2% FCS, 2mM EDTA, 0.1% NaN3) 
and stained for 60-90min by addition of fluorescently labeled antibodies at 4°C in the 
dark. Afterwards cells were washed and filtered through a 100µm mesh to get a 
single cell suspension and to prevent clogging of the flow cytometer. Unstained and 
single stain controls were always included and used to correct for fluorescent channel 
bleed through by manual compensation. Unless otherwise indicated populations 
were gated according to the negative control. 
 
5.5.2 Sorting 
 
Flow cytometric sorting of cells was done using the BD FACS Aria III. All cells were 
prepared as described above (section 5.5.1). The machine was cleaned prior to 
every sort by flushing the cytometer for at least 5min with BD FACS Clean, rinsing 
the flow cell for 5min with BD FACS flow by activating the stream when the nozzle 
was not inserted and by sonification of the nozzle itself. Afterwards the machine was 
calibrated by determining the drop delay using BD Accudrop beads and the “auto 
drop delay” option. The calibration was controlled by sorting and reanalyzing a “test” 
population and only accepted if purities over >99% were accomplished. Afterwards 
the electric field strength was adjusted to ensure the proper localization of sorted 
cells in tubes or multi well plates. All tubes and multi well plates were cooled to 4°C 
during the whole procedure to maximize cell viability. All sorts were done using the 
single cell mode to achieve the highest purity possible. Purities of all sorts were 
controlled by reanalyzing at least one sorted population and were always ≥98%.   
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5.6 Isolation of hematopoietic stem and progenitor 
cells 
 
Hematopoietic stem and progenitor cells were isolated as described earlier with 
minor modifications as described below (Ema et al., 2006). Briefly, femur, tibia and 
coxae were isolated, mortared in FACS buffer (PBS, 2% FCS, 2mM EDTA, 0.1% 
NaN3)and filtered through a 100µm mesh. After the cell number was determined, 
cells were washed (5min, 1200rpm, 4°C) and resuspended in FACS buffer to 
1x108cells/mL. Next, 0.1µL/1x106 cells biotin conjugated B220, CD3e, CD19, CD41, 
CD11b, Gr-1, and ter-119 antibodies were added and incubated for 10-20min on ice. 
In order to remove unbound antibodies the cells were washed once and resuspended 
to 1x108 cells/mL FACS buffer. Next, 0,1µL/1x106 cells streptavidin conjugated 
magnetic particles were added and incubated 20min on ice. After filling up the 
volume to 10mL the cells were placed for 5-7min into a magnet where the lineage 
marker expressing cells were selectively retained due to their association with the 
magnetic particles. Inversion of the magnet therefore selectively transferred cells 
negative or low in expression for lineage marker into a new tube, a process called 
lineage depletion. The lineage depleted cells were counted, washed resuspended in 
50µL FACS buffer and stained with 0.1µL/1x106 cells CD150-PE, CD34-eFluor450, 
c-KIT-PECy7, sca-1-PCPCy5.5, CD48-FITC and Streptavidin-APCeFluor780 for 60-
90min on ice. After washing and resuspension in 200µL/1x107 cells the suspension 
was filtered, analyzed and sorted into SFEM, 1%P/S.  
 
5.7 Transduction of hematopoietic stem and 
progenitor cells 
 
Sorted hematopoietic stem and progenitor cells were washed with PBS, counted and 
resuspended in 100µL infection media (SFEM, 10ng/mL SCF, 20ng/mL TPO, 1µM 
11R-VIRVIT). 11R-VIVIT is a cell permeable NFAT inhibitor and is supposed to keep 
hematopoietic stem cells in a quiescence state (Sugimura, 2011). Next, titrated 
lentiviral particles were added to achieve a multiplicity of infection (MOI) of 300-600 
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and cells were incubated for 24h at 37°C and 5% CO2. The MOI was thereby 
calculated as follows: 
    
      (     )                                 
      (      )                      
     
  
 
 
The next day the cells were washed 2-3 times in 15mL PBS to remove residual virus 
particles and resuspended in the medium required for subsequent assays. 
 
5.8 Colony assays 
5.8.1 Cytospins and May-Giemsa-Grünwald staining 
 
In order to determine the cell identity of hematopoietic cells based on their 
morphology independently of antibodies, cells were spun onto object slides and 
stained consecutively with May-Grünwald and Giemsa solutions. The May-Grünwald 
solution consists out of acidic eosin, alkaline methylene blue and methanol and 
colors granules blue-violet, acidic granules red and neutral granules light red-purple. 
The cytoplasm of erythrocytes is staining light red while thrombocytes are colored as 
light blue. The Giemsa solution on the other hand consists of azure A-eosinat, azure 
B-eosinat, methylenblue-eosinate and methylenblue chloride and colors the nuclei 
purple while the cytoplasm acquires a bluish coloration. The combination of both 
solutions allows the discrimination of different hematopoietic cells based on nuclear 
morphology, coloration, appearance of granules and the nuclear:cytoplasm ratio. 
The reaction was carried out as follows. Cells were washed in PBS, 5%FCS and 
transferredinto a cytospin chamber containing a standard objective slide and 
centrifuged for 3min at 270RCF and RT. Afterwards the supernatant was discarded 
andthe slide was centrifuged for 1min at 1100RCF at RT. Next, the slide was stained 
for 4 min in concentrated May-Grünwald solution and washed twice in H2O 
bidest.,before the 5% Giemsa solution (diluted in H2O bidest.) was added. After 
16min incubation at RT and 3 washes in H2O bidest. the slides were air dried and 
mounted onto a coverslip. 
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5.8.2 Single cell Liquid Culture Colony Assay (SC-LCCA) 
The Liquid Culture Colony assay was done as described earlier (Takano et al., 2004). 
Briefly, single hematopoietic stem cells or multipotent progenitors were sorted into a 
96 well plate containing 150-200µL of LCCA media and incubated for 14 days at 
37°C and 5% CO2. At day 14 the colonies were harvested and either stained with 
May-Giemsa-Grünwald solution for morphological analysis or with CD11b-eF450, 
Ly6G-FITC, FcyR-PCP-Cy5.5, c-KIT-APCeF780, CD150-PE, CD41-APC and ter119-
PECy7 antibodies for flow cytometric analysis. 
Liquid culture colony assay medium: 
 StemPRO34 
 1:40 BIT (media supplement) 
 10% pre-tested FCS(14) 
 100ng/mL SCF 
 100ng/mL TPO 
 10ng/mL IL-3 
 2U/mL EPO 
 2mM L-Glutamine 
 50µM β-mercaptoethanol 
 1%P/S 
 
5.9 Daughter cell separation assay 
 
The daughter separation assay was established to compare the differentiation 
potential of individual daughter cells and to investigate its correlation to the 
asymmetric segregation of proteins. It consists of 4 consecutive steps: (1) Isolation of 
hematopoietic stem and progenitor cells (see section 5.6); (2) Stochastic separation 
of daughter cells (3) Quantification of daughter fluorescence intensities (4) Liquid 
culture colony assay of individual daughter cells (see section:5.8.2) 
First hematopoietic stem and progenitor cells were isolated and sorted as single cells 
into a round bottom 96-well plate containing 20µL of liquid culture colony assay 
medium (see section5.8.2) supplemented with 100ng/mL Cholera Toxin B-a488and 
 
Dirk Löffler – Research Unit Stem Cell Dynamics 
 
96 Methods 
96 
incubated at 37°C, 5%CO2. After 40h the majority of the cells have divided once so 
that 2 cells were expected to be present per well. In order to separate the two 
daughters, the content of each individual well was mixed and 10µL of the cell 
suspension transferred into two adjacent wells of a 1536 glass bottom well plate, 
respectively. It is important that both daughters were situated in the same volume 
since different media volumes above cells would affect the background intensities 
differentially therefore influence the quantification of absolute fluorescence 
intensities.  
Next, the plate was centrifuged for 5min at 1200rpm, 4°C to sediment the cells and to 
remove air bubbles.A gas permeable foil was applied to prevent evaporation. Every 
well of the plate was then imaged completely using a 10xPlan-NeoFluar Objective, a 
0,4x TV-Adapter and a 38HE filter set. Each picture was acquired at a resolution 
1388x1024pixels and saved in the uncompressed file format .png. During the 
imaging process the plate was continuously gassed (5%CO2, 5%O2, 90%N2) to avoid 
acidification of the media.  
After 3 pictures of each individual wells had been acquired the plated was incubated 
for additional 12 days at 37°C, 5%CO2 after which the daughter colonies were 
harvested, stained and analyzed by flow cytometryas described for the single cell - 
Liquid culture colony assay (see section:5.8.2) 
 
5.10 Immunofluorescence analysis 
 
Immunofluorescence analysis were performed as previously published with the 
following minor modifications (Ema et al., 2006). HSC were isolated as described 
above (see section 5.6). After the indicated times of in vitro culture the cells were 
transferred in a total volume of 10µL to four chamber silicon inserts (Ibidi, #cat 
80246) placed onto object slides. Before loading, the wells were coated with Poly-L-
Lysine according to manufactures instructions (1h, 37°C 1:10 diluted). After 30min 
incubation at 37°C, 5%CO2 cells were fixed by addition of 10µL of 4%p-formaldedyd 
(PFA). In order to assure that all cells are fixed the object slide was spun for 10s at 
500 rpm. After 20min incubation at RT cells were washed with PBST (PBS, 0.05% 
Tween-20) and permeabilized for 20min in PBS, 0,1% Triton-X 100, 0,1% NaN3). 
After one wash with PBST cells were incubated for 1h at RT in blocking solution 
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(PBST, 10% donkey serum, 1:1000 FcyR block) before primary antibodies diluted in 
blocking solution were added. Primary antibodies used were chicken anti-GFP at 
1:500 (Aves Lab) and rat anti-sca-1 at 1:200 (eBioscience). 
After overnight incubation at 4°C in a moisture chamber cells were washed at least 
three times with PBST before secondary antibodies (all used as 1:500 dilution) were 
added. After an additional incubation for 2h at RT cells were washed at least three 
times in PBST and mounted under a coverslip using VECTASHIELD hard set 
mounting medium + DAPI (Vector Laboratories, #cat H-1500). The coverslip was 
fixed to the object slide by application of nail polish. 
 
5.11 Time-lapse microscopy 
5.11.1 General imaging parameters and microscope settings 
 
Imaging and quantification of fluorescence signals of living cells requires the careful 
optimization and prioritization of the following parameters: (1) photo toxicity (2) 
temporal resolution (3) spatial resolution (4) dynamic range (5) noise and (6) signal to 
noise. Depending on the addressed questions, the priorities and therefore the applied 
microscope settings are different. The described settings below have been optimized 
to image hematopoietic stem and progenitor cell divisions over several days and 
might not be applicable to other cell types and/or experimental approaches. 
 
However, when imaging living cells the most pressing concern is always the photo 
toxicity. The reduction of photo toxicity is mandatory for cell survival during imaging 
and has been accomplished by (1) increasing the gain of the CCD camera to level 1-
2 when possible (2) setting the white point for image acquisition to a value of 0.12 
when 14-bit to 8-bit conversion was used (3) adjusting the diaphragm to minimize 
exposure of adjacent, currently not imaged positions (4) optimizing the order of 
commands required to take a picture (5) usage of glass bottom plates to improve the 
signal to noise ratio by reducing background fluorescence (6) using phenol-red free 
medium to improve the signal to noise ratio by reducing background fluorescence (7) 
application of fast fluorescence shutter (response time <50ms) or LED based 
systems (response time <5ms) (8) favoring low exposure times over a high dynamic 
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range (9) using epifluorescence imaging instead of confocal microscopy (10) using 
low magnification objectives to reduce the exposure of adjacent, currently not imaged 
positions (11) minimizing the imaging frequency to the smallest amount required to 
keep cell identity. 
 
Another important consideration is the temporal resolution. After the survival of the 
cells has been ensured by reducing the photo toxicity to a minimum the temporal 
resolution is the main factor determining the data throughput and quality. Imaging the 
cells more frequently than required not only increases the photo toxicity but also 
decreases the amount of data that can be acquired per experiment. Imaging the cells 
less frequently than required will lead to the loss of cell identities over time and there 
for reduce the data quality. The requirements for the temporal resolution depend 
strongly on the cell type and the length of the experiment. While a lower temporal 
resolution might be sufficient to keep the cell identity at the beginning of an 
experiment it might not be sufficient after several days. In order to keep cell identity, 
adherent cells, which are usually less motile, can be imaged less frequently than 
highly motile suspension cells.  
Hematopoietic stem and progenitor cells are suspension cells and therefore highly 
motile. The motility of these cells can be reduced by either coating the plates with an 
extracellular matrix components like fibronectin, collagen etc. or by co-culturing them 
with stromal cells. Experiments using fibronectin coating were usually done with a 
temporal resolution between 1-3min, while images acquired in experiments using a 
coculture system were taken every 2-5min.Another way to restrict the motility of 
hematopoietic stem and progenitor cells is the application of micro wells or micro well 
inserts restricting essentially the maximum distance a cell can migrate by reducing 
the dimension of the well and there for the imaging area. This can be favorable since 
the imaging area and temporal resolution are inversely correlated. In other words, the 
higher the temporal resolution the less area can be imaged and vice versa. 
 
5.11.2 HSC/OP9 coculture – time lapse experiments 
 
Glass bottom 12 or 24 well plates were equipped with silicon inserts (ibidi) and 
coated with 0.1% gelatine for 5-10 min at room temperature. Afterwards3x103OP9 
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stromal cells were plated per microwell in OP9 medium (see section4.5) and 
incubated for 24h at 37°C, 5%CO2. Before the time-lapse experiment was started the 
OP9 medium was removed and replaced with 100µL of hematopoietic stem and 
progenitor cell suspension. The cells were allowed to settle down for 30min at 37°C, 
5%CO2. Next, coculture medium was added until the silicon insert was completely 
covered with medium. In order to maintain a stable atmosphere while imaging the 
plate was sealed with adhesive tape and gassed (5%CO2, 5%O2, 90%N2) through a 
hole in its lid. Depending on the experiment either a 10xFLUAR Objective was used 
in combination with a 0,63x-TV-Adapter or a 20xFLUAR Objective with a 1x-TV-
Adapter. 
 
HSPC/OP9 Coculture imaging medium: 
 
 SFEM 
 20% FCS 14 
 100ng/mL SCF 
 1%P/S 
 
5.11.3 Stromal cell free – time lapse experiments 
 
Stromal cell line free time-lapse experiments were done in glass bottom multi well 
plates coated with 50ng/mL fibronectin for 1h at 37°C, 5%CO2. Two chamber silicon 
inserts were used when necessary to reduce the imaging area. Before the time lapse 
movie was started cells were transferred in the indicated media into the wells and 
incubated for 30min at 37°C, 5%CO2 to allow the cells to sink to the bottom of the 
wells. In order to maintain a stable atmosphere while imaging the plate was sealed 
with adhesive tape and gassed (5%CO2, 5%O2, 90%N2) through a hole in its lid. 
Depending on the experiment either a 10xFLUAR Objective was used in combination 
with a 0,63x-TV-Adapter or 0,5x-TV-Adapter.  
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Table 5.6: Stromal cell free imaging media 
 
[ng/mL] ST STT SI SIT 
SCF 100 100 100 100 
TPO 100 100 - - 
IL-3 - - 10 10 
EPO - - - - 
TGFβ1 - 100 - 5 
 
All media were based on phenol red free SFEM and supplemented with 50µM β-
mercaptoethanol, 2mM L-Glutamine and 1%P/S. 
 
5.11.4 Live antibody / dye staining 
 
For live antibody staining, fluorescently labeled antibodies were added in dilutions 
ranging from 1:5.000-1:10.000 (100-200ng/mL) to the imaging medium. If several live 
antibodies were used in parallel, non-overlapping fluorescent dyes were used with 
optimized filter sets to avoid spectral bleed-through. In order to avoid degradation of 
fluorescent dyes over time during time lapse movie only Alexa-Fluor dyes were used.  
Other live cell dyes were used in the following dilution: LysoTracker Red - 1:20.000 
(50µM), Cyto-ID green - 1:5.000, Hoechst33342 - 1:200.000 (50ng/mL). 
 
5.12 Image acquisition, processing and data 
analysis 
5.12.1 Data Acquisition – Timm´s Acquisition Tool (TAT) 
 
Brightfield and fluorescence pictures were acquired using Zeiss Axio Observer Z1 
microscopes (Carl Zeiss), equipped with Spectra-X (Laser2000) or HXP fluorescence 
light sources, the monochromatic 14-bit CCD camera AxioCam HRm (native 
resolution of 1388x1040 pixel), motorized stages, automated temperature control 
units and transmitted light LEDs. The microscope itself and the peripheral devices 
 
Dirk Löffler – Research Unit Stem Cell Dynamics 
 
101 Methods 
101 
were controlled by a custom made VBA (Visual Basic Application), named Timm´s 
Acquisition Tool (TAT), controlling Axiovision 4.8.2 microscope imaging software, 
thereby allowing for fully automated image acquisition using predefined settings. 
Images were saved as 8-bit in portable networks graphics (.png) format and 
transferred directly onto removable 0.5-2TB hard drives. Brightfield images were 
acquired every 1 to 3min at 50-100ms, fluorescence pictures using optimized filter 
sets every 5 to 30min at 50-500ms, depending on the channel used. The camera 
gain was increased from 0 two 2 when fluorescence images were acquired with low 
time intervals in order to minimize photo toxicity. Depending on the experiment 12-
1536 glass bottom multi well plates were used, sealed with adhesive tape and 
constantly gassed (5%CO2, 5%O2, 90%N2) through a custom made inlet in the multi 
well plate lid for the entire duration of an experiment. The duration of the time-lapse 
experiments ranged depending on the question from 0.5-10days.    
 
5.12.2 Generation of cellular genealogies - Timm´s Tracking Tool 
(TTT) 
 
The acquired brightfield and fluorescence images were loaded into a custom made 
program, called Timm´s Tracking Tool (TTT), where the x,y coordinates of cells and 
their fates (division, death, fluorescence, etc.) were manually annotated over time 
(tracking). The program integrates the annotated information to generate the cellular 
genealogy of single cells or whole colonies in form of pedigrees. Tracks with 
uncertain single cell identity were marked as lost and not considered for analysis.  
 
5.12.3 Background correction 
 
All fluorescence pictures were corrected and normalized to eliminate position and 
time dependent quantification artifacts as previously described (Schwarzfischer et. al, 
submitted). Briefly, each fluorescence image was subdivided into tiles to identify and 
remove cellular signals using a machine-learning algorithm. The pixel intensities of 
the remaining gaps were interpolated based on the properties of the surrounding tiles 
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and estimated background pictures generated.  
In order to remove position dependent artifacts, the changes in pixel intensities over 
time derived from the estimated background pictures were integrated for every field 
of view. Plotting these changes against the mean background signal of a given field 
of view illustrates that the intensities of pixels located at different positions in a 
fluorescence picture change differently over time (Figure 1D). This change of pixel 
intensity per mean background signal is individually described by the slope of linear 
regression and is used to generate a time independent correction factor (=gain) for 
every field of view. Fully normalized and corrected fluorescence pictures were 
generated by subtracting the estimated background intensities from the raw 
fluorescence pictures for every time point and dividing the result by the calculated 
gain function (Figure 1E).  
 
5.12.4 Quantification of fluorescence pictures (QTFy) 
 
The quantification of fluorescence intensities was done as previously described 
(Schwarzfischer et al., submitted). Briefly, a custom made program termed QTFy, 
was used to semi-automatically calculate the corrected fluorescence intensities as 
described in section 4.11.3. The results were integrated with the previously 
generated cellular genealogies as described in section 4.11.2. All quantification were 
manually inspected and corrected if necessary before used for further analysis.  
5.12.5 staTTTs 
 
Data derived from cellular genealogies generated by TTT as well as quantifications 
generated by QTFy were integrated into a common source by using the custom 
made software termed staTTTs. In staTTTs, the data was filtered and sorted 
exported for further analysis.  
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5.13 Statistical analysis 
 
Statistical analysis was performed using Graphpad Prism 5. Whenever the 
distribution of data points was normal (=Gaussian) two-tailed student´s t-test or 
student´s t-test with Welch´s correction (in case of unequal variances) was used. For 
not normally distributed data one- or two-tailed Mann Whitney U test was used as 
indicated. Statistical significant results are indicated with: * p<0.05, ** p<0.01, *** 
p<0.001. ns refers not significant (p>0.05). 
 
6 Results 
6.1 Isolation and quantitative imaging of single 
hematopoietic stem cells over time 
 
In order to test the hypothesis that HSC self-renewal and differentiation is controlled 
by asymmetric cell division, a list of putative candidate genes was compiled (see 
table 2). Some of these candidates have previously been suggested to segregate 
asymmetrically during cell division in non-hematopoietic tissues of other model 
organisms (i.e. NUMB, inscuteable, centrin1). Others are known parts of complexes 
that have been shown to be highly polarized during the interphase of hematopoietic 
cells (i.e. VANGL2, Inversin, Inturned). In order to quantify and compare the amount 
of candidate protein inherited by both daughters after HSC division, the proteins need 
to be visualized. This has previously been done by antibody staining of fixed cells 
(Giebel and Beckmann, 2007; Wu et al., 2007a). However the fluorescence 
intensities of both daughter were not quantified and the functional relevance of any 
putative asymmetric segregation could not been demonstrated since the daughter 
cells were fixed and therefore not available for subsequent analysis. In order to 
circumvent this problem we required a technique allowing us to quantify protein levels 
in living cells. Since mice expressing these candidates fused to a fluorescence 
reporter were not available and the generation of these mice for an initial screen  
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Figure 6.1: Isolation and quantitative imaging of single hematopoietic stem and progenitor 
cells over time. 
(A) Gating scheme for the flow cytometric isolation of HSC, early and late MPPs by flow cytometry. (B) 
Lentiviral transduction of HSPCs and their OP9 coculture for time-lapse imaging. (C) Generation of 
cellular genealogy by manual tracking of HSPCs over time.  
would be time consuming and expensive we decided to clone lentiviral constructs in 
which the candidate genes are fused to the fluorescence reporter VENUS. HSCs 
(CD150+CD48-CD34-KSL), early (CD150-CD48-CD34+KSL) or late MPPs (CD150-
CD48+CD34+KSL) were isolated from 12-14 week old C57BL/6J males (Figure 5.1A), 
transduced and subsequently transferred onto an OP9 stromal cell layer for 
quantitative time lapse imaging over several days (Figure 5.1B). Brightfield and/or 
fluorescence images were acquired in constant time intervals allowing us to keep the 
single cell identity for over 10 days. The cellular genealogy of whole colonies was 
deduced by manually annotating the x, y coordinates and kinship of cells at every 
given time point (Figure 5.1C).  
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Figure 6.2: Normalization of fluorescence images is required for reliable quantifications of 
fluorescence signals 
(A) Raw fluorescence images are subdivided into tiles and segmented to indentify fluorescence and 
background signals. (B) The background intensity of tiles containing fluorescence signals in 
interpolated based on the background intensities of adjacent tiles. Intensities of pixels at the edge or 
 
Dirk Löffler – Research Unit Stem Cell Dynamics 
 
106 Results 
106 
center of the images changes differently over time and need to be corrected if fluorescence signals 
want to be quantified reliably (C) Changes of pixel intensities over time yield a linear regression, when 
plotted again mean background intensity over a given pictures. The slope represents the gain for each 
individual pixel. The combination of all slopes according to the x,y coordinates of the pixels yields the 
gain function used to correct for position dependent differences (D) Normalized fluorescence images 
are generated by subtracting the estimated background (B) from the raw images (A) and dividing the 
results by the gain function (C). (E) Quantification of normalized cellular fluorescence intensities over 
time can be integrated with cellular genealogies. This allows the correlation of changes in fluorescence 
intensities with previous and/or future cellular behavior.   
The physical properties of light result in an uneven illumination of fluorescence 
images making reliable quantifications difficult. In time-lapse experiments where 
fluorescence images are acquired over several days or weeks these difficulties are 
even enhanced. Bleaching effects, position differences and intensity changes of the 
fluorescence light source over time negatively affect the accuracy of quantification 
results and need to be corrected (Figure 5.2 A-D) before cellular genealogy and the 
results of fluorescence quantifications can be integrated (Figure 5.2E). The 
corrections were done using specialized software (Schwarzfischer et al., in 
preparation) by normalizing every fluorescence image according to position and time 
dependent changes of pixel intensities. Briefly, using a machine-learning algorithm, 
raw fluorescence images were divided into subimages (tiles) and subsequently 
clustered according to their fluorescence intensities to filter out images containing 
cellular signals and retain images containing background only (Figure 5.2A). The 
background intensities of filtered subimages were interpolated based on the 
intensities of adjacent images creating estimated background images (Figure 5.2B). 
The rate pixel intensities change over time depends on the location of every pixel. 
Pixels in the center of images change their intensities at different rates as pixels 
located at the edges or corners (figure 5.2 B). The intensity changes over time can be 
used to estimate the relationship between pixel intensities and the mean background 
intensity (Figure 5.2C). The combination of these relationships results in the gain 
function which corrects for location dependent intensity changes and normalizes the 
fluorescence intensities to the same intensity scale. In order to generate normalized 
fluorescence images estimated backgrounds were substracted from raw images and 
subsequently divided by the gain (Figure 5.2D). The integration of continuous 
quantification of normalized fluorescence images and cellular genealogies (Figure 
5.1C) allows us to correlate changes in fluorescence intensities to previous and/or 
future cellular behaviors (Figure 5.2E).  
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6.2 Proteins can be asymmetrically inherited 
during in vitro HSC divisions 
 
A variety of proteins has been demonstrated to segregate asymmetrically in other 
tissues and model organisms and is therefore assumed to behave in a similar fashion 
in HSCs. The most prominent of these proteins is NUMB, which has been shown to 
segregate asymmetrically in the Drosophila SOP (Rhyu et al., 1994). However 
although one report suggests, importantly, without showing its functional relevance, 
that NUMB is asymmetrically segregating in HSC as well (Wu et al., 2007b), another 
report could not confirm this observation (Ting et al., 2012). In order to clarify if 
NUMB is asymmetrically segregating during HSC divisions in vitro we overexpressed 
NUMB1VENUS by lentiviral transduction in freshly isolated HSCs and (Figure 5.1A 
and 5.1B) imaged them on OP9 stromal cells as previously described (Ting et al., 
2012; Wu et al., 2007b). Besides NUMB1, 16 other fluorescence fusion constructs 
were transduced (Figure 5.3A) and their inheritance quantified during the first in vitro 
HSC divisions. Among the analyzed proteins, PRKCVENUS, InversinVENUS, 
Centrin1VENUS, InturnedVENUS, FYVEVENUS, InscuteableVENUS mitoVENUS 
and PRKCVENUS did not differ from the control and therefore do not show any sign 
of asymmetric segregation in the culture conditions used in this study. However since 
these proteins are overexpressed we cannot exclude that asymmetric segregation of 
the wild type proteins occurs at endogenous protein levels. The other proteins, 
namely CD63VENUS, SCA1VENUS, VANGL2VENUS, LAMP1VENUS, 
NUMB1VENUS, PROM1VENUS, MSI2VENUS, CD53VENUS and TGFβRIVENUS 
differed despite their overexpression from cells overexpressing VENUS (Figure 
5.3A). As with the symmetrically segregating candidates, the possibility that the 
observed asymmetric segregation is caused by the overexpression or the FP fusion 
cannot be excluded. It is interesting to note that in contrast to other studies the  
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Figure 6.3: Asymmetric inheritance of fluorescence fusion reporter during HSC divisions. 
(A) Quantification of asymmetric and symmetric inheritance of fluorescence fusion reporter during cell 
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divisions by continuous, quantitative imaging of living HSCs in vitro (B) Asymmetric inheritance can be 
confirmed visually (C and D) Representative examples of symmetric and asymmetric segregeation of 
fluorescence reporter fusions during HSC divisions as determined by quantitative time-lapse imaging. 
(C) Quantification of HSC daughter intensities demonstrates that some fluorescence reporter fusions 
can segregate asymmetrically during in vitro divisions.     
majority of daughter cell intensities range from 0 (absolute symmetric segregation) to  
0.3 (2:1 daughter ratio) and are thereby much smaller than what one would expect 
based on the pictures shown in previous reports (Giebel and Beckmann, 2007; Wu et 
al., 2007b). However, since these reports did not quantify the fluorescence intensities 
inherited by the daughters it is difficult to judge whether the few shown pictures are 
representative. Anyways, our results suggest that a difference as small as 0.1 (10% 
of mother cell fluorescence intensity or 1.22:1 daughter intensity ratio) can only be 
observed in 1-2% of divisions in the control and that these differences are stable over 
hours (Figure 5.3C and D). It should be mentioned that even smaller stable 
differences have been observed. However, since these differences do not exceed the 
values of the control they are not considered as asymmetric segregations in this 
study. 
In order to investigate if the quantification results could be confirmed visually, 
transduced HSCs cultured for 3-4 days were imaged with higher spatial and temporal 
resolution. In line with the quantification results, symmetric as well as asymmetric 
segregation of CD63VENUS, VANGL2VENUS, SCA1VENUS and LAMP1VENUS 
could be observed (Figure 5A right and 5B). With the high temporal resolution we 
were thereby able to confirm that the differences in daughter cell intensities are 
indeed caused by their asymmetric segregation and are not the result of a rapid 
protein production immediately after division in one daughter. However, we were not 
able to confirm the asymmetric segregations of TGFβRIVENUS, CD53VENUS, 
MSI2VENUS, Prominin1VENUS and NUMB1VENUS visually (Figure 5.3A right). The 
reasons for this discrepancy are unclear, but might reflect a quantification artifact. 
Alternatively, it is possible that these proteins are asymmetrically inherited, but that 
there localization is less concentrated and therefore less obvious. However, the 
differences in normalized sister intensity ratio are less pronounced when compared to 
CD63VENUS, VANGL2VENUS, SCA1VENUS and LAMP1VENUS. 
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Figure 6.4: Asymmetric inheritance is a generic feature of HSPCs and is not influenced by the 
microenvironment. 
(A) HSCs were isolated, transduced with NUMB1VENUS and cultured in medium containing 
20%Serum, 100ng/mL SCF on either OP9 or 7F2 stromal cells. (B) Asymmetric inheritance of 
NUMB1VENUS does not differ between HSCs cultured on OP9 and 7F2. Statistical results were 
calculated using one-tailed Mann-Whitney U test and are indicated with: * p<0.05, ** p<0.01, *** 
p<0.001. ns refers to not significant (p>0.05). 
NUMB has previously been suggested to segregate more asymmetrically when 
cultured on 7F2 instead on OP9 stromal cells in vitro (Wu et al., 2007b). If this 
difference could also be quantified using our imaging technique one could conclude 
that the lack of visual confirmation is negligible since it is a rather subjective than 
objective criterion. We transduced HSCs, cultured them on OP9 and 7F2 stromal 
cells and quantified the amount of NUMB1VENUS that was inherited by the HSC 
daughters (Figure 5.4A). Although both differed from the VENUS control we could not 
detect any difference between OP9 and 7F2 stromal as previously described (Figure 
5.4B). The reasons for this discrepancy are unclear. One possibility would be that the 
overexpression of NUMB1VENUS alters its subcellular localization. However,  cell-
cycle dependent changes in the localization of the fusion protein were exactly as 
previously described for wild type NUMB protein (Schmit et al., 2012), strongly 
suggesting normal localization of the NUMB1VENUS fusion protein.   
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Since the asymmetric segregation of CD63VENUS, VANGL2VENUS, SCA1VENUS 
and LAMP1VENUS was detected by image quantification and could be seen by eye 
in living (Figure 2D) as well as fixed cells (data not shown) we decided to analyze 
these candidates in more depth.  
 
6.3 Asymmetric inheritance of CD63, VANGL2, 
SCA1 and LAMP1 is a generic feature of HSPCs 
and is not influenced by the microenvironment 
 
HSCs reside in a specialized microenvironment. Although the exact location and 
cellular architecture of the niche in vivo is controversial, it has been speculated to 
provide external cues required to induce polarity and asymmetric HSC divisions. This 
assumption is based on observations made in other model systems, like D. 
melanogaster (Morrison and Spradling, 2008; Oliaro et al., 2010). In order to test 
whether the observed asymmetric segregations of CD63VENUS, VANGL2VENUS, 
SCA1VENUS and LAMP1VENUS are induced by the in vitro microenvironment, 
HSCs overexpressing these proteins were cultured on OP9 stromal cells, or only 
fibronectin or glass (Figure 5.5A). Similar frequencies of asymmetric and symmetric 
segregations were observed in all three culture conditions, suggesting that the 
segregation of these proteins is not influenced by the microenvironment (Figure 
5.5B). Interestingly, VENUS was inherited more symmetrically when HSCs were 
cultured in stromal cell free conditions. Although the differences are minute it might 
indicate a potential interaction with the microenvironment. However, since we did not 
observe differences in CD63VENUS, VANGL2VENUS, SCA1VENUS and 
LAMP1VENUS cultured HSCs this putative influence does not seem to alter the 
segregation of these proteins.    
In order to investigate if the observed asymmetric segregation is restricted to HSCs, 
we overexpressed VENUS, CD63VENUS, VANGL2VENUS, SCA1VENUS and 
LAMP1VENUS in early and late MPPs and cultured them on OP9 (Figure 5.6A). The 
frequencies of asymmetric and symmetric segregation in early as well as late MPPs 
are comparable to what has been observed in HSCs (Figure 5.6B). This suggests  
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Figure 6.5: Asymmetric inheritance is a generic feature of HSPCs and is not influenced by the 
microenvironment. 
(A) HSCs were isolated, transduced with fluorescence reporter fusions and cultured in medium 
containing 20% Serum, 100ng/mL SCF on OP9 stromal cells, fibronectin or glass only to determine 
whether the asymmetric segregation is influenced by the environment. (B)  The environment does not 
influence the inheritance of fluorescence fusion reporters. Each dot represents the normalized 
daughter intensity ratio of a single HSC division calculated by the indicated formula. Statistical results 
were calculated using one-tailed Mann-Whitney U test and are indicated with: * p<0.05, ** p<0.01, *** 
p<0.001. ns refers to not significant (p>0.05). 
that the observed asymmetric segregations are a more generic feature of 
hematopoietic cells and are not restricted to stem cells.  
As mentioned above we cannot exclude that the observed asymmetric segregations 
were caused by the overexpression of fluorescence fusion reporters. We therefore 
cultured HSCs, early and late MPPs on fibronectin and labeled endogenous SCA1 
with live antibody staining (Figure 5.7A). Live antibody staining of CD63, LAMP1 and  
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Figure 6.6: Asymmetric inheritance of different proteins is a generic feature of early 
hematopoietic populations 
HSC, early and late MPPs were isolated, transduced with fluorescence reporter fusions and cultured in 
medium containing 20%Serum, 100ng/mL on OP9 stromal cells to determine whether the asymmetric 
segregation is cell type specific. (B)  Asymmetric inheritance of fluorescence reporter fusions during 
HSPC divisions on OP9 in not cell type specific. Each dot represents the normalized daughter intensity 
ratio of a single HSPC division calculated by the indicated formula. Statistical results were calculated 
using one-tailed Mann-Whitney U test and are indicated with: * p<0.05, ** p<0.01, *** p<0.001. ns 
refers to not significant (p>0.05). 
VANGL2 was tested as well but no signals could be detected (data not shown). 
However, asymmetric segregation of endogenous SCA1 could be observed and 
quantified even with live antibody staining (Figure 5.7B-D). Interestingly, the degree 
of asymmetric inheritance although present in all 3 populations was more 
pronounced in early and late MPPs compared to HSCs (Figure 5.7B). The staining 
pattern between these 3 populations differed already during interphase showing a 
highly localized SCA1 signal in late MPPs and an increasingly more evenly 
distributed signal across the plasma membrane in early MPPs and HSCs (Figure 
5.7C). Interestingly the localized signal could also be observed in HSCs and early 
MPPs and was asymmetrically inherited during cell divisions of all 3 populations  
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Figure 6.7: Live antibody staining reveals asymmetric inheritance of endogenous SCA1 
(A) HSCs, early and late MPPs were isolated and cultured on fibronectin in medium containing 
20%Serum, 100ng/mL SCF supplemented with fluorescently tagged SCA1 antibody to determine 
whether endogenous SCA1 is asymmetrically inherited as well. (B) Quantification of HPSC cell 
divisions shows that asymmetric segregation of endogenous SCA1 can be detected and is more 
pronounced in early and late MPPs. Each dot represents the normalized daughter intensity ratio of a 
single HSPC division calculated by the indicated formula. (C) Representative images of endogenous 
SCA1 in living HSCs, early and late MPPs during mitosis and interphase demonstrate that 
endogenous SCA1 is accumulating already during interphase and that this accumulation is 
asymmetrically segregated during cell division. Scale bars: 10µm. (D) High temporal and spatial 
resolution time-lapse movie demonstrates that endogenous SCA1 is accumulating in subcellular 
compartments and confirms asymmetric segregation occurs indeed during cell division. Scale bar: 
20µm. Statistical results were calculated using one-tailed Mann-Whitney U test and are indicated with: 
* p<0.05, ** p<0.01, *** p<0.001. ns refers to not significant (p>0.05). 
(Figure 5.7C). The localized signal resembled the previously observed signal 
accumulation in virally transduced cells (Figure 5.3B), and therefore is not an effect of 
overexpression. The fact that the signal accumulation is present in all four 
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overexpressed fluorescent fusion reporters as well as endogenous SCA1 labeled by 
live antibody staining points towards a common subcellular localization and 
mechanism. This idea is supported by the observation that the frequencies of 
asymmetric segregations were comparable between different fluorescence fusion 
reporters (Figure 5.3A, 5.5B and 5.6B). 
 
6.4 Lysosome like compartments are inherited 
asymmetrically during HSPC divisions 
 
In recent years, lipid rafts have been reported to be involved in the activation of 
quiescent HSCs. Upon cytokine stimulation the evenly distributed lipid rafts form 
highly polarized clusters (Vannini et al., 2012; Yamazaki et al., 2006, 2009). SCA1 as 
a GPI-anchored protein has been reported to be located in lipid rafts (Horejsí et al., 
1999). We therefore speculated that the highly localized SCA1 signal observed by 
overexpression of SCA1VENUS (Figure 5.3B) or by live antibody staining (Figure 
5.7C and D) might colocalize with the commonly used lipid raft marker Cholera toxin 
B (CTxB). To test this hypothesis HSCs were transduced with SCA1VENUS and 
stained live with fluorescently labeled CTxB. SCA1/CTxB colocalization could be 
observed in SCA1VENUS expressing HSCs as well as HSCs labeled by SCA1 live 
antibody staining (Figure 5.8A and B). Asymmetric and symmetric cosegregation of 
both SCA1 and CTxB during HSC divisions could be detected (Figure 5.8B). 
Furthermore we were able to confirm the colocalization by high spatial resolution 
confocal imaging of fixed HSCs after cytokine stimulation (Figure 5.8C). Surprisingly, 
also CD63VENUS, VANGL2VENUS and LAMP1VENUS showed a strong 
colocalization with the lipid raft marker when imaged in living HSCs (Figure 5.8A). 
This suggests that CD63, VANGL2, LAMP1 and SCA1 localize to the same 
subcellular compartment and that their asymmetric inheritance is based on a 
common mechanism. This idea is supported by the previously described similarities 
in form of a single localized fluorescence fusion reporter accumulation (Figure 5.3A 
and B) and the comparable frequencies of asymmetric inheritance between different 
fluorescence fusion reporters (Figure 5.3A, Figure 5.5B and 5.6B).    
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Figure 6.8: Fluorescence fusion reporter and endogenous SCA1 colocalize with lipid raft 
marker CTxB. 
(A) Representative images of living HSPCs transduced with fluorescence fusion reporters stained with 
Hoechst33342 and CTxB. Fluorescence fusion reporters strongly colocalize with the lipid raft marker 
CTxB. Scale bar: 5µm (B) Representative images of symmetric and asymmetric inheritance of 
endogenous SCA1 and CTxB in 100ng/mL SCF, 100ng/mL TPO demonstrates that both markers 
cosegregate during HSC divisions in vitro. Scale bar: 10µm (C) Representative confocal images of 
fixed HSPCs demonstrating that CTxB and SCA1 colocalizes in freshly isolated cells (stimulated for 
30min with 100ng/mL SCF, 100ng/mL TPO). Scale bar: 10µm. 
 
Since CD63VENUS and LAMP1VENUS are commonly used marker for lysosomes 
we tested the colocalization of all asymmetrically segregating fluorescence fusion 
reporters with the lysosomal marker LysoTracker Red in living HSCs. CD63VENUS 
and LAMP1VENUS colocalized with the lysosomal marker as expected (Figure 5.9A). 
Surprisingly, also SCA1VENUS and VANGL2VENUS colocalized with LysoTracker 
Red (Figure 5.9A). This observation is in line with the previously mentioned idea that 
the asymmetrically segregating fluorescence fusion reporter localize to the same 
subcellular compartment. Furthermore, since all fluorescence fusion reporter 
colocalize with CTxB as well (Figure 5.8A), the presented results suggests that the 
specificity of CTxB to mark lipid rafts has been grossly overestimated in previous 
studies and that the previously described lipid raft clusters are most likely part of the 
degradative machinery. The accumulation of fluorescence fusion reporters in the 
degradative machinery would explain why CD63VENUS, VANGL2VENUS, 
SCA1VENUS and LAMP1 show similar, highly localized signal accumulations (Figure 
5.3B) and why this accumulation is more pronounced when endogenous SCA1 is 
labeled by live antibody staining in late MPPs (Figure 5.7B). In contrast to HSCs and  
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Figure 6.9: Lysosomes colocalize with fluorescence fusion reporter and are inherited 
asymmetrically during HSPC divisions in vitro 
(A) Representative images of living HSPCs transduced with fluorescence fusion reporters stained with 
Hoechst33342 and LysoTracker Red. Fluorescence fusion reporters colocalize with the lysosomal 
marker LysoTracker Red. Scale bar: 5µm (B) Representative images of living HSPC stained with 
LysoTracker and the autophagosomal marker Cyto-ID demonstrate colocalization of both markers It 
demonstrates that lysosomes can asymmetrically segregate also in the absence of live antibody 
staining or viral overexpression. Scale bar: 5µm. 
early MPPs which actively produce SCA1, its production in late MPPs is 
downregulated. SCA1 therefore disappears shortly after isolation of late MPPs from 
the plasma membrane and accumulates in lysosomes. In contrast, in HSCs and early 
MPPs, where SCA1 is abundantly expressed, the accumulation is less obvious since 
it is masked by the SCA1 expression on the plasma membrane (Figure 5.7C). The 
asymmetric inheritance of lysosomes would also explain why fluorescence fusion 
reporters as different as CD63VENUS, VANGL2VENUS, SCA1VENUS and 
LAMP1VENUS are asymmetrically inherited in similar frequencies (Figure 5.3A, 
Figure 5.5B and 5.6B). However, if fluorescence fusion reporters accumulate in 
lysosomes which can be asymmetrically inherited during cell division, it is surprising 
that only 4 out of 17 candidates show this behavior. The reasons for that are currently 
unclear.    
A recent report demonstrated the importance of autophagy for HSC maintenance 
(Warr et al., 2013). Since the autophagosomal and lysosomal pathways merge to 
form the autolysosome we wanted to determine whether autophagosomes are 
asymmetrically segregating as well. We therefore used the autophagosome marker 
Cyto-ID and imaged HSCs live. Asymmetric as well as symmetric segregation of  
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Figure 6.10: Asymmetric inheritance of endogenous SCA1 can be modulated by cytokines. 
(A) To determine whether its segregation influenced by different extracellular derived signals, HSCs 
were isolated and cultured on fibronectin using the indicated cytokine conditions supplemented by 
fluorescently tagged SCA1 antibody. (B) The asymmetric segregation of endogenous SCA1 can be 
modulated by the cytokine conditions used. The occurrence of asymmetrically inherited endogenous 
SCA1 more pronounced in SCF, TPO and SCF, IL3, TGFβ1 compared to SCF, TPO, TGFβ1 and 
SCF, IL3. Each dot represents the normalized daughter intensity ratio of a single HSC division 
calculated by the indicated formula. Statistical results were calculated using one-tailed Mann-Whitney 
U test and are indicated with: * p<0.05, ** p<0.01, *** p<0.001. ns refers to not significant (p>0.05). 
autophagosomes could be detected (Figure 5.9B). However, since this marker 
strongly overlaps with the lysosomal marker we assume that the specificity of these 
dyes is limited. Nevertheless, taken together the presented evidence suggests that 
CD63VENUS, VANGL2VENUS, SCA1VENUS and LAMP1VENUS as well as 
endogenous SCA1 accumulate in lysosomal-like organelles that can asymmetrically 
segregate during HSPC divisions in vitro.   
It has recently been reported that the frequency of lipid raft cluster formation in HSCs 
can be increased or decreased depending on the cytokines used (Vannini et al., 
2012). We therefore speculated that different cytokines might influence the 
degradative machinery and its segregation during HSPC divisions. HSCs were 
therefore labeled with SCA1 live antibodies and cultured in SCF/TPO, 
SCF/TPO/TGFβ1, SCF/IL3 and SCF/IL3/TGFβ1 on fibronectin (Figure 5.10A). The 
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SCA1 inheritance of the HSC daughters was quantified and compared. Interestingly, 
SCF/TPO and SCF/IL3/TGFβ1 showed a more pronounced asymmetric segregation 
compared to SCF/TPO/TGFβ1 and SCF/IL3 (Figure 5.10B). The meaning of these 
differences is currently unclear and requires further investigation. Even though the 
frequencies of asymmetric inheritance are increased in SCF/TPO and 
SCF/IL3/TGFβ1, HSCs do not react in a unified manner. It will therefore be 
interesting to see if the asymmetric segregation of the degradative machinery is a 
stochastic event with a certain probability depending on the culture conditions used 
or if the different responses are based on different subpopulations.  
 
6.5 Asymmetric segregation of SCA1 does not 
correlate with early in vitro differentiation 
 
We could demonstrate that SCA1 and other proteins are asymmetrically segregating 
during HSPC divisions in vitro. As a next step, its functional relevance had to be 
tested. We were therefore looking for ways to identify asymmetric daughter cell fates 
allowing us to identify differentiation and lineage choice in vitro. Linking asymmetric 
fates to the observed asymmetric segregation would allow us to prove the control of 
HSPC fates through asymmetric cell division.  
It has previously been published that in vitro cultured HSCs change their 
immunophenotype (Zhang and Lodish, 2005). It is therefore not trivial to find reliable 
in vitro marker as indicators of differentiation. The expression of SCA1 and CD48 has 
been shown to correlate with loss of HSC capacity and differentiation in vitro as well 
as in vivo (Noda et al., 2008; Zhang and Lodish, 2005). As in vivo, all in vitro cultured 
HSCs are contained within the SCA1+CD48- fraction while the downregulation of 
SCA1 or the CD48 onset are indicative of their differentiation (Figure 5.11A-C).  
It has previously been suggested that HSCs divide asymmetrically when cultured in 
SCF and TPO (Ema et al., 2000; Takano et al., 2004). However since cell divisions 
were not observed directly it was not clear if the cause for these asymmetries is  
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Figure 6.11:SCA1 offset is an early, quantifiable event indicative of differentiation. 
(A-B) Freshly isolated HSCs, early and late MPPs and hematopoietic progenitors were stained with 
antibodies and analyzed by flow cytometry for SCA1 and CD48 expression demonstrate the SCA1 
downregulation and CD48 upregulation during differentiation in vivo. (B) Culturing HSCs for 7 days in 
SCF, TPO on fibronectin shows that SCA1 downregulation precedes CD48 upregulation. Thus, SCA1 
is the earlier differentiation marker. (C-E) SCA1 is downregulated before CD48 onset occurs. 
Representative fluorescence images and quantification of double positive living HSPCs stained by live 
SCA1 and CD48 antibodies. Scale bar: 10µm. (F) Analysis of SCA1 fluorescence intensities in living 
HSPCs over 4 generations show that the downregulated of SCA1 can be detected and quantified. 
Each dot represents the normalized SCA1 intensity at the end of the cell cycle. Statistical results were 
calculated using two-tailed unpaired student´s t-test and are indicated with: * p<0.05, ** p<0.01, *** 
p<0.001. ns refers to not significant (p>0.05). 
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linked to events happening during HSC division or caused post mitotically. We 
speculated that asymmetric daughter cell fates might have been caused by 
asymmetric segregations and decided to use these culture conditions for our further 
analysis. As a first step, we determined the SCA1 offset and CD48 onset kinetics on 
a population level as markers for differentiation. While SCA1 levels were rapidly 
downregulated, CD48 positive cells did not emerge before day 5-6 (Figure 5.11C). 
After 7-8 days, a massive upregulation of CD48 could be observed (data not shown). 
However, the majority of HSCs had become SCA1 negative days before that (Figure 
5.11C). In fact, we rarely observed double positive cells, indicating that SCA1 
downregulation precedes the CD48 onset (Figure 5.11D and E). This idea is 
supported by the rapid downregulation of SCA1 protein levels over 3 generations 
(Figure 5.11F). 
The rapid downregulation of SCA1 in these culture conditions was also found when 
individual HSC colonies were tracked over time (Figure 5.12B). While some of the 
colonies can be characterized by a rapid downregulation of SCA1 which is almost 
always associated with symmetric SCA1 segregations (Figure 5.12B left), other 
colonies are more heterogeneous and give rise to cells of various SCA1 intensities 
(Figure 5.12B middle/right). These colonies are sometimes, but not always 
associated with asymmetric SCA1 segregations. In summary, the loss of SCA1 
expression precedes the CD48 onset and is therefore an earlier and potentially more 
reliable marker for differentiation than CD48.   
In order to correlate the asymmetric segregation of SCA1 with its downregulation as 
an indicator for differentiation or other cellular attributes, HSC divisions were sorted 
according to their normalized daughter sister intensity ratio into symmetrically 
(normalized sister intensity ratio: <0.05) and asymmetrically segregating HSCs 
(normalized sister intensity ratio: >0.1) (Figure 5.12C). Next, the sister cells receiving 
more or less SCA1 in asymmetric segregations were pooled and the SCA1 
production of the daughter cells themselves as well as the total SCA1 production of 
their future progeny (for 3 generations) compared (Figure 5.12D and E). The SCA1 
production was calculated by subtracting the SCA1 intensities at the beginning of the 
cell cycle from the SCA1 intensities at the end and added over several generations in 
case of the total sister colony SCA1 production. Negative values would thereby be 
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Figure 6.12: Asymmetric inheritance of endogenous SCA1 does not correlate with future 
daughter cell fates 
(A) HSCs were isolated and cultured in SCF, TPO on fibronectin supplemented by fluorescently 
tagged SCA1 antibody to determine whether its asymmetric inheritance correlates with future daughter 
cell fates. (B) Representative examples of HSC derived colonies with integrated SCA1 quantification 
demonstrates highly heterogeneous SCA1 offset behaviors between different colonies. (C) SCA1 
inheritance during HSC divisions was quantified using the depicted formula and clustered into 
symmetric and asymmetric segregations based on arbitrary thresholds as indicated. (D-E) Asymmetric 
SCA1 inheritance does affect the SCA1 production or maintenance of individual daughter cells or 
daughter cell derived colonies. Daughters of asymmetric divisions receiving more or less SCA1 were 
pooled the SCA1 production of the daughters themselves or the total SCA1 production 
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(=maintenance) of their future progeny compared. (F) Asymmetric SCA1 inheritance does not affect 
the cell life time or morphology (=perimeter) of the daughters, but correlates with daughter cell size or 
adherence (=area). Statistical results were calculated using one-tailed Mann-Whitney U test and are 
indicated with: * p<0.05, ** p<0.01, *** p<0.001. ns refers to not significant (p>0.05). 
 
indicative of active degradation of SCA1, positive values for a net production. 
However, we were not able to detect differences in the production and maintenance 
of SCA1 intensities between HSC daughter cells or HSC daughter colonies (Figure 
5.12D and E).  
In addition to the loss of SCA1 other cellular attributes like HSC daughter cell life time 
and area as an indicator of size were normalized and analyzed in a way, that a 
random set of variables (in case of a symmetric segregation it is random which 
daughter is defined as the one that receives [more] or [less]) would give a Gaussian 
distribution centered around 0. An ordered data set (in case of asymmetric 
segregation, where it is clearly defined which daughter receive [more] or [less]) on 
the contrary would deviate from this distribution if the attributes where correlated with 
the segregation. If the distribution would shift towards the right (positive) the daughter 
cell receiving more SCA1 would have also have bigger numerical values in this 
attributes (positive correlation). If the distribution would shift towards the left 
(negative) the cell receiving more SCA1 would have the smaller numerical value and 
vice versa (negative correlation). Since the distributions of the neither the cell life time 
nor their shape (=perimeter) in asymmetric segregation deviate from the distribution 
of symmetric segregations we conclude that the asymmetric segregation of SCA1 
does neither influence the cell cycle length of the daughters nor their shape 
(=perimeter) (Figure 5.12F and H). However, the daughters receiving more SCA1 
tend to occupy a bigger area than the daughter receiving less SCA1 (Figure 5.12G). 
This might either indicate that HSPCs receiving more SCA1 give rise to bigger 
daughters, or that the daughters differ in their ability to adhere to the fibronectin 
coated surface. The meaning of this observation is currently unclear. 
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6.6 The asymmetric inheritance of SCA1 does not 
correlate with TGFβ1 induced apoptosis 
 
TGFβ1 is considered to be an inhibitory cytokine controlling proliferation, 
differentiation and quiescence. It has been suggested to induce hibernation of HSCs 
while inducing apoptosis in differentiated CD34+ cells when cultured with SCF and 
TPO (Yamazaki et al., 2009). Interestingly, HSC self-renewal and differentiation 
potential were maintained for a period of 5 days. We speculated that apoptosis would 
be indicative of differentiation in these culture conditions and could therefore be used 
as a marker in our time-lapse experiments. If this assumption would be correct, any 
asymmetric occurrence of apoptosis in the cellular genealogy might correlate with the 
asymmetric segregation of SCA1 in case it is associated with this process. 
In order to test this hypothesis we cultured HSCs, early and late MPPs in SCF, TPO 
and TGFβ1 (Figure 5.13A). HSC derived colonies were able to survive longer than 
their counterparts derived from early or late MPPs (Figure 5.13B), which were rarely 
able to divide at all in these culture conditions (data not shown). If TGFβ1 were to 
induce apoptosis of differentiated cells one would expect a selective enrichment of 
SCA1 high expressing cells. In order to test that, we cultured freshly isolated HSC for 
3 days in SCF/TPO and SCF/TPO/TGFβ1 and analyzed their SCA1 expression level 
by flow cytometry (Figure 5.13C). As expected, HSCs cultured with TGFβ1 
maintained high SCA1 expression levels when compared to HSCs cultured in 
SCF/TPO only. This observation is in line with a recent publication suggesting that 
SCA1 inhibits TGFβRI mediated signaling by preventing its hetero dimerization with 
TGFβRII (Upadhyay et al., 2011). In order to determine if asymmetric cellular 
genealogies can be observed we tracked HSCs cultured in SCF and TPO with and 
without TGFβ1 (Figure 5.14A). The frequency of asymmetric apoptotic genealogies 
up to generation 2 increased from 4.2% (7/168) in SCF/TPO to 22.6% (30/133) in 
SCF/TPO/TGFβ1 (Figure 5.14B). This strongly suggested that cells inheriting less 
SCA1 were more sensitive to TGFβ1 mediated apoptosis. In order to test this 
hypothesis we tried to correlate the occurrence of asymmetrically segregating SCA1 
with the occurrence of cell death. As described before (section 5.5) the quantified  
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Figure 6.13: TGFb1 enriches for HSCs and increases or maintains SCA1 expression levels. 
(A) To determine whether TGF1 selectively induces apoptosis in differentiated cells as previously 
published, HSCs, early and late MPPs were isolated and cultured in medium containing SCF, TPO, 
TGFβ1on fibronectin supplemented by fluorescently tagged SCA1 antibody to determine whether 
TGF1 selectively induces apoptosis in differentiated cells as previously published. (B) HSC derived 
colonies are selectively enriched when cultured in SCF, TPO, TGFβ1 and have a total colony life time 
(=colony survival) that is longer than early and late MPP derived colonies(B) Representative flow 
cytometric analysis showing that SCA1 expression levelsof HSCs are increased or maintained when 
cultured for 3 days with TGFβ1.  
HSC divisions were defined as symmetric (59 of 128 divisions) or asymmetric (32 of 
128 divisions) according to the normalized SCA1 daughter intensity ratios (Figure 
5.15B). The daughters receiving more or less SCA1 derived from the as asymmetric 
defined divisions were pooled and the frequency of apoptosis within the same 
generation calculated (Figure 5.15C). Daughters receiving more SCA1 did not die 
more frequently than their sisters, demonstrating that the asymmetric segregation of 
SCA1 does not directly affect the viability of HSC daughters (Figure 5.15C). Since the 
overall colony life time of HSCs declines with time (Figure 5.13B) and the frequency 
of asymmetric apoptotic genealogies increases (Figure 5.14B), we speculated that 
the asymmetric segregation of SCA1 might affect the viability of the subsequent 
generations. In order to test this hypothesis we tracked all colonies for at least one 
additional generation. The cellular genealogies derived from this analysis are highly  
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Figure 6.14: TGFβ1 induces asymmetric apoptotic daughter cell and colony fates in HSC 
derived cellular genealogies. 
(A) To determine whether TGF1 induced asymmetric apoptotic fates could be detected, HSCs were 
isolated and cultured in medium containing SCF, TPO and TGFβ1 on fibronectin. (B) HSC derived 
asymmetric apoptotic genealogies are increased in the presence of TGF1 compared to SCF, TPO 
only as determined by time-lapse imaging. (C) Tracking HSC derived colonies for over 3 generations 
reveals a highly heterogeneous occurrence of apoptosis making the definition of asymmetric apoptotic 
fates difficult. (D) Differences in sister colony survival also reveal and increase occurrence of 
asymmetric apoptotic genealogies. Statistical results were calculated using two-tailed unpaired 
student´s t-test and are indicated with: * p<0.05, ** p<0.01, *** p<0.001. ns refers to not significant 
(p>0.05). 
heterogeneous. The majority of the colonies previously regarded to contain 
asymmetric fates (Figure 5.14C) showed an early death of both daughters in the 
following generation. Colonies in which both daughters were surviving showed a  
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Figure 6.15: Asymmetric SCA1 inheritance does not correlate with TGFβ1 induced asymmetric 
apoptotic daughter cell fates 
(A) To determine whether TGF1 induced asymmetric apoptotic cell fates correlate with the 
asymmetric inheritance of SCA1, HSCs were isolated and cultured in medium containing SCF, TPO 
and TGFβ1 on fibronectin supplemented by fluorescently tagged SCA1 antibody. (B) SCA1 
inheritance during HSC divisions was quantified using the depicted formula and clustered into 
symmetric and asymmetric segregations based on arbitrary thresholds as indicated. (C) Asymmetric 
SCA1 inheritance does not influence the occurrence of apoptosis in HSC daughter cells (D-G) 
Asymmetric SCA1 inheritance does affect the  daughter cell life or daughter colony life time and does 
not influence cell morphology (=perimenter), but correlates with daughter cell size or adherence 
(=area). Statistical results were calculated using one-tailed Mann-Whitney U test and are indicated 
with: * p<0.05, ** p<0.01, *** p<0.001. ns refers to not significant (p>0.05). 
sudden cell death of all daughters just one generation further (Figure 5.14C). Since 
we do not know if the number of surviving generations or the absolute time of survival 
is of importance for cells, we defined asymmetric apoptotic genealogies as trees 
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where the absolute difference of the HSC daughter colony life time was bigger than 
36h. Using this definition, HSCs cultured with TGFβ1 showed an increased frequency 
of asymmetric apoptotic fates (29 of 105 colonies) when compared to the control (9 of 
116 colonies) (Figure 5.14D). However, neither daughter colony life time, daughter 
cell life time or daughter cell shape (=perimeter) correlated with the asymmetric 
segregation of SCA1 (Figure 5.15.D-G). Interestingly, as observed before when 
cultured in SCF/TPO, the SCA1 segregation positively correlates with the determined 
area of the daughter cells, demonstrating the cells receiving more SCA1 occupy a 
bigger area and might therefore either be bigger or more adherent (Figure 5.15F).       
 
6.7 A quantitative differentiation assay as a reliable 
in vitro readout for lineage potential 
 
So far we did not find a clear correlation between the asymmetric segregation of 
SCA1 and early differentiation events like the downregulation of SCA1 itself or the 
TGFβ1 induced apoptosis. Instead of being involved in controlling stemness we 
speculated that the asymmetric segregation might be involved in the regulation of 
lineage choice. Indeed, SCA1 has been suggested to be a negative regulator of 
erythropoiesis (Azalea-Romero et al., 2012; Chang et al., 2008). In order to test if the 
asymmetric segregation of SCA1 is associated with lineage choice we required 
culture conditions that would permit the differentiation into as many hematopoietic 
lineages as possible. Unfortunately, no culture condition promoting the differentiation 
into the entire hematopoietic system has been reported yet. However, liquid culture 
conditions supporting the differentiation of single HSCs into megakaryocytes, 
erythrocytes, granulocytes and macrophages have been described (Ema et al., 2006; 
Takano et al., 2004). These culture conditions have been successfully used to detect 
asymmetric lineage potential of HSC daughters separated via micromanipulation 
(Takano et al., 2004). However, the readout of this assay is based on May-Giemsa-
Grünwald staining of colonies and the morphological classification of up to 1000 cells 
per colony by microscopy. Screening a bigger number of colonies is therefore not  
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Figure 6.16: A quantitative, clonal differentiation assay to readout lineage potential 
(A) HSCs were isolated, stained and sorted as single cells into 96 well plates and incubated for 10-
18days in the indicated culture conditions in order to determine the lineage potential of the initially 
sorted cells by flow cytometry and/or morphological analysis. (B-C) Combinatorial analysis of 6 
antibodies by flow cytometry (B) and morphological analysis by May-Giemsa Grünwald staining (C) of 
the same colonies give the same results. Scale bar: 200µm (D) Optimal time-point to readout 
multipotency (GemM potential) is day 14, as determined by time course and flow cytometric analysis. 
(E) Colony frequency generated by HSC, early and late MPPs determined by flow cytometry at day 14 
resemble previously published frequencies determined by morphological analysis. Statistical results 
were calculated using two-tailed unpaired student´s t-test and are indicated with: * p<0.05, ** p<0.01, 
*** p<0.001. ns refers to not significant (p>0.05). 
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feasible in a reasonable amount of time. In addition to that is the morphological 
classification of hematopoietic cell types highly subjective and varies between 
individuals. Although this problem has been controlled for in the original publication 
by analyzing each colony by two individuals, the lineage contribution of the colonies 
was not analyzed quantitatively and potential lineage biases might have been 
missed. 
We therefore needed to improve the throughput and sensitivity of this assay while 
simultaneously making the readout more objectively. Classical flow cytometry has 
been described to allow the simultaneous and quantitative measurement of up to 17 
different markers and allows the analysis of thousands of cells within seconds 
(Perfetto et al., 2004). In order to test if we could reproduce the results of the original 
publication using a different readout we sorted single HSCs into 96 well plates and 
analyzed half of the generated colonies after 14 days by May-Giemsa-Grünwald 
staining and the other half with fluorescent labeled antibodies and flow cytometry 
(Figure 5.16A). Combinatorial analysis of 6 different antibodies by flow cytometry 
(Figure 5.16.B) showed a strong correlation with the morphological classification 
achieved by May-Giemsa-Grünwald staining (Figure 5.16C)). Based on these results 
we defined macrophages as cKIT-FcyR+CD11b+Ly6G-, granulocytes as cKIT-
FcyR+CD11b+Ly6G+, megakaryocytes as cKIT-FcyR-CD41+TER119- and erythrocytes 
as cKIT-FcyR-CD41-TER119+.  Based on the presence of these 4 lineages the 
colonies were classified as GemM (G= Granulocytes, e= erythrocytes, m= 
macrophages, M= Megakaryocytes), GmM, Gm etc. However it should be mentioned 
that although megakaryocytes, macrophages and granulocytes were easily 
detectable by May-Giemsa-Grünwald staining we are not certain about the 
morphological classification used for erythrocytes. However, since the small cells 
detected in GemM colonies were not present in colonies classified as Gm and GmM 
we conclude that this population must represent cells of the erythroid lineage. Using 
this classification we determined the optimal time point for detection of GemM 
colonies (Figure 5.16D) and compared the different colony forming potentials 
between HSCs, early and late MPPs (Figure 5.17). GemM colony frequencies were 
comparable to what has been described in the literature (Takano et al., 2004) and the 
colony forming potential differed between HSCs, early and late MPPs as expected. 
Flow cytometric classification of colonies thus is able to reproduce the same data and  
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Figure 6.17: Validation of flow cytometric gating using a megakaryocyte reporter mouse. 
(A) HSCs were isolated, stained and sorted as single cells into 96 well plates and incubated for 
14days in the indicated culture conditions in order to determine whether the combinatorial usage of 6 
antibodies recapitulates the expression pattern of a megakaryocyte reporter (VWF2-eGFP) mouse. (B) 
Classical hematopoietic hierarchy illustrating the expression of lineage marker used: VWF2-eGFP, 
cKIT, FcyR, CD41, TER-119. (C) Flow cytometric gating scheme used to identify megakaryocytes (D) 
VWF2-eGFP is expressed in putative megakaryocytes identified by combinatorial gating scheme, but 
absent in all other populations, demonstrating that Megakaryocytes can be detected reliably. (E) 
Representative fluorescence image of a single HSC derived megakaryocyte containing colony isolated 
from VWF2-eGFP mice. Megakaryocytes are recognizable by morphology and VWF2-eGFP 
expression. 
can be used as a surrogate assay. In order to further validate that we can detect 
different hematopoietic lineages reliably, we repeated the analysis with sorted single 
HSCs derived from VWF-eGFP (Figure 5.17) and Pu.1Yfp/Gata1mCherry mice 
(Figure 5.18). Von Willebrand factor is a marker of the megakaryocytic lineage and 
should therefore be expressed in megakaryocytes (Figure 5.17B) identified by 
morphology as well immunophenotype 
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Figure 6.18: Validation of flow cytometric gating scheme using a Gm- and MegE-lineage 
reporter mouse. 
(A) HSCs were isolated, stained and sorted as single cells into 96 well plates and incubated for 
14days in the indicated culture conditions in order to determine whether the combinatorial usage of 6 
antibodies recapitulates the expression pattern of a Gm- and MegE-lineage reporter 
(PU.1YFP/GATA1mCHERRY) mouse. (B) Classical hematopoietic hierarchy illustrating the expression 
of lineage marker used: PU.1, GATA1, FcyR, cKIT. (C) Putative Gm- and MegE-lineages (population I 
and II) are PU.1YFP
+
/GATA1mCHERRY
-
 and PU.1YFP
-
/GATA1mCHERRY
+
 respectively 
demonstrating that both lineages are detected reliably.  
(Sanjuan-Pla et al., 2013). As expected, VWF-eGFP is expressed in cells of the cKIT-
FcyR-CD41+TER119- population (Figure 5.17CIII and DIII), but not in erythrocytes 
(Figure 5.17CV and V) or cells of the granulocytic, macrophage lineage (Figure 
5.17EII and DII). Also, morphologically recognizable megakaryocytes were VWF-
eGFP positive (Figure 7E lower panel). However, it should be noted that only about 
50% of all cKIT-FcyR-CD41+TER119- cells showed detectable levels of VWF-eGFP 
indicating that this marker combination is not sufficient to detect megakaryocytes with 
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100% purity.   
PU.1 is a transcription factor expressed in B-cells as well as in cells of the 
granulocytic/macrophage lineage. GATA1 on the contrary is expressed on cells of the 
megakaryocytic/erythroid lineage (Figure 5.18B). All cells of the 
granulocytic/macrophage lineage are therefore PU.1+GATA1- and cells of the 
megakaryocytic/erythroid lineage PU.1-GATA1+. Another hallmark of the 
granulocytic/macrophage lineage is the expression of the Fc receptor (FcR). 
Megakaryocytes and erythrocytes on the other side are negative for this marker. If 
our gating scheme would reliably distinguish between the granulocytic/macrophage 
and the megakaryocyte/erythroid lineage, cKIT-FcR+CD11b+Ly6G- macrophages 
and cKIT-FcR+CD11b+Ly6G+granulocytes would expected to be PU.1+GATA1-. 
Furthermore would we expect that cKIT-FcyR-CD41+TER119- megakaryocytes and 
cKIT-FcyR-CD41-TER119+ erythrocytes are PU.1-GATA1+. Indeed, FcR+cKIT- cells 
are low or negative for GATA1mCHERRY (Figure 7F II and III) while PU.1YFP is 
expressed at intermediate or high levels (Figure 5.18C). FcR-cKIT- cells also 
express GATA1mCHERRY as expected, but are negative for PU.1YFP (Figure 
5.18C). Cells positive for cKIT+ are considered to be immature progenitors and are 
low or negative for PU.1 and GATA1. In summary, flow cytometric analysis of single 
cell derived colonies allows the reliable identification of myeloid blood lineages.   
 
6.8 The asymmetric segregation of CTxB does not 
correlate with in vitro lineage potential 
 
After the in vitro readout for lineage potential had been established we wanted to 
determine if HSCs would give rise to daughters with different lineage potential and if 
so, if we could correlate this with asymmetric segregations. Due to technical reasons 
we were using CTxB instead of SCA1 as an asymmetric segregation marker. As 
demonstrated before, SCA1 and CTxB colocalize strongly and cosegregate during 
symmetric and asymmetric segregations in vitro (Figure 5.8A-C). Instead of using 
micromanipulation we were separating the daughters by transferring manually half of 
the medium into two adjacent wells of a 1536 multi well plate, and visually confirming 
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the presence of only one sister, respectively. A total of 9216 putative HSC daughter 
cells were separated, quantified and analyzed by flow cytometry for the lineage 
potential in 7 independent experiments (Figure 5.19C). The theoretical maximum of 
successful separation of two daughter cells is ~33%. The divisional kinetics however 
dictate a narrow time window (36-50h after isolation) where the daughter separation 
can take place efficiently. At 36h after isolation, around 50% of the HSCs had already 
divided while the remaining ones would divide to a later time point and were therefore 
not available for successful daughter separation. This decreases the theoretical 
efficiency to successfully separate HSC daughters to ~16%. The time window for 
daughter separations is the limiting factor of this assay. Earlier separations will 
decrease the available HSC daughter pairs while later separations increase the 
likelihood for additional cell divisions of at least one of the separated daughters 
before the amount of CTxB in both daughters can be quantified. The latter as well as 
an expected cloning efficiency of 90% in these culture conditions further decrease 
the number of the theoretical successful separations. After the HSC daughters have 
been successfully separated the amount of CTxB was determined in 3 technical 
replicates (Figure 5.19B) and all data points with inconsistent quantification results 
were excluded from the analysis. Comparing the quantification results of two cells in 
two different wells is not trivial because a number of factors like, fluctuation of the 
fluorescence light source, differences in the illumination pattern etc. can influence the 
quantification result. However, comparing the distribution calculated for the daughter 
separation assay with the previously calculated distributions determined in time-lapse 
experiment suggests that our image correction minimizes these effects (compare 
Figure 5.19C with 5.15B and 5.12C). In order to determine if the asymmetric 
segregations of CTxB influences the differentiation potential of the HSC daughters, 
asymmetric (97 of 272) and symmetric (101 of 272) segregations were defined as 
described above (Figure 5.19C). The lineage contributions of a HSC daughter colony 
pairs were normalized using the depicted formula and pooled for asymmetrically and 
symmetrically segregating HSC. Since the values of symmetrically segregating HSCs 
are entered in a random fashion into the formula one would expect a gaussian 
distribution centered around 0. The values of asymmetrically segregating HSCs are 
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Figure 6.19: The asymmetric segregation of CTxB does not correlate with in vitro lineage 
potential. 
(A) HSC daughters were manually separated, fluorescence images acquired, quantified and lineage 
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potential of sister colonies determined by flow cytometry. (B) Representative images and quantification 
of successfully separated HSC daughters were classified according to the calculated normalized sister 
intensity ratio as symmetric (top; int. 14.6 vs. 14) and asymmetric (bottom; CtxB int.13.8 vs. 9.4 ) 
segregation. Scale bar: 10µm. Two-tailed unpaired student´s t-test. (C) Frequency distributions of 
normalized sister CTxB intensity ratio were calculated using the depicted formula. (D-E) Asymmetric 
CTxB inheritance does not affect the lineage output of HSC daughter cells as determined by flow 
cytometric analysis. (J) The absolute colony forming potential is not affected by asymmetric 
inheritance of CTxB. (K) The number of asymmetric colony forming potential is not affected by CTxB 
inheritance. Statistical results were calculated using one-tailed Mann-Whitney U test and are indicated 
with: * p<0.05, ** p<0.01, *** p<0.001. ns refers to not significant (p>0.05). 
entered into an ordered way according to the CTxB intensity of the colony and should 
deviate from the frequency distribution of the symmetric segregation if the lineage 
potential is influenced by the amount of CTxB inherited by the daughters. Neither the 
frequencies of granulocytes, macrophages, erythrocytes or megakaryocytes nor the 
overall frequencies of the megakaryocytic/erythrocytic (MegE) or 
granulocytic/macrophage (Gm) lineage of the HSC daughters are influenced by the 
asymmetric segregation of CTxB (Figure 5.19 D-I). This is also reflected in the overall 
frequencies of daughter colony types (Figure 5.19K) and the absolute colony 
frequencies generated by daughters receiving more or less CTxB (Figure 5.18J).
 
7 Discussion 
7.1 The asymmetric segregation of proteins in 
highly purified, living HSCs can be observed 
and quantified in vitro 
 
Hematopoietic stem cells are capable of maintaining their numbers while 
simultaneously giving rise to all cell types of the hematopoietic system lifelong. Based 
on findings in other model organisms it has been suggested that this is accomplished 
by a mechanism referred to as asymmetric cell division. According to the hypothesis, 
cell fate determinants are asymmetrically inherited by the HSC daughters and exert 
different cellular programs to induce asymmetric fates such as self-renewal or 
differentiation. The simplicity and elegance of this hypothesis has led to its general 
acceptance in the field. However, neither the asymmetric segregation of proteins nor 
their functional relevance has ever been demonstrated directly in living HSCs. In 
other words, the experimental evidence required to support this hypothesis has not 
been demonstrated.  
In order to test this hypothesis we screened the behavior of a number of putative cell 
fate determinants during in vitro divisions of living HSCs using a novel quantitative 
bio imaging approach. We investigated if the first prerequisite of the asymmetric cell 
division hypothesis, the asymmetric inheritance of proteins, could be confirmed. In 4 
out of 17 analyzed candidates we were able to detect evidence for asymmetric 
segregations as determined by fluorescence quantification and visual examination of 
time-lapse experiments (Figure 2C and D). One of these candidates, CD63 had 
previously been suggested to segregate asymmetrically during in vitro divisions of 
human umbilical cord blood derived CD34+CD133+ cells as determined by 
immunofluorescence analysis of fixed cells (Beckmann et al., 2007). However, since 
the HSC purity of this population is smaller than 1% (Drake et al., 2011), it is unclear 
if and to what extend this segregation actually occurs in human HSCs. The other 
asymmetrically segregating proteins, namely SCA1, VANGL2 and LAMP1 have 
recently been described also by others to be highly polarized themselves or to be 
part of highly polarized complexes in hematopoietic cells, but their segregation during 
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HSC divisions has never been analyzed before (Sugimura et al., 2012; Thaunat et 
al., 2012; Vannini et al., 2012a). Since the screen to identify asymmetrically 
segregating proteins was based on lentiviral delivery of fluorescence reporter fusion 
proteins, the observed effects could be the result of overexpression. Although we 
cannot entirely exclude this possibility for CD63, VANGL2 and LAMP1 the 
occurrence of an overexpression artifact is unlikely given that we were able to 
reproduce the observed asymmetric segregations of SCA1VENUS when 
endogenous SCA1 was labeled by live antibody staining (Figure 3C, E, F and 5G). 
Although live antibody staining of the other asymmetrically segregating candidates 
did not work, we conclude from the observations made using SCA1 antibodies that 
the overexpression of fluorescence reporters does not necessarily induce artifacts 
resembling asymmetric segregations. This is further supported by the observation 
that 8 out of 17 overexpressed candidates did not show any signs of asymmetric 
segregation (Figure 2C).  
We therefore demonstrate, to our knowledge for the first time, that CD63, VANGL2, 
SCA1 and LAMP1 are asymmetrically segregating during in vitro divisions of highly 
purified, living HSCs. Besides that, this is the first report analyzing HSC divisions 
quantitatively over time, allowing us to use objective criteria rather than the previously 
applied qualitative assessments to classify asymmetric and symmetric segregations. 
Although we did not see convincing evidence for the asymmetric segregation of the 
remaining candidates we cannot exclude the possibility of their asymmetric 
inheritance when expressed at endogenous protein levels or in different 
microenvironments. It is possible that the cellular sorting machinery has been 
overloaded by the overexpression of the fusion proteins and that putative 
asymmetries were masked. Indeed, TGFβRI, CD53, Msi2, Prominin1 and Numb 
fusion proteins demonstrated, based on the quantification of HSC daughter 
fluorescence intensities, a slight but significant tendency to be inherited more 
unequally when compared to the control (Figure 2C). However, since these results 
could not be confirmed by the visual examination of the cell divisions we did not 
consider them to be asymmetric. It is anyways interesting to note that CD53, 
Prominin1 and Numb have previously been suggested to segregate asymmetrically 
(Beckmann et al., 2007; Lathia et al., 2011; Wu et al., 2007a). Especially whether 
NUMB, a widely accepted cell fate determinant in other model organisms, is 
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asymmetrically segregating in HSCs, is still highly controversial. Our results confirm a 
recently conducted study that did not see a clear asymmetric segregation of NUMB 
when overexpressed as a mCHERRY fusion (Ting et al., 2012). However,  an older 
study suggested its asymmetric segregation by analyzing fixed cells via 
immunofluorescence microscopy (Wu et al., 2007b). It is therefore possible, as 
mentioned above, that the actual overexpression of proteins is masking potential 
asymmetric segregations by overloading the cell. Alternatively, the use of the 
microtubli depolymerization agent nocodazole in the latter study might have 
introduced artifacts as well. Indeed, nocodazole has recently been shown to be 
inappropriate to study the asymmetric segregation of proteins due to its effects on the 
positioning of centrosomes and its overall cytotoxicity (Nteliopoulos and Gordon, 
2012). Regardless, given that the future daughter fates of fixed cells cannot be 
analyzed, it is not possible to demonstrate the functional relevance of any putative 
asymmetric segregation directly by using this technique. It is therefore likely that this 
issue will not be solved until a fluorescently tagged NUMB knock-in mouse line is 
available for analysis. 
 
7.2 Asymmetric segregation of candidate proteins 
is regulated by secreted growth factors and not 
influenced by the microenvironment 
 
It has previously been suggested that the asymmetric segregation of proteins during 
HSC divisions is influenced by the microenvironment (Ting et al., 2012; Wu et al., 
2007b). However, we did not find evidence that this is true for CD63, SCA1, LAMP1 
or VANGL2 (Figure 3A). No detectable changes in asymmetric segregation 
frequencies could be observed for HSCs cultured on OP9 stromal cells, on the extra 
cellular matrix protein fibronectin or on glass. The comparison with early and late 
MPPs, populations committed to differentiation, demonstrated that the asymmetric 
segregations are not restricted to the HSC compartment. This suggests that the 
underlying mechanism is a common feature of hematopoietic cells and is not based 
on a specialized interaction between HSCs and the niche. The observation that 
different cytokine cocktails alter the asymmetric segregation frequencies of 
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endogenous SCA1 (Figure 4F) demonstrates, that secreted growth factors, rather 
than cell-cell or cell-matrix mediated signals are responsible for the observed 
asymmetric segregations. We therefore conclude that the observed asymmetric 
segregations are controlled extrinsically.  
Although we do not see evidence for a cell-cell contact mediated control of the 
asymmetric segregations of CD63, SCA1, LAMP1 or VANGL2 we cannot exclude 
this possibility when different culture conditions are used. That VENUS expressing 
HSCs show a higher degree of unequal inheritance during HSC divisions when 
cultured on OP9 stromal cells compared to fibronectin or glass might be indicative of 
a potential influence mediated by cell-cell contacts (Figure 3A). However, this effect 
does not seem to influence the asymmetric segregation of CD63, SCA1, LAMP1 and 
VANGL2 and its implications are unclear. 
 
7.3 Lysosomal like compartments are 
asymmetrically segregating and are equivalent 
to CTxB labeled lipid raft cluster 
 
That different cytokines can either induce or decrease the polarity of HSCs has 
recently been demonstrated by measuring the formation of lipid raft clusters by 
staining of living hematopoietic cells with fluorescently labeled Cholera Toxin B 
(Vannini et al., 2012b). Although this study did not determine the behavior of lipid raft 
clusters during the in vitro divisions of HSCs, it demonstrated that SCA1 is able to 
form similar clusters upon cytokine stimulation, implying that the asymmetric 
segregation of SCA1 detected by us and the formation of lipid raft clusters might be 
associated. SCA1, as well as CD63, VANGL2 and LAMP1 colocalize with the lipid 
raft marker CTxB and are present in clusters in cytokine stimulated, living HSCs 
(Figure 4A and C), suggesting a common localization and mechanism for the 
asymmetric segregation of these proteins. Although the colocalization of SCA1 and 
CTxB was expected, the localization of CD63, LAMP1 and VANGL2 in lipid rafts had 
not been reported before. Since CD63 and LAMP1 are known to be enriched in the 
lysosomal membrane we tested their colocalization with a commonly used marker for 
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acidified organelles, LysoTracker Red, demonstrating that not only CD63 and 
LAMP1, but also SCA1 and VANGL2 are located in lysosomes. Taken together the 
presented data suggests that CD63, VANGL2, SCA1 and LAMP1 accumulate and 
colocalize in lysosomes (Figure 4D) which are asymmetrically segregating during 
HSC divisions (Figure 2D and 4E). Furthermore we demonstrated that Cholera Toxin 
B, a commonly used marker for lipid rafts is accumulating in lysosomes of activated 
HSCs, and that so called lipid raft clusters might actually reflect its transport to this 
compartment upon internalization. The internalization of Cholera Toxin B and its 
delivery to lysosomes has been reported before (Ewers and Helenius, 2011; te 
Vruchte et al., 2010) but the exact nature of these clusters has never been 
investigated in hematopoietic stem and progenitor cells. The concept of lipid raft 
cluster formation is based on studies of T-cell receptor signaling and the formation of 
the immunological synapse (Miceli et al., 2001; Yamazaki et al., 2006) and has been 
applied to the activation of quiescent HSC given that similar clusters have been 
observed (Yamazaki et al., 2006). However, the colocalization with lysosomal 
markers strongly suggests that the observed CTxB clusters in activated HSPCs are 
in fact lysosomes. A thorough reanalysis and reinterpretation of the published 
literature of lipid raft cluster formation in HSCs will therefore be required.  
 
7.4 Lysosomes - more than the cellular trash bin 
 
Lysosomes are classically considered to be the terminal degradative compartments 
for molecules derived from the extracellular space via endocytosis or from 
intracellular sources via autophagy (Kornfeld and Mellman, 1989). However, an 
accumulating body of evidence suggests that lysosomes are more than the cellular 
“trash bin”. 
Lysosomes have been described to be a major regulator of apoptosis. The lysosomal 
pathway of apoptosis can be activated by death receptors, lipid mediators and photo 
damage. Upon its activation, the lysosomal membrane is permeabilized and 
proteases are released into the cytoplasm to contribute to the apoptotic cascade 
upstream of mitochondria (Guicciardi et al., 2004). Interestingly, lysosomal 
accumulation of cholesterol has recently been described to stabilize the lysosomal 
 
Dirk Löffler – Research Unit Stem Cell Dynamics 
 
142 Discussion 
142 
membrane in neurons to protect the cells from oxidative stress induced apoptosis 
(Appelqvist et al., 2012). In addition, autophagy, another closely related branch of the 
degradative pathways, has recently been shown to be required for the survival of 
HSCs under metabolic stress (Warr et al., 2013). 
Beside their role in regulating apoptosis, lysosomes were recently shown to be 
involved in signal transduction. In the presence of nutrients the Transcription Factor 
EB (TFEB) colocalizes with the master growth regulator mTOR complex 1 (mTORC1) 
on the lysosomal membrane. Upon starvation and lysosomal disruption TFEB is 
activated and translocates to the nucleus to induce the transcription of genes 
involved in autophagy, lysosomal biogenesis and starvation response (Settembre et 
al., 2012). Another study reported that a C-terminal lysosomal sorting motif is 
required for proper NOTCH activation in HeLa cells (Zheng et al., 2013). And that the 
lysosomal inhibitors bafilomycin (Baf) and glycyl-L-phenylalanine-β-naphthylamide 
(GPN) are able to block the FasL-induced formation of lipid raft clusters has been 
shown in  coronary artery endothelial cells (CAEC) cells (Jin et al., 2007). 
It is surprising how little is known about the role of lysosomes in HSPCs. Although 
studies demonstrating that lysosomes exceed their previously recognized function as 
the terminal degradative compartment have not been conducted in HSPCs yet, it is 
possible that similar mechanisms participate in the regulation of hematopoietic cells 
as well. The discovery that HSCs exert a pro-autophagy gene program demonstrates 
that the degradative compartment is critical for the regulation of HSCs (Warr et al., 
2013).  
 
7.5 The functional relevance of asymmetrically 
segregating lysosomes remains unclear. 
 
Although the asymmetric segregation of proteins is indicative of an underlying 
mechanism used by HSCs, it is not sufficient to demonstrate asymmetric cell division 
as long as its functional implications (correlating asymmetric daughter cell fates) have 
not been demonstrated (Horvitz and Herskowitz, 1992; Morrison and Spradling, 
2008). Several studies have reported either directly or indirectly the occurrence of 
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asymmetric HSC daughter cell fates (Ema et al., 2000a; Noda et al., 2008; Takano et 
al., 2004; Yamazaki et al., 2009). Based on these reports, three different in vitro 
readouts were established and adapted in ways that allowed us to use them in 
quantitative time-lapse microscopy (Figure 5-8). Two of these readouts were based 
on early detectable differentiation events as measured by the loss of the stem cell 
marker SCA1 or the TGFβ1 mediated apoptosis of differentiated cells. The third 
readout was supposed to detect putative influences on the lineage choice during 
long-term differentiation in permissive culture conditions. Although we were able to 
successfully detect the expected asymmetric fates in all three readouts (Figure 5F, 
6F-G and 8K) we were not able to find a clear correlation with the observed 
asymmetric segregations of SCA1 or CTxB (Figure 5, 6 and 8). Neither the lineage 
choice, the TGFβ1 induced apoptosis nor the SCA1 offset were influenced by the 
asymmetric segregation. Since we demonstrated that SCA1 and CTxB accumulate in 
the degradative compartment over time (see section 7.3) they are used as surrogate 
markers and their asymmetric inheritance can be interpreted as the asymmetric 
segregation of lysosomes. We therefore conclude that lysosomes are not directly 
associated with the regulation of differentiation and lineage choice in the culture 
conditions used in this study. However, we cannot exclude the possibility that the 
asymmetric segregation of lysosomes has functional relevance in other culture 
conditions. That different cytokine cocktails alter the frequency of the observed 
asymmetric segregations suggests that the lysosomal inheritance is an actively 
controlled process instead of a random event. It is interesting to note that the 
combination of cytokines with opposing functions seems to increase the frequency of 
asymmetric segregation. While TGFβ1 is considered to be an inhibitory cytokine 
promoting the quiescence of HSCs, IL3 has been known for its ability to induce 
proliferation (Takano et al., 2004; Vannini et al., 2012b; Yamazaki et al., 2009). 
Although we can currently not generalize this observation it will be interesting to see 
if this is true for other cytokines as well. 
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7.6 Conclusions, critical points and future 
perspective 
 
HSCs are able to give rise to daughters with equal (symmetric) or unequal 
(asymmetric) cell fates. If these cell fate decision are made during cell divisions or by 
post mitotic events is not well understood. We conducted this study to clarify this 
issue by testing for the first prerequisite of the asymmetric cell division hypothesis, 
the asymmetric inheritance of cell fate determinants. 
As predicted by the hypothesis we were able to identify several asymmetrically 
segregating proteins. Although this had been suggested before (Beckmann et al., 
2007; Ting et al., 2012; Wu et al., 2007a), we are providing for the first time 
quantitative evidence that this is happening in highly purified, living HSCs at 
endogenous protein levels. Furthermore could we demonstrate that asymmetric 
inheritance of these proteins is based on their accumulation in lysosomes. We also 
demonstrated that our approach, in contrast to previous studies, can be used to 
directly test the correlation of asymmetric protein segregations to future asymmetric 
daughter cell fates.  
However, the asymmetric segregations detected in this study do not seem to be 
involved in the regulation of HSC differentiation or lineage choice. We are therefore 
currently not able to provide the experimental evidence required to demonstrate that 
HSCs utilize asymmetric cell divisions to regulate cell fate decisions. However, the 
possibility that HSC fate decisions are controlled by asymmetric cell divisions also 
cannot be excluded. Besides the possibility that there is simply no correlation 
between the asymmetric segregation of lysosomes and the investigated asymmetric 
daughter cell fates the elusive functional correlation might be related to a variety of 
either technical or biological reasons which are discussed below.    
(1) Instead of being involved in the regulation of differentiation and lineage choice, the 
asymmetric segregation of lysosomes might affect alternative cell fate decisions that 
have not been addressed in this study. Although a variety of alternative cell fate 
decisions can be analyzed, the recently reported importance of autophagy for the 
HSC survival under starvation conditions might provide hints for the functional 
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relevance of asymmetrically inherited lysosomes (Warr et al., 2013). Based on the 
assumption that the degradative compartment exerts pro survival effects, its 
asymmetric segregation during division might provide the daughter receiving the 
lysosome an advantage when external sources of nutrients are limited. Alternatively, 
the asymmetric segregation of cellular trash contained within lysosomes might lead to 
the rejuvenation of one daughter while “toxic” proteins are accumulating in the other. 
A similar mechanism has been reported for the aggresome, an aggregate of 
misfolded proteins (Lerit et al., 2013). If the asymmetric inheritance of the lysosome 
would reduce the “fitness” of one daughter one would expect an increased apoptosis 
rate in daughters receiving the lysosome over several rounds of asymmetric 
segregation. 
(2) Although other asymmetric fates might reveal the functional relevance of the 
asymmetric segregation the absence of correlation might also be explained by the 
lack of polarized cues from the microenvironment. It is possible that the asymmetric 
segregation of lysosomes alone, although necessary, is not sufficient to establish 
stable asymmetric fates by itself. The daughter cells would therefore be merely 
primed to acquire asymmetric fates, but the acquisition of these fates manifested by 
different environmental cues. Since the in vitro environment in our culture conditions 
does not provide different environmental cues, initially different daughter cells are 
exposed to the same microenvironment and might therefore be prone to acquire the 
same fate. The asymmetric fates observed in our cultures would in this model be 
explained by stochastic fluctuations. Similar systems have been described before 
and involve the regulated spindle orientation upon stem cell divisions (Lerit et al., 
2013; Morrison and Spradling, 2008). GSC in Drosophila´s testis are attached to the 
hub, specialized niche cells ensuring the maintenance of stem cells by localized 
unpaired signaling. Upon division the regulated spindle orientation at the hub/GSC 
ensures that one daughter is displaced from the niche and ends up in a different 
signaling environment, determining its fate. Based on the observation that the mother 
centrosome is associated with the GSC-hub cortex interface and is retained by the 
stem cell we speculate that if similar mechanisms are utilized by HSCs one would 
expect that the asymmetric segregation of lysosomes should correlate with the 
segregation of mother or daughter centrosome. Furthermore would we expect that 
the introduction of localized signals (i.e. cytokine or antibody labeled beads) should 
lead to a directed segregation of lysosomes (i.e. into the cell touching the bead) if 
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HSC utilize mechanisms dependent on the controlled displacement of daughter cells 
by the regulated spindle orientation during divisions. 
(3) A third explanation is based on the observations that lysosomes are involved in 
antigen processing and presentation to cells of the immune system (Hsing and 
Rudensky, 2005). Indeed, asymmetric segregation of antigens during  B-Cell division 
has recently been reported and functionally linked to their capacity to activate T-cells 
(Thaunat et al., 2012). Interestingly, the antigens in this study colocalized with 
compartments positive for the lysosomal marker LAMP1 as well as the major 
histocompatibility complex 2 (MHC-II). It is therefore possible that effects mediated by 
the asymmetric segregation of lysosomes in HSCs do not affect the HSCs or their 
progeny but act by modulating the activity of cells of the immune system. If this would 
be true one would expect that lysosomes receiving daughters are able to induce the 
proliferation of immune cells more efficiently than their sisters. However, HSCs have 
not been reported to function as antigen presenting cells and the expression of MHC-
II has not been demonstrated. It is anyways interesting to note that MHC-I has been 
shown to be involved in the engraftment of HSCs after transplantation (Huang et al., 
2004).  
 
In order to clarify the functional implications of the asymmetric inheritance of 
lysosomes we are planning to address the above mentioned alternative explanations 
in future experiments. Continuous, quantitative imaging of dividing HSPCs under 
starvation conditions, in culture with antibody or cytokine labeled beads or in 
coculture with naive T-cells should allow us to determine whether these processes 
are related to lysosome segregation or not. The combination of quantitative time-
lapse imaging and classical single snap shot analysis after fixation might also provide 
valuable insights. Using antibodies specific for phosphorylation events might reveal 
changes in the activation status of certain signaling cascades and its relation to 
lysosome segregation. Analyzing whether lysosomes cosegregate with either the 
mother or daughter centrosomes is also of interest. Furthermore do we want to test 
what happens to the lysosome associated transcription factor TFEB during the 
asymmetric inheritance of lysosomes. In addition to that do we want to test if 
additional functional assays to determine HSC potential such as the LTC-IC or single 
daughter cells transplantations correlate with the observed asymmetric segregations. 
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9 Supplementary information 
 
9.1 Supplementary Movie 5.2A-R 
 
Time-lapse movies corresponding to figure 5.2C showing the symmetric segregation 
of indicated candidate genes in virally transduced HSCs cocultured on OP9 stromal 
cell line 3-4 days after infection. Magnification: 20x/1xTVadaptar; Time scale: days - 
hours:minutes:seconds. 
 
9.2 Supplementary Movie 5.2S-V 
 
Time-lapse movies corresponding to figure 5.2D showing the asymmetric segregation 
of indicated candidate genes in virally transduced HSCs cocultured on OP9 stromal 
cell line 3-4 days after infection. Magnification: 20x/1xTVadaptar; Time scale: days - 
hours:minutes:seconds. 
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10 Abbreviations 
 
Abbreviation Meaning 
% Percent 
°C Degree Celsius 
µL microliter 
µm mircometer 
µM Micromolar 
2-me β-Mercapto Ethanol 
A Adenosine 
A488 Alexa488 
A555 Alexa555 
A647 Alexa647 
a-MEM Alpha-Minimel Essential Medium 
AP-2 adaptor-protein 2 
AP2A2 AP-2 complex subunit alpha-2 
APC allophycocyanin 
APC-eFluor780 Allophycocyanin-eFluor780 
Ang1 Angiopoietin 1 
aPKC Atypical Protein Kinase C 
Baf Bafilomycin (lysosomal inhibitor) 
Bidest. Bidestillated 
BM Bone Marrow 
bp Basepair 
BS Beam Splitter 
c concentration 
C Cytosine 
C.elegans Caenorhabditis elegans 
CXCL12 CXC-Motif ligand 12 (=SDF-1) 
CAEC coronary artery endothelial cells 
CaPO4 CalciumPhosphate 
CCD Charged Coupled Device 
CD Cluster of Differentiation 
CD11b Itgam 
CD150 Slamf1 
CD34 Sialomucin CD34 
CD48 Cluster of differentiation 48 
CD62L L-selectin 
CD71 Transferin receptor 
Celsr2 Cadherin EGF LAG Seven-Pass G-Type Receptor 2 
CFSE Carboxyfluorescein succinimidyl ester 
c-KIT CD117 
CLP Common Lymphoid Progenitor 
cm
2
 Square centimeter 
CMP Common Myeloid Progenitor 
c-mpl Myeloproliferative leukemia virus oncogene 
CO2 Carbondioxide 
Conc. concentration 
CTxB Cholera toxin B 
D.melanogaster Drosophila melanogaster 
DAPI 2-(4-amidinophenyl)-1H -indole-6-carboxamidine 
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ddH2O Double-distilled water 
Dlg Disc large 
DMEM Dulbeco´s Modified Eagle Medium 
DMSO dimethylsulfoxide 
DNA Desoxyribonucleinacid 
dNTP Desoxyribonucleotides 
DTT Dithiothreitol 
EDTA EthyleneDiamineTetraAcetic acid 
eGFP Enhanced GFP 
EML Erythroid Myeloid Lymphoid 
EPO Erythropoietin 
EtOH Ethanol 
FACS Fluorescence Activated Cell Sorting 
FBS Fetal Bovine Serum 
FCS Fetal calf serum 
FcγR Fcy-receptor 
FITC fluoresceinisothiocyanat 
Flk2 Fetal liver kinase-2 
Fmi Flamingo 
Fz8 Frizzled8 
G Guanosine 
Gata-1 GATA-binding factor 1 
GFP Green Fluorescence Protein 
Gm Granulocytic megakaryotic 
GM1 monosialotetrahexosylganglioside 
GMP Granulocyte Macrophage Progenitor 
GPI Glycosil -PhosphatidylInositol 
GPN glycyl-L-phenylalanine-β-naphthylamide 
GSC germ line stem cells 
h Hours 
H2B-GFP Histone 2B Green Fluorescence Protein 
H2O water 
Hd Homeodomain 
HE High efficiency 
HEK293T Human Embryonic Kidney 293 T 
HeLa HenriettaLacks 
HEPES 2-(4-(2-Hydroxyethyl)- 1-piperazinyl)-ethansulfonacid 
HLPC High Performance Liquid Chromatography 
HoxA10 HomeoboxA10 
HSC Hematopoietic Stem Cell 
HSPC Hematopoietic Stem and Progenitor Cells 
IFNy Interferon y 
IFNyR Interferon y Receptor 
IL-3 Interleukin-3 
IL-6 Interleukin-6 
IL7Rα Interleukin-7 Receptor alpha 
ISC Intestinal stem cell 
Jak Janus Kinase 
Kb Kilobase 
KSL c-KIT+sca1+Lineage- 
Lamp Lysosomal associated membrane protein 
Laser Light Amplification by Stimulated Emission of Radiation 
LB Lysogenic broth 
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LCCA Liquid culture colony assay 
LED Light Emitting Diode 
Lepr Leptin receptor 
L-Gln L-Glutamine 
LMPP Lymphoid Biased Multipotent Progenitor 
LP Long Path 
LTC-IC Long Term Culture – Initiating Cell 
LT-HSC Long Term-Hematopoietic Stem Cells 
mCherry Monomeric Cherry 
MDKC Madin-Darby Caninie Kindney cells 
MegE Megakaryocytic erythrocytic 
MEP Megakaryocyte Erythrocyte Progenitor 
MgCl2 Magnesiumcloride 
MHCI Major histocompatibility complex I 
MHCII Major histocompatibility complex II 
min minute 
Mito  mitochondria 
mL Milliliter 
mm Millimeter 
mM Millimolar 
MOI Multiplicity of infection 
MPP MultiPotent progenitor 
MPP9 Matrix Metallo Proteases 9 
mTORC1 master growth regulator mTOR complex 1 
N2 Nitrogen 
NaCl Sodiumchloride 
NaN3 Sodium azide 
N-Cad N-Cadherin 
NFAT Nuclear Factor of Activated T-cells 
ng Nanogramm 
NIH3T3 Nationla Institute of Health 3T3 
nm nanometer 
NMuMG Mus Musculus Mammary Gland 
Nup98 Nucleoporin98 
O2 Oxygen 
OD Optical density 
OP9 OsteoProgenitor 9 
P/S Penicillin / Streptomycin 
Par-2 partitioning defective 2 
Par-3 partitioning defective 3 
Par-6 partitioning defective 6 
PBS Phosphate buffered saline 
PBST Phosphate Buffered Saline Tween20 
PCP Planar Cell Polarity 
PCP-Cy5.5 Peridinin-chlorophyll-protein complex-Cyanin5.5 
PCR Polymerase chain reaction 
PE phycorerythrin 
PE-Cy7 Phycoerythrine-Cyanin7 
PEI PolyEthylenImine 
PFA Para-FormAldehyde 
Pins Parter of inscuteable 
PKB Protein Kinase B 
PMT Photo Multiplier Tube 
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png Portable network graphics 
Pol Polymerase 
Prkci Protein kinase C iota (or lambda) 
Prkcz Protein kinase C zeta 
QTFy Quantify 
QTFy single Quantify single 
Rcf Relative centrifugal force 
RNA RiboNucleinAcid 
Rpm Round per minute 
RT Room temperature 
s Second 
Sca-1 Stem cell antigen-1 
SCF Stem cell factor 
Scl Stem Cell Leukemia 
SC-LCCA Single Cell-Liquid Culture Colony Assay 
SFEM Serum free essential medium 
SI SCF/IL3 
SIT SCF/IL3/TGFb1 
SOP Sensory Organ Precursor 
ST SCF/TPO 
STAT Signal Transducer and Activator of Transcription 
ST-HSC Short Term-Hematopoietic Stem Cells 
STT SCF/TPO/TGFb1 
T Thymindine 
TAE Tris-Acetate-EDTA 
Taq Thermus aquaticus 
TAT Timm´s acquisition tool 
TB Terrabyte 
TEM Tetraspanin Enriched Microdomains 
TFEB Transcription Factor EB 
TGFβ1 Transforming growth factor beta 1 
TGFβRI Transforming growth factor beta receptor 1 
TGFβRII Transforming growth factor beta receptor 2 
TPO Thrombopoietin 
tTa tetracycline-regulated transactivator 
TTT Timm´s tracking tool 
U Units 
UV Ultraviolet 
V Voltage 
v/v Volume/volume 
VBA Visual Basic Application 
VSVG Vesicular stomatidis virus glycoprotein 
w/v Weight/volume 
YFP Yellow fluorescent protein 
αMEM α-Minimal Essential Medium 
λ Lambda 
Rag Recombination activating gene 
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